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ABSTRACT 
 
Sorting of Inner Nuclear Membrane- Directed Proteins at the Endoplasmic Reticulum 
Membrane. (December 2005) 
Suraj Saksena, B.S.; M.S. Biochemistry, University of Delhi 
Chair of Advisory Committee: Dr. Max D. Summers 
 
The current “diffusion-retention” model for protein trafficking to the inner nuclear 
membrane (INM) proposes that INM proteins diffuse laterally from the membrane of the 
endoplasmic reticulum into the INM and are then retained in the INM by binding to 
nuclear proteins or DNA. Because some data indicate that the sorting of baculovirus 
envelope proteins to the INM is protein-mediated, we have examined the early stages of 
INM protein integration and sorting using photocrosslinking. Both viral and host INM-
directed proteins were integrated cotranslationally through the endoplasmic reticulum 
translocon, and their nonrandom photocrosslinking to two translocon proteins, Sec61α 
and translocating chain-associated membrane protein (TRAM), revealed that the first 
transmembrane sequence (TMS) of each viral and host INM-directed protein occupied a 
very similar location within the translocon. Because few TMSs of non-INM-directed 
membrane proteins photocrosslink to TRAM, it seems that the INM-directed TMSs 
occupy different sites within the translocon than do non-INM-directed TMSs. The 
distinct proximities of translocon components to INM-directed TMSs strongly suggest 
that such TMSs are recognized and initially sorted within the translocon. 
 iv
Previous work with the envelope protein ODV-E66 (E66) showed that E66 
trafficking to the INM is mediated via an INM sorting signal (Sorting Motif or SM).  In 
this study, using a site-specific crosslinking approach we demonstrate that following ER 
membrane integration, the SM is adjacent to two viral proteins: FP25K & BV/ODV-E26 
(E26). Deletion of FP25K from the viral genome results in the accumulation of E66 at 
the ONM, suggesting that FP25K may facilitate protein movement at the nuclear pore. 
While the role of the E66-E26 interaction remains to be determined, these data suggest 
that E66 trafficking to the INM is a protein-facilitated process. Crosslinking experiments 
using E66 integration intermediates revealed that during co-translational integration at 
the ER, the SM is adjacent to two cellular proteins of ~10kDa and ~25kDa, referred to as 
SMAP 10 (SM associated protein of 10kDa) & SMAP25 respectively. Thus, contrary to 
the widely accepted “diffusion-retention” model for protein trafficking to the INM, our 
data indicate that protein sorting to the INM is a multistep process initiated upon 
membrane integration in which the INM sorting signal sequentially associates with 
various sorting factors. 
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CHAPTER I 
INTRODUCTION 
Protein sorting at the ER membrane1
Nearly all proteins in eukaryotic cells are synthesized by cytosolic ribosomes, but 
many proteins ultimately perform their functions in other locations such as the various 
cellular organelles or, in the case of secreted proteins, outside the cell. Eukaryotic cells 
have developed elaborate mechanisms to ensure the efficient delivery of proteins to their 
final destinations (Barlowe et al., 2003). This process of delivering proteins to their final 
destinations is termed protein trafficking or protein sorting, and often involves the 
translocation of a protein substrate through a membrane bilayer. 
A few fundamental principles control the sorting of soluble and membrane proteins 
in the cell. First, there must be a systematic method to identify the proteins that need to 
be sorted. This information is encoded in the primary structure of the protein and is 
referred to as the sorting signal, which contains the sequence and structural features 
necessary to determine the final intracellular localization of the protein. The sorting 
signal is often found near the amino-terminus of the protein allowing the sorting process 
to begin early in the biosynthetic pathway while the nascent protein is still bound to the 
ribosome (Johnson et al., 1999). Once the information within the sorting signal is 
decoded, a targeting mechanism is required to deliver each protein substrate to its  
 
                                                 
1This dissertation follows the style and format of Cell. 
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final cellular destination or, in the case of membrane proteins, to the appropriate cellular 
membrane. The targeting process often involves specialized molecules in the cytoplasm, 
and unique receptors on the cytoplasmic side of the membrane to ensure accurate 
delivery of substrates.  
The focus of this dissertation is the sorting of inner nuclear membrane (INM)-
directed proteins at the endoplasmic reticulum (ER) membrane. Proteins destined to 
reside in the ER, Golgi, nuclear envelope (outer and inner nuclear membrane) and other 
organelles, as well as secretory proteins are directed first to the ER membrane. The first 
part of this chapter focuses on the fundamental principles of protein translocation across 
and protein integration into the membrane of the ER.  
Targeting of proteins to the ER translocation site. In mammalian cells, ribosomes are 
found in the cytoplasm and at the membrane of the ER. These two classes of ribosomes 
differ in the nature of their translation products, with membrane-bound ribosomes 
engaged in the synthesis of secretory and membrane proteins. Membrane-bound 
ribosomes are identified by the presence of a nascent chain that contains a signal 
sequence at the N-terminus (Fig. 1). As the signal sequence emerges from the ribosome, 
it is recognized and bound by a ribonucleoprotein termed the signal recognition particle 
(SRP) (reviewed in Walter & Johnson, 1994). The binding of SRP induces a slowing or 
temporary halting of the protein-chain elongation process, and the “elongation-arrested 
complex” diffuses to the ER membrane. The ER targeting of the SRP-ribosome complex 
involves a specific interaction between SRP and SRP receptor (SR). The GTP-dependent 
interaction between SRP and its receptor initiates a series of events which includes the 
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binding of the ribosome-nascent chain complex to the translocation and integration 
machinery (translocon) at the ER membrane, release of the signal sequence from SRP, 
release of SRP and SRP receptor from the translocon, and resumption of peptide chain 
(translational) elongation by the ribosome, now engaged with the translocon (Fig. 1).  
The Sec61/SecY complex. In every membrane, a complex of polypeptides associate 
together to form a protein-conducting channel (referred to as the ‘translocon’) that 
mediates protein translocation across the membrane. The proteins that form the 
translocation channel in the membrane of the ER were identified using an elegant 
approach that involved the cotranslational incorporation of photoreactive probes within 
the nascent chain (in the process of translocation or membrane integration).  The 
photoreactive probes directly reported the proteinaceous environment of the substrate, 
and thus allowed the specific identification of ER membrane proteins that were adjacent 
to the nascent chain throughout its translocation or during its integration (Krieg et al., 
1989; Wiedmann et al., 1989; High et al., 1991; Thrift et al., 1991). The information 
obtained from the photocrosslinking experiments was then used by several groups to 
purify the translocon proteins that crosslinked to the nascent chain, reconstitute them 
into proteoliposomes and demonstrate that they were successful in carrying out protein  
translocation and integration (Nicchitta & Blobel, 1990; Gorlich et al., 1992a,b; Gorlich 
& Rapoport, 1993). Using this approach, two protein components of the mammalian 
translocon were identified. The first component, the translocating chain-associated 
membrane protein (TRAM) (Gorlich et al., 1992a), was found to be essential for the 
translocation or integration of most, but not all, proteins (Gorlich & Rapoport, 1993; 
 4
 
 
Figure 1. Translocation across the ER membrane. The ribosome-free translocon pore has an internal 
diameter of 9-15Å, and as shown in the figure is sealed at the lumenal end directly or indirectly by the lumenal chaperone BiP. Once 
the signal sequence emerges from the ribosome, it is bound by SRP resulting in the formation of an SRP-RNC (ribosome nascent 
chain) complex (i) that diffuses in the cytosol. The SRP-RNC complex is targeted to the membrane of the ER via an interaction 
between SRP and the SRP receptor (ii). The interaction results in ribosome binding to the translocon pore and the insertion of the 
nascent chain into the translocation channel. Fluorescence studies have revealed that following targeting to the ER membrane, the 
nascent chain initially remains in an aqueous environment inaccessible to either the cytoplasm or the ER lumen (iv). When the 
nascent chain reaches ~70 residues in length, BiP is released allowing translocation of the nascent chain into the ER lumen (iv). 
Following termination of translation, the secretory protein is released into the ER lumen, BiP seals the lumenal end of the translocon 
pore and the ribosome is released into the cytosol (v). “Reprinted with permission from the Annual Review of Cell and 
Developmental Biology, Volume 15© 1999 by Annual Reviews www.annualreviews.org” 
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Oliver et al., 1995; Voigt et al., 1996). The second component identified using this 
approach was designated Sec61α (Gorlich et al., 1992b) based on its homology with the 
yeast protein, Sec61p. Genetic screens for secretion mutants had previously identified 
and thus implicated Sec61p in the translocation process (Deshaies & Schekman, 1987; 
Stirling et al., 1992). Sec61α was found to purify in a heterotrimeric complex with two 
other polypeptides termed, Sec61β and Sec61γ (Gorlich & Rapoport, 1993). Thus, the 
reconstitution experiments allowed the identification of the core components of the 
translocon, which include the heterotrimeric Sec61 complex and TRAM.  
Identification of the core components of the mammalian translocon raised two 
important issues. First, which translocon component lines the protein-conducting 
channel? Second, what is the driving force for protein translocation at the ER 
membrane? Photocrosslinking experiments revealed that substrates with probes at 
different positions predicted to be within the membrane could be crosslinked to the α 
subunit of the Sec61 complex (High et al., 1993; Mothes et al., 1994), but not to other 
membrane proteins. Since, the α subunit was the primary crosslinking target within the 
pore, the photocrosslinking experiments suggested that the walls of the channel are 
formed by the α-helices of Sec61α. This result was consistent with the observation that 
some of the Sec61α transmembrane segments have limited hydrophobicity (Wilkinson et 
al., 1996).  
Translocon-associated partners power the translocation process, and depending on 
the partner, the channel can function in three different translocation modes. During 
cotranslational translocation, the ribosome serves as the major channel partner. 
 6
Following SRP-mediated targeting to the ER membrane, the signal sequence is released 
from SRP and the ribosome-nascent chain complex binds to the protein-conducting 
channel formed by the heterotrimeric Sec61 complex (Fig. 2). Once docked at the 
translocon, the ribosome resumes protein synthesis, and the energy of translation (GTP 
hydrolysis) powers the movement of the nascent polypeptide chain into the translocation 
channel.  
Both eukaryotes and yeast have a second mode of translocation at the ER membrane, 
in which substrate translocation is initiated following the termination of translation 
(posttranslational translocation). Proteins that use this mode generally have a signal 
sequence whose hydrophobicity is not sufficient to elicit an interaction with cytoplasmic 
SRP (Ng et al., 1996). Posttranslational translocation has been reconstituted in 
proteoliposomes containing Sec61p, Sbh1p and Sss1p (the yeast homologs of Sec61α, 
Sec61β, and Sec61γ), in addition to the tetrameric Sec62/63 complex and the lumenal 
chaperone BiP (Panzner et al., 1995; Rapoport et al., 1996). In yeast, the tetrameric 
Sec62/63 complex contains two essential proteins Sec62p and Sec63p, and two 
nonessential components Sec71p and Sec72p. Mammalian cells lack the proteins Sec71p 
and Sec72p but contain Sec62p and Sec63p (Meyer et al., 2000; Tyedmers et al., 2000). 
Photocrosslinking experiments have revealed that the protein-conducting channel in 
the posttranslational translocon is formed, at least in part, by Sec61p (Musch et al., 1992; 
Sanders et al., 1992) and the other four membrane proteins have been suggested to be 
involved in other pathway-specific roles (Rapoport et al., 1996). 
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Figure 2. Cotranslational translocation of a secretory protein. (1-2) During the course of 
secretory protein synthesis, as the signal sequence emerges from the ribosome, it is bound by cytosolic 
SRP that also makes contacts with the ribosome (large subunit, light blue; small subunit, pink). The 
binding of SRP induces a temporary translational-elongation arrest and the SRP-RNC complex diffuses in 
the cytosol. The targeting of the SRP-RNC complex to the ER membrane is achieved via an interaction 
between SRP and SRP receptor (3). The interaction results in a series of events at the ER membrane, 
including release of SRP from the signal sequence, and the docking of the RNC complex at the translocon 
pore (4). The release of SRP relieves the elongation arrest, and the energy of translation drives the 
cotranslational translocation of the nascent chain into the lumen of the ER (5). Following termination of 
translation, the secretory protein is released into the ER lumen and the ribosome is released into the 
cytosol. “Reprinted with permission from the Annual Review of Cell and Developmental Biology, Volume 
21© 2005 by Annual Reviews www.annualreviews.org” 
 8
Soluble Kar2p, the yeast homolog of mammalian BiP, is a member of the Hsp70 
family that is localized at the posttranslational translocon via interactions with the J-
domain of Sec63p (Brodsky & Schekman, 1993; Corsi & Schekman, 1997). A ratcheting 
mechanism is thought to provide the driving force for posttranslational translocation 
(Matlack et al., 1999). In this model, the interaction of ATP-bound BiP with the J-
domain of Sec63p results in rapid ATP hydrolysis and the closure of the peptide binding 
cleft around the incoming polypeptide chain (Fig. 3), which prevents “back-sliding” and 
results in forward translocation. Once the polypeptide has moved a sufficient distance 
into the ER lumen, another BiP molecule binds to it, and this process is repeated until 
the polypeptide chain has completely traversed the channel. The exchange of ADP for 
ATP results in an opening of the peptide-binding pocket and the release of BiP from the 
polypeptide chain. 
The third mode of translocation that is used by most secretory proteins in eubacteria 
occurs posttranslationally (reviewed in Mori & Ito, 2001), and is thought to involve the 
cytosolic ATPase, SecA. In this model, cytosolic SecA binds a polypeptide substrate 
with an N-terminal signal sequence, and the complex is targeted to the bacterial inner 
membrane via interactions between SecA and the translocon component, SecY (bacterial 
homolog of Sec61α) Fig. 4). Following targeting, the polypeptide substrate inserts as a 
loop into the channel. The SecA polypeptide-binding groove opens, moves away from 
the channel, binds to the next section of the polypeptide chain and closes around it. The 
polypeptide-binding groove again moves towards the channel and pushes the 
polypeptide segment into the channel. These steps are repeated until the polypeptide  
 9
 
 
Figure 3. Posttranslational translocation in eukaryotes. (1) After synthesis in the cytosol, a 
posttranslational translocation substrate is kept in an unfolded, translocation-competent state by 
interactions with cytosolic chaperones. (2) The chaperone-bound substrate is targeted to the 
posttranslational translocon, comprised of the Sec61 complex, and the Sec62/63 complex via its signal 
sequence. The J-domain of Sec63 stimulates ATP hydrolysis by BiP, and the BiP-ADP complex binds to 
the polypeptide chain emerging into the ER lumen. (3) As the polypeptide enters the ER lumen, another 
BiP molecule can bind to it, resulting in forward translocation (pulling). (4) This process is repeated until 
the polypeptide chain has completely traversed the channel. (5) The exchange of ADP for ATP results in 
an opening of the peptide-binding pocket and the release of BiP from the polypeptide chain. “Reprinted 
with permission from the Annual Review of Cell and Developmental Biology, Volume 21© 2005 by 
Annual Reviews www.annualreviews.org” 
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chain is fully translocated across the membrane (Economou & Wickner, 1994). 
Although the current data suggests that SecA-mediated translocation is processive (Joly 
& Wickner, 1993; Schiebel et al., 1991), a nonprocessive mechanism that involves the 
occasional disengagement of SecA cannot be ruled out.  
 
 
 
 
Figure 4. SecA-mediated posttranslational translocation in eubacteria. (1) Cytosolic 
SecA binds to a polypeptide substrate bearing an N-terminal signal sequence, and the complex is targeted 
to the SecY translocon (2). Following targeting to the translocon, the polypeptide-binding groove in SecA 
opens, moves away from the channel (3), and binds to the next section of the incoming polypeptide chain 
(4). The polypeptide-binding domains move towards the channel, pushing the polypeptide segment into 
the SecY channel (5). Steps (3)-(5) are repeated until the polypeptide chain is fully translocated across the 
membrane (not shown). “Reprinted with permission from the Annual Review of Cell and Developmental 
Biology, Volume 21© 2005 by Annual Reviews www.annualreviews.org” 
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Translocon composition and structure. The largest subunit of the heterotrimeric 
Sec61/SecY complex is the α-subunit, termed Sec61α in mammals, Sec61p in 
Saccharomyces cerevisiae, and SecY in eubacteria and archaea (reviewed in Rapoport et 
al., 1996). The α-subunit has ten membrane-spanning domains and orients in the 
membrane with its N- and C-termini in the cytosol. The β-subunit is termed Sec61β in 
mammals, Sbh1p in S. cerevisiae, SecG in eubacteria and Secβ in archaea. The γ-subunit 
is termed Sec61γ in mammals, Sss1p in S. cerevisiae, and SecE in eubacteria and 
archaea.  
Fluorescence lifetimes and collisional quenching studies have revealed that the 
protein-conducting channel has a hydrophilic interior (Crowley et al., 1994) that spans 
the entire membrane. The translocon pore is flexible, as indicated by its ability to 
translocate proteins containing bulky chemical moieties linked to amino acid side chains 
(Kurzchalia et al., 1988) or a disulfide-bonded peptide loop of 13 residues in a secretory 
protein (Tani et al., 1990). During the integration of membrane proteins, the channel 
allows lateral movement (partitioning) of the TMSs from the aqueous pore into the 
hydrophobic lipid bilayer. The ability of the protein-conducting channel to open in two 
directions, across the membrane (for forward translocation) and laterally within the 
membrane (for lateral exit of transmembrane segments) is not seen in other membrane 
channels. 
The first image (view) of the channel came from freeze-fracture electron microscopy 
(EM) and subsequent cryo-EM studies of proteoliposomes reconstituted from purified 
and ribosome-associated Sec61 complexes. The translocon appeared to be an irregular 
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ovoid disc ~100Å wide and 50-60 Å high with an extensive lumenal projection and a 
large central pore (Hanein et al., 1996; Menetret et al., 2000; Beckmann et al., 2001; 
Morgan et al., 2002). The size of the protein-conducting pore was consistent with the 
estimates derived from fluorescence-quenching studies (Hamman et al., 1997), and 
suggested that the translocon is formed from either three or four copies of the 
Sec61/SecY complex. Freeze fracture EM of the reconstituted proteoliposomes also 
revealed that the assembly of the Sec61- oligomeric structures is a regulated process. For 
instance, the number of oligomeric structures observed were higher when ribosomes 
were bound or when the Sec62/63 complex was co-reconstituted with Sec61 (Hanein et 
al., 1996), indicating that the binding of channel partners induces the formation of Sec61 
oligomers.  
A recent high-resolution (3.2 Å) structure of the SecY complex from the archaea, 
Methanococcus jannaschii revealed a 45-50 Å cuboidal structure with a central 5-8 Å 
pore (van den Berg et al., 2004). The α- subunit consists of two domains, TM1-5 
(shaded blue in Fig. 5) and TM6-10 (shaded red in Fig. 5) that are clamped together by 
the essential γ-subunit which extends one TMS across the interface of the two domains 
and has an N-terminal amphipathic helix that lies flat on the surface of the cytoplasmic 
face of the membrane. The β-subunit contains a single TMS and makes limited contact 
with the α- subunit, which is consistent with its being non-essential.  
The ten helices of the α- subunit surround a large water-filled cavity that has the 
shape of a funnel. The cavity is open on the cytoplasmic side and extends halfway across 
the plane of the membrane. The helices on the extracellular side of the membrane form a  
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Figure 5. X-ray structure of the M. jannaschii SecY complex. (a) A view of the SecY complex 
from the cytoplasm. The two domains of the α subunit, the N-terminal domain (TM1-5) and the C-terminal domain (TM6-10) are 
depicted in blue and red respectively. The translocon pore is shown in its gated/closed state via the action of the ‘plug’ (TM2a), 
depicted in yellow.  The β and γ subunits of the complex are depicted in white. (b) The interior of the translocon pore as revealed by 
slicing through the middle of the SecY complex. “Reprinted from Trends in Cell Biology, 14, Rapoport et al., Membrane protein 
integration and the role of the translocation channel, Page: 570, © 2005, with permission from Elsevier”. 
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similar cavity, with the two cavities meeting in the center of the structure to form an 
“hourglass” structure (Fig. 5). A ring of six hydrophobic residues (mostly isoleucines) 
forms the constriction in the center of the membrane bilayer where the two aqueous 
(funnel- shaped) cavities meet. An additional short helix on the extracellular side that 
extends halfway through the membrane has been termed as the ‘plug’, which fills the 
center of the cavity. Upon engagement of the translocon by binding of both a ribosome 
and a signal sequence (or a TMS), the plug probably moves into a cavity on the 
extracellular side of the channel, resulting in pore opening (illustrated in Fig. 5B). This 
idea of pore opening as a result of plug movement is consistent with crosslinking 
experiments showing that residues in the plug helix can be crosslinked to the γ-subunit 
(Harris et al., 1999). 
Based on the crystal structure of the substrate-free archeal SecYEβ complex (Fig. 5), 
van den Berg et al. (2004) proposed that the translocon contains only a single 
heterotrimer. In addition, the authors also proposed that the pore residues could fit like a 
gasket around the translocating polypeptide and thus function in maintaining the 
membrane permeability barrier during cotranslational translocation. This model is 
different from the proposals derived from fluorescence studies in which the ribosome on 
the cytoplasmic side of the membrane, and BiP on the lumenal side of the membrane 
maintain the permeability barrier during cotranslational translocation. (Crowley et al., 
1994; Hamman et al., 1998).  
One possible explanation of this discrepancy as outlined by Woolhead et al. (2004), 
is that in the absence of a preprotein substrate, the archeal SecYEβ complex crystallizes 
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in a closed monomeric conformation. Also, since the crystal structure was resolved using 
detergent-purified SecYEβ complex, it is possible that the purified complex lacks other 
translocon-associated proteins that are an integral part of the active translocon structure. 
Hence, the structure obtained by van den Berg et al. (2004) may reflect the conformation 
of an individual SecY (mammalian Sec61α) complex prior to its association with other 
proteins, such as TRAM, TRAP, OST, Signal Peptidase (SP) etc. (discussed below) to 
form a translocation-competent, multimeric translocon.  
Although the core translocation machinery consists of only Sec61αβγ, SRP and SR 
(Gorlich & Rapoport, 1993), fluorescence resonance energy transfer (FRET) studies 
aimed at probing the relative proximities of endogenously expressed translocon 
components in cells have shown that functional translocons contain multiple Sec61 
heterotrimers and other translocon-associated proteins (Snapp et al., 2004). The 
translocon-associated proteins include the signal peptidase (SP), responsible for 
removing the signal sequence; the oligosaccharyl transferase (OST) complex, 
responsible for protein glycosylation; TRAM, involved in facilitating translocation 
(Gorlich et al., 1992; Gorlich & Rapoport, 1993; Hegde et al., 1998b), formation of the 
ribosome-translocon junction (Voigt et al., 1996; Hegde et al., 1998a,c) and membrane 
integration of TMSs (High et al., 1993; Martoglio et al., 1995; Do et al., 1996); and the 
translocon-associated protein (TRAP), which influences nascent chain orientation and 
facilitates initiation of post-targeting translocation (Fons et al., 2003).  
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The nuclear envelope and proteins of the INM: General features 
In eukaryotic cells, the nucleus is separated from the cytoplasm by the nuclear 
envelope (NE). The NE is composed of three parts: the nuclear lamina, the nuclear pore 
complexes and the nuclear membranes (inner, outer and pore) (Fig. 6). The inner and 
outer membranes are separated by a narrow lumen (perinuclear space) and join 
periodically at the pore membrane where nuclear pore complexes (NPCs) are inserted. 
NPCs are large proteinaceous structures spanning the outer and inner nuclear membrane 
to form aqueous, gated channels that allow diffusion of small molecules and ions and the 
active transport of macromolecules. 
The outer nuclear membrane (ONM) is directly continuous with and similar in 
composition to the endoplasmic reticulum (ER) membrane, whereas the nuclear lamina 
is linked to the inner nuclear membrane (INM) by integral proteins. The lamina is a 
fibrous meshwork of intermediate filament proteins called lamins (types A and B) that 
polymerize to form 10nm-diameter filaments (Aebi et al., 1986; Fisher et al., 1986; 
McKeon et al., 1986). Chromatin, the lamina, NPCs and proteins of the INM form a 
network of interactions responsible for nuclear and NE stability. 
Although a recent proteomics analysis suggests that as many as eighty 
transmembrane proteins are localized to the INM (Schirmer et al., 2003), only a few 
have been characterized in detail. These proteins include the lamin B receptor (LBR), the 
lamina-associated polypeptide-1 (LAP1), the lamina-associated polypeptide-2 (LAP2), 
emerin, MAN1 (reviewed in Worman & Courvalin, 2000), Luma (Dreger et al., 2001),  
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Figure 6. Cross-sectional view of the nuclear envelope showing its three main 
components. This figure was downloaded from the University of Miami website. 
 
UNC-84 (Malone et al., 1999; Lee et al., 2002), and nesprins (Zhang, 2001). Other 
proteins including the IP3/IP4 receptors (reviewed in Rogue & Malviya, 1999), and the 
multifunctional protein Ire1 (Sidrauski & Walter, 1997) are also thought to localize in 
the INM, although definitive morphological evidence supporting an exclusively inner 
membrane localization of these proteins is lacking.  
The common feature found in all these INM proteins is direct or indirect attachment 
to nuclear structures, such as the underlying nuclear lamina and/or chromatin, as 
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indicated by either resistance to detergent extraction or slow fluorescence recovery after 
photobleaching (FRAP) (Ellenberg et al., 1997; Rolls et al., 1999; Dreger et al., 2001). 
The only sequence or structural features shared by the proteins of the INM is an N-
terminal nucleoplasmic domain of >200 amino acids found in LBR, LAP1 and 2, MAN1 
and emerin, and a short stretch of sequence similarity within this domain in LAP2, 
emerin and MAN1 {LEM domain} (Laguri et al., 2001). Finally, four INM proteins 
(LAP1, LAP2, MAN1 and emerin) possess coiled-coil motifs (Martin et al., 1995), 
which may be involved in formation of homo- or hetero- oligomeric structures in vivo. 
A recent revolution occurred in the field of muscle pathophysiology when mutations 
in nuclear envelope proteins were shown to cause muscular dystrophy and 
cardiomyopathy (Worman & Courvalin, 2005; Gruenbaum et al., 2003; Bione et al., 
1994; Bonne et al., 1999). Human LBR (615 residues) has an amino-terminal 
nucleoplasmic domain of ~210 amino acids and a hydrophobic domain consisting of 
eight membrane spanning segments. The hydrophobic domain of LBR exhibits high 
sequence similarity to sterol reductases in yeast, plants and mammals (Holmer et al., 
1998; Schuler et al., 1994). Mutations in LBR cause Pelger-Huet anomaly, an autosomal 
dominantly inherited condition characterized by incomplete segmentation of granulocyte 
nuclei (Hoffmann et al., 2002). A homozygous LBR mutation was also found in a case 
of HEM/Greenberg skeletal dysplasia (Waterham et al., 2003). Patients suffering from 
this ailment exhibit skeletal dysplasia, short-limbed dwarfism, and notable bone 
calcification and cartilage disorganization. Cultured skin fibroblasts derived from these 
patients also exhibit elevated levels of cholesterol precursors, consistent with the 
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deficiency of the cholesterol biosynthetic enzyme 3-β-hydroxysterol delta (14)-reductase 
(Waterham et al, 2003). Thus most of the clinical manifestations of mutations in LBR 
are consistent with its known associations with nuclear structures such as lamins, 
chromatin, and its sequence similarity with sterol reductases.  
Loss of function mutations in MAN1 have been implicated in a number of diseases 
including Osteopoikilosis (skeletal dysplasia), Buschke-Ollendorff syndrome, and 
Melorheostosis (muscle atrophy and skin lesions) (Hellemans et al., 2004). Similarly, 
mutations in the gene coding for emerin have been implicated in an X-linked form of 
muscular dystrophy characterized by a slow and progressive wasting of the muscles, and 
cardiomyopathy termed Emery-Dreifuss muscular dystrophy (Bione et al., 1994). 
Although, the pathophysiological mechanisms of how mutations in proteins of the 
INM cause different diseases remains unknown, two hypotheses have been proposed (as 
reviewed in Muchir & Worman, 2004). According to the “mechanical stress” hypothesis, 
abnormalities in nuclear structure (either due to mutations in INM proteins or lamins) 
lead to increased susceptibility to cellular damage by physical strain. The “gene 
expression” hypothesis on the other hand is based on the interaction between the nuclear 
envelope and chromatin. Genetic and cell biological experiments have suggested that the 
coupling of chromatin domains to the nuclear envelope results in their transcriptional 
inactivation (Andrulis et al., 1998), implying that the INM serves to concentrate 
transcriptional silencers or chromatin-remodelling factors. Thus, the “gene expression” 
model proposes that mutations in lamins and associated proteins alter the interaction 
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between chromatin and the nuclear envelope, which regulates tissue-specific gene 
expression. 
Protein targeting to the INM 
The use of highly sensitive protein-imaging and detection methods has greatly 
enhanced our understanding of nuclear envelope dynamics (envelope disassembly and 
assembly) during the cell cycle (Ellenberg et al., 1997; Lee et al., 2000; Lenart & 
Ellenberg, 2003). However, interphase protein sorting to the INM poses a unique 
challenge since proteins of the INM are immobilized at their final destination, making 
intermediates in the trafficking pathway difficult to discern or visualize. Despite these 
challenges, a number of groups have used a range of innovative approaches to define the 
important features of the pathway (discussed below). 
Although the physio-chemical properties of the nuclear membranes have not been 
directly determined, studies using intact nuclei and nuclei lacking large pieces of the 
ONM have suggested that the inner and outer membranes have essentially the same lipid 
mobility and lipid composition (Schindler et al., 1985). In addition, a structural 
relatedness between the NE and the ER membrane has been suggested by observations 
that NE assembly in Xenopus extracts involves ‘rough’ vesicles and tubular 
intermediates, which bear morphological resemblance to the ER cisternae (Wiese et al., 
1997; Dreier & Rapoport, 2000). These observations suggest that the NE can be thought 
of as a specialized domain of the ER. 
Integral membrane proteins of the INM can diffuse freely between the ER and the 
interconnected inner, pore and outer nuclear membranes (Ellenberg et al., 1997; Ostlund 
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et al., 1999). Although, the ER and the NE represent a continuum, the proteins of the 
INM and the pore membrane do not ‘leak’ to the ONM or the peripheral ER and remain 
stably localized in the corresponding territories (reviewed in Gant & Wilson, 1997). This 
is believed to be a result of the difference in mobility of the INM proteins localized in 
the ER versus the INM. FRAP studies on the well-characterized INM proteins such as 
LBR, emerin and MAN1 have shown that these proteins freely diffuse laterally in the ER 
membrane, where they are synthesized (Ellenberg et al., 1997; Ostlund et al., 1999; Wu 
et al., 2002). However, their diffusional mobilities are significantly reduced in the INM. 
Protein retention at the INM is believed to be the result of protein-protein interactions 
either between the nucleoplasmic domains of these proteins and other nuclear structures 
(chromatin, lamins etc.) or between transmembrane segments in the plane of the 
membrane. Consistent with this notion, the major nuclear envelope targeting domain of 
most INM proteins has been found to contain lamin- and/or chromatin- binding 
determinants. For example, the nucleoplasmic domain of the well-characterized INM 
protein, lamin B receptor (LBR), which confers INM retention (Soullam & Worman, 
1993, 1995; Ellenberg et al., 1997), binds to B-type lamins (Worman et al., 1988; Ye & 
Worman, 1994), DNA (Ye & Worman, 1994), chromatin (Pyrpasopoulou et al., 1996) 
and HP-1, a chromatin-binding protein (Ye and Worman, 1996). The transmembrane 
domain of LBR (Smith & Blobel, 1993) and nurim (Rolls et al., 1999) are also involved 
in INM retention possibly via interactions with transmembrane segments of other 
resident proteins. As seen with LBR, the major nuclear envelope targeting domain of 
LAP2 contains a lamin-binding site (Furukawa et al., 1998).  
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The results of a number of studies are consistent with a “diffusion-retention” model 
for the targeting of integral membrane proteins to the INM (Worman & Courvalin, 
2000). The model proposes that proteins synthesized on the rough ER with cytoplasmic 
domains less than ~60kDa appear to travel through the continuous outer nuclear 
membrane and enter into the INM by diffusion through the pore membrane. It is 
believed that once the proteins arrive at the INM, they are retained there by binding to 
nuclear ligands or via interactions with the transmembrane segments of other resident 
proteins. Integral membrane proteins with cytoplasmic domains in excess of 60kDa are 
excluded from the INM because of steric constraints imposed by the lateral channels of 
the nuclear pore complexes. On the other hand, integral proteins with nucleo-
cytoplasmic domains less than 60kDa that do not bind to nuclear ligands (lamins, 
chromatin), cytoplasmic structures or endoplasmic reticulum proteins such as the KDEL 
receptor (involved in protein retention at the ER) ultimately enter the secretory pathway. 
In support of this model, most integral membrane proteins of the INM have 
nucleoplasmic domains less that 60kDa, consistent with the size constraints imposed by 
the 10nm lateral channels of the nuclear pore complex (Hinshaw et al., 1992) and FRAP 
analysis shows that INM proteins are freely mobile in the ER membrane and 
immobilized at the INM (Ellenberg et al., 1997; Ostlund et al., 1999; Wu et al., 2002).  
An alternate mechanism to explain the transit of integral proteins to the INM involves 
periodic fusion of the INM and ONM to provide transient connections to allow 
diffusional exchange of protein between the two membranes. However, a recent study 
demonstrated that protein accumulation at the INM is inhibited by antibodies specific for 
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the nuclear pore protein, gp210, and to a significant, albeit lesser, degree by the lectin 
WGA that is known to block the central channel of the nuclear pore complex (Ohba et 
al., 2004).  The results of Ohba et al. (2004) indicate that the antibodies and lectin act by 
sterically occluding protein movement to the INM. Although the authors note the 
possibility that the antibodies and the lectin could induce conformational changes in the 
NPC, which indirectly affect protein channels that allow integral proteins to pass around 
the pore membrane, these data provide strong evidence that as proposed by the 
“diffusion-retention” model, the nuclear pore membrane is the conduit for movement of 
integral membrane proteins from the ONM to the INM. In the same report the authors 
also reported that the movement of a reporter protein to the INM was completely 
inhibited by ATP depletion, and also by cooling cells to 20°C. Although these results 
suggested that membrane-fusion may be involved in the movement of integral 
membrane proteins to the INM, pretreatment of cells with inhibitors of vesicular 
trafficking that block fusion between cytosolic membrane surfaces was found to have no 
significant effect on reporter movement to the INM. These data argue against the 
membrane fusion model and strongly suggest that the nuclear pore membrane is 
involved in protein transport to the INM. 
Diffusion-retention: Exceptions to the rule? 
Although the results of many studies are consistent with the “diffusion-retention” 
model (described above), a number of observations suggest that protein transport to the 
INM may be regulated by something more complex than passive diffusion and retention.  
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The model predicts that specific interactions with other proteins or chromatin result in 
protein immobilization at the NPC or the INM, respectively. Consequently, one would 
expect pore membrane proteins lacking their protein-interaction domain to diffuse in the 
ER and ultimately enter the secretory pathway. However, POM121 [1-129]-GFP which 
lacks signal(s) for targeting to the NPC, was found to distribute exclusively in the ER-
nuclear membrane system and was absent from the Golgi, annulate lamellae (AL) or 
plasma membrane (Imreh et al., 2003). Using experiments blocking retrograde vesicular 
transport from the Golgi to the ER as well as fluorescence loss in photobleaching (FLIP) 
experiments, the authors also demonstrated that POM121 [1-129]-GFP was strictly 
restricted to the ER.  
Studies on proteins of the INM and pore membrane, which were unable to target to 
their proper location either due to excessive overexpression or deletion of their 
targeting/retention domain(s), have shown that the majority of proteins including LBR 
(Smith & Blobel, 1993; Soullam & Worman, 1993; Soullam & Worman, 1995; 
Ellenberg et al., 1997), LAP2 (Furukawa et al., 1995), MAN1 (Lin et al., 2000), and 
nurim (Rolls et al., 1999) distributed in the ER. The only exception was emerin, which, 
when overexpressed, distributed in the INM, ER and the plasma membrane (Ostlund et 
al., 1999). These results suggest the existence of a regulatory mechanism that prevents 
even excess INM proteins from entering the secretory pathway. 
If protein movement from the ER to the interconnected nuclear membranes was 
governed by simple diffusion alone as proposed by the “diffusion-retention” model, one 
would predict INM localization of a substrate (of interest) to be independent of any other 
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protein(s) or putative interacting partner(s). However, a recent report by Murthi et al 
(2005) shows that YIL090W/Ice2p, an integral membrane protein located in the ER, is 
necessary for efficient tethering of Trm1p-II-GFP (tRNA specific m22G 
methyltransferase) to the INM. YIL090W∆ was identified in a genome-wide deletion 
study as being synthetically lethal with kar3∆ (Tong et al., 2004), and Kar3p is known to 
be required for nuclear fusion during mating (Rose et al., 1996). However, YIL090W 
was recently identified as Ice2p, an integral membrane protein with eight transmembrane 
domains. GFP-tagged versions of YIL090W reside in the ER rather than the INM, and 
play an important role in the structure of the cortical ER (Martin et al., 2005). Murthi et 
al (2005) eliminated the possibility that YIL090W∆/ice2∆ disrupts the structure of the 
nuclear membranes by showing that the deletion has no effect on nuclear pore structure. 
Instead they favor the explanation that Ice2p is an ER component that indirectly affects 
the INM tethering of Trm1p-II-GFP perhaps by directing authentic tether(s) to the INM. 
While it remains to be seen whether Ice2p is involved in the tethering of other INM 
proteins, the requirement of Ice2p in the INM-tethering/localization of Trm1p-II-GFP 
indicates the participation of other proteins in this pathway.  
Clearly, there is growing evidence that protein transport to the INM is not 
completely a function of or is not simply defined by simple diffusion in the 
interconnected ER and nuclear membranes. Instead, the INM transport process instead 
appears to be mediated by other proteins that are involved in the active restructuring of 
the NPC to facilitate protein movement across the lateral channels (discussed above). 
Also, the INM transport process exhibits remarkable specificity, contrary to the 
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randomness predicted by simple diffusion in the interconnected membranes. This 
specificity reflects the existence of sorting events mediated by putative INM-sorting 
factors, which confer directionality to protein transport towards the INM and prevent 
random protein distribution.  
Protein transport to the INM: Lessons learned from Baculovirus 
The baculovirus Autographa californica nucleopolyhedrovirus (AcMNPV) is an 
enveloped, double-stranded DNA virus (132kbp), which is distinguished by a unique 
biphasic life cycle in its Lepidopteran host. Infection results in two forms of progeny 
virus, budded virus (BV) and occlusion-derived virus (ODV), which mature at different 
cellular membranes. The proteins of the BV envelope are transported to the cell surface 
where they are incorporated into the viral envelope as the nucleocapsids bud through the 
plasma membrane (Kawamoto et al., 1977; Volkman & Goldsmith, 1985; Fraser et al., 
1986; Adams & McClintock, 1991). In contrast, the strategy employed by the ODV to 
obtain its envelope is unique. The maturation and envelopment of the ODV occurs 
within the nucleoplasm of infected cells. AcMNPV infection is also characterized by the 
appearance of foci of unit membrane structures within the nucleus, which are referred to 
as “microvesicles” based on their small size and vesicle-like appearance (Fraser et al., 
1986). Although there was a suggestion that the intranuclear microvesicles were formed 
as a result of de novo membrane morphogenesis (Stoltz et al., 1973), ultrastructural 
studies revealed that viral infection results in extensive proliferation and invagination 
(into the nucleoplasm) of the INM, raising the possibility that the INM serves as the 
source of the intranuclear microvesicles (Summers et al., 1969; Fraser et al., 1986; Hong 
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et al., 1994). When the ODV-envelope proteins, ODV-E66 (Hong et al., 1994) and 
ODV-E56 (Braunagel et al., 1996), were overexpressed, the protein was detected in the 
intranuclear microvesicles, the viral envelope, the outer and inner nuclear membranes 
and the ER membrane, suggesting that the INM indeed serves as the source of the 
intranuclear microvesicles and the viral envelope. Hence, the envelope proteins of the 
ODV must be transported into the INM prior to incorporation into the viral envelope. 
These proteins therefore constitute excellent substrates for examining the molecular 
mechanisms that mediate protein movement into the INM. 
There are significant similarities between the trafficking of viral ODV-envelope 
proteins and resident proteins of the INM (Fig. 7). Both viral and cellular proteins utilize 
the continuous membranes of the ER and the nuclear envelope (ONM & INM) to traffic 
to the INM, and the budding of the INM to form the intranuclear microvesicles removes 
proteins from the diffusible pool as effectively as retention. However, experimental data 
obtained with the viral envelope protein ODV-E66 (E66) suggests that transport to the 
INM may be regulated by something more complex than passive diffusion and retention. 
As observed with cellular proteins of the INM (LBR, LAP2, MAN1 and nurim), when 
E66 was overexpressed, the protein was found in the ER membrane, ONM and the INM, 
but was not found in the plasma membrane or non-ER cytoplasmic membranes (Hong et 
al., 1997). This result suggests the existence of a sorting event which prevents INM-
directed proteins (viral & cellular) from entering the secretory pathway.  
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Figure 7. Trafficking of E66 to the INM, microvesicles and the ODV envelope. The 
trafficking of E66 to the microvesicles, which are the source of the viral envelope, is similar to the INM 
trafficking of resident INM proteins. The first step involves the cotranslational integration of the protein 
into the membrane of the ER via the translocon. Once integrated into the membrane of the ER, the protein 
diffuses in the continuous membranes of the ER and the ONM. Since the ONM and the INM join 
periodically at the nuclear pore complexes, the protein (E66) uses the lateral channels of the nuclear pore 
complex (pore membrane) to move from the ONM to the INM. Resident proteins of the INM are 
immobilized there by binding to nuclear proteins or DNA, but E66 accumulates in regions of the INM that 
undergo extensive proliferation and invagination (into the nucleoplasm) as a result of viral infection. The 
invaginations of the INM bud/pinch off into the nucleoplasm to produce unit membrane structures 
(vesicle-like in appearance) referred to as microvesicles (MV). The microvesicles fuse together to form the 
envelope of the maturing virus particle within the nucleoplasm of the infected cell.  
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Simple diffusion from the ER to the INM would predict that the INM-trafficking of 
E66 should be independent of the involvement of any other gene products. However, 
when the gene coding for FP25K was deleted from the viral genome, the trafficking of 
E66 during infection appeared to be blocked at the nuclear envelope. E66 was found to 
accumulate in punctate regions associated with the ONM, but was clearly not detected in 
the INM or the intranuclear microvesicles (Rosas-Acosta et al., 2001). The effect of the  
FP25K deletion was E66-specific, since the trafficking of another ODV envelope 
protein, ODV-E25 to the INM and microvesicles was unaffected (Rosas-Acosta et al., 
2001).  
Protein sorting to the ER and post-ER compartments occurs at several levels, 
requires multiple sorting signals and sorting events, and is regulated by protein-protein 
and protein-lipid interactions (Rothman & Wieland, 1996; Gomord et al., 1999; 
Mellman & Warren, 2000). Although it is possible that the continuous membranes of the 
ER, ONM, pore membrane and INM require a less elaborate mechanism of trafficking, it 
is also possible that more than one mechanism exists for protein trafficking from the ER 
to the INM. The diffusion-retention model (Worman & Courvalin, 2000) may describe 
the essential features for some resident INM proteins; however, proteins with large 
cytoplasmic/nucleoplasmic domains may require other factors for movement across the 
10nm lateral channels of the nuclear pore complexes. The viral protein E66 may be an 
example of such a protein since its cytoplasmic domain is at the upper limit (~76kDa) of 
free passage across the lateral channels of the nuclear pore complexes. Taken together, 
these observations suggest that diffusion-retention does not fully describe the trafficking 
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of E66 from the ER to the INM (en route to the microvesicles/ODV envelope). Instead, 
the sorting of E66 to the INM appears to be a regulated process involving the active 
participation of other proteins (sorting factors). 
Identification of the viral INM sorting motif (SM) 
A deletion analysis of E66 revealed that the N-terminal 33 amino acids of E66 are 
sufficient to traffic fusion proteins to the microvesicles and ODV envelope with 
efficiency similar to wild type E66 (Fig. 8, #1 and 2) (Hong et al., 1997). Because of the 
functional ability to direct proteins fused to it to the INM, this sequence has been termed 
an INM- sorting motif (SM). The SM consists of a stretch of 16-18 nonpolar residues 
that form a transmembrane sequence (TMS) and positively charged amino acids that are 
located 5-8 residues from the TMS on the nucleoplasmic or cytoplasmic face of the 
membrane. If the charged amino acids flanking the TMSs are maintained, this INM-
sorting motif sequence can be shortened to 23 amino acids (Fig. 8, # 3). As observed 
with E66, when the SM-fusions are overexpressed, the protein can be detected in the ER 
membrane, and the nuclear membranes (ONM & INM) (Braunagel et al., 2004).  
Since, E66 and SM fusion proteins traffic to the INM, identification of the INM-
sorting signal within E66 raises the issue whether resident proteins of the INM have an 
SM or SM-like sequence. Sequence comparison revealed that known resident proteins of 
the INM also have an SM-like sequence (Fig. 9) (Braunagel et al., 2004), even though 
many are oriented in the opposite direction in the bilayer and are inserted into the bilayer 
by different mechanisms (either via a translocon-mediated process or as C-tail anchored 
proteins {Wattenberg et al., 2001}). Since, some INM proteins are multispanning  
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1. ODV-E66:  MSIVLIIVIVVIFLICFLYLSNSNNKNDANKNNAFIDLNP----- 
 
2. 33-GFP:   MSIVLIIVIVVIFLICFLYLSNSNNKNDANKNNAGAMVSK------ 
 
3. 23-GFP:      MSIVLIIVIVVIFLICFLYLSNSKDPRVPVELM------------ 
 
Figure 8. Sorting motif (SM) sequences. (1) The N-terminal sequences of wild type E66; and 
the sorting motif fusions (2) and (3) are shown. The TMS is highlighted in yellow; the charged amino 
acids are highlighted in red (basic) and blue (acidic); and the GFP sequence is highlighted in green. 
 
 
membrane proteins (nurim, LBR etc.), the comparison was made with the TMS that is 
critical for protein accumulation at the INM (TMS 1 of nurim and LBR). 
The features conserved among the viral (E66) SM sequence and the resident INM 
proteins include the lack of any charged amino acid within the TMS and the presence of 
positively charged amino acids on the cytoplasmic/nucleoplasmic face of the membrane 
within 3 to 8 residues from the TMS. Studies on the viral SM fusion (23 GFP; Fig. 8, # 
3) have shown that the spacing between the charged residues and the end of the TMS 
seems to be critical for protein accumulation at the INM (Braunagel et al., 2004). When 
the spacing was increased to 11 residues, a less intense nuclear rim (indicative of protein 
accumulation at the INM) was observed and more protein was detected in the peripheral 
ER (Fig. 10; Group 2) (for reference the localization of 23 GFP is shown in Fig. 10; 
Group 1). Deletion of the lysine residues and increase in the length of the TMS resulted 
in protein accumulation at the cell surface (Fig. 10; Group 3), and a decrease in the
  
 
Figure 9. Comparison of the E66 SM sequence with cellular INM proteins. The TMS and flanking sequences most likely to influence INM localization are shown. 
Reprinted in accordance with Copyright ©1993-2004 by The National Academy of Sciences of the United States of America, all rights reserved (Braunagel et al., 2004).  
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spacing between the charged residues and the end of the TMS resulted in protein 
distribution throughout the peripheral ER in a manner indistinguishable from the ER-
marker protein, calreticulin (Fig. 10; Group 4). These data indicate that the lysine 
residues within the SM are at or near a functionally important site that influences the 
INM trafficking of the SM fusion. Since, the essential features of the viral (E66) SM are 
conserved within resident INM proteins of mammalian cells, E66 seems to be a relevant 
substrate to examine the sorting of mammalian INM proteins.  
 
 
 
Figure 10. Localization of SM mutants. Clones from each group were transiently expressed in 
Sf9 cells, and a representative Z section is shown. ER was identified using antibodies specific for 
calreticulin and DNA was labeled with the dye DAPI, while the SM-fusion was detected by GFP 
autofluorescence. If two clones are represented within the same group, the results were visually 
indistinguishable. Reprinted with permission from Proc. Natl. Acad. Sci. (Braunagel et al., 2004). 
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Sorting of E66 to the INM: Possible sites of regulation 
Since the SM of E66 is sufficient to direct non-nuclear proteins into the INM when 
only 13 and 2 residues are exposed on the cytoplasmic and lumenal sides, respectively, 
of the INM or ER INM or ER bilayer (Braunagel et al., 2004), SM sorting must be 
mediated by the TMS and/or sequences close to the membrane surface. Now that the 
TMS of E66 has been identified to be critical for sorting to the INM, the stage has been 
set to ask a different type of question: is the key cellular event of TMS integration into 
the ER membrane (the first step in the trafficking of proteins to the INM) subject to 
regulation? In other words: is the ER translocon involved in protein sorting? This is a 
provocative question to ask, considering the multitude of integral membrane proteins 
handled by the translocon. The ER membrane serves as the site of integration not just for 
resident ER membrane proteins, but also for proteins of the nuclear envelope (outer and 
inner nuclear membranes) and the secretory pathway. Following membrane integration, 
these proteins destined for different intracellular locations need to be sorted and 
exported, which involves multiple sorting signals and sorting events. Although, the 
sorting signals and factors involved in the transport of proteins to post-ER compartments 
such as the Golgi, plasma membrane are well characterized (Barlowe et al., 2003), most 
of these sorting events have been found to function at the post-translational level or after 
the full-length protein has been synthesized, released from the ribosome and integrated 
into the membrane bilayer. It is unclear how early in the biosynthesis of the protein 
(substrate) can the sorting process initiate. Can sorting factors associate with the 
substrate cotranslationally while the nascent protein is in the process of membrane 
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integration? Does the translocon ‘know’ or ‘sense’ whether a TMS in the process of 
integration represents a resident ER substrate versus a protein of the INM? 
If sorting indeed could initiate cotranslationally or early in the biosynthesis of the 
substrate, one can envision two scenarios: first, all disengaged (empty) translocons are 
associated with a different set of (relevant) sorting factors (Fig. 11) that makes them 
specialized/dedicated to handle (exclusively) a particular class of substrates (resident 
ER/INM/plasma membrane substrates). This implies that all disengaged (empty) 
translocons are not equal (same in overall protein composition) but instead there are 
different subpopulations of translocon specialized to handle proteins destined for the 
INM, the resident ER membrane proteins, and proteins destined for the cell surface. This 
idea of translocons associated with different interacting protein (partners) was recently 
reported in yeast (Yan & Lennarz, 2005). The second possibility is that all disengaged 
(empty) translocons are equal (same in overall protein composition) but modular in 
nature, implying that the core translocation/integration machinery is the same but is 
subject to the action of regulatory factors (sorting factors) recruited by the core 
machinery in a substrate-dependent manner (Fig. 12). This model predicts a more 
dynamic and active role for the translocon in protein sorting, whereby once engaged, it 
not only ‘senses’ the substrate (resident ER versus INM versus plasma membrane 
protein) in the translocation channel, but also responds via recruiting the appropriate 
sorting factor(s). In short, the difference between the two models is that while the first 
model predicts the pre-existence of specialized translocons, the second model predicts  
 
 
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recognition of ER-retention  
                  signal 
Recognition of ER-export  
              signal
Recognition of INM export     
                signal 
 
Figure 11. The specialized translocon model. For simplicity, three (among numerous) empty translocons 
are depicted in the first row of events. A translocon specialized for handling resident ER membrane proteins is associated with a 
sorting factor (depicted in purple), which is able to recognize the ER-retention signal on resident ER membrane proteins. Thus, a 
cytosolic ribosome in the process of translating a resident ER membrane protein (depicted in red) is targeted to the translocon 
associated with the ER-specific sorting factor (depicted in purple). Following, termination of translation the sorting factor may either 
continue to be proximal to the resident ER membrane protein (as depicted in this figure) or it may hand off the substrate to the next 
sorting factor (not shown) in the pathway. In the same way, the ER membrane has translocons specialized for handling proteins of 
the INM (depicted in yellow) via the association of INM-specific sorting factor(s) (depicted in blue), and translocons specialized for 
handling proteins destined for the plasma membrane (depicted in green) via the association of sorting factor(s) (depicted in orange) 
capable of recognizing the ER-export signal.  
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  Recognition of ER-retention  
                 signal 
 Recognition of INM- export
               signal 
 
Recognition of ER-export 
                 signal 
 
 
Figure 12. The modular translocon model. For simplicity, three (among numerous) engaged 
translocons are depicted in the first row of events. When engaged with a ribosome translating a resident 
ER membrane protein (depicted in red), the translocon is able to recruit an ER-specific sorting factor 
(depicted in purple) from a pool of lumenal sorting factors. Note that although the figure shows the 
different sorting factors to be lumenal, they may be present in the cytosol or both in the lumen and cytosol. 
Following termination of translation, the ER-specific sorting factor may either continue to stay associated 
with the substrate (as shown in the figure) or it may dissociate and hand off the substrate to the next 
sorting factor in the pathway (not shown). Similarly, a translocon engaged with a ribosome translating a 
plasma membrane protein (depicted in green) is able to recruit the ER-export specific sorting factor 
(depicted in orange), while a translocon engaged with an INM protein (depicted in yellow) recruits an 
INM-specific sorting factor (depicted in blue).  
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that translocons become specialized only when engaged with substrate. While it is 
experimentally difficult to test which between the two models is correct, the second 
model (modular translocon) is more likely to represent the physiological operational 
state of the translocon.  
There are a number of parallels to support the modular translocon model. Key 
cellular events such as transcription, splicing, translation and protein degradation are all  
carried out by core machinery subject to the action of regulatory factors. There is 
growing evidence that the stability of the ribosome-translocon junction may be 
physiologically regulated, depending on specific properties of the signal sequence and its 
dependence on translocation-associated factors (TrAFs) such as TRAM, or TRAP 
(Hegde & Lingappa, 1997,1999; Hegde et al., 1998). There is also a body of evidence to 
suggest that the translocon is not merely a passive pore during protein translocation or 
membrane protein integration. Protein-protein interactions have been shown to exist 
between the nascent chain and the translocon during cotranslational membrane protein 
integration (McCormick et al., 2003). However, as proposed by the modular translocon 
model, once engaged by a particular substrate, the translocon needs to recruit the 
appropriate sorting factor(s). How might such events be regulated? It is possible that 
topogenic sequences within the nascent chain are ‘recognized’ /‘sensed’ by the 
translocation machinery to initiate dynamic changes in the translocon.  Several 
experimental results support the existence of such long-range signal transduction 
pathways, where topogenic sequences within the ribosomal tunnel are able to initiate 
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changes in the translocon structure and dynamics (Liao et al., 1997; Hamman et al., 
1998; Woolhead et al., 2004). 
If the modular translocon model, in which the translocon is able to ‘sense’ the 
substrate in the translocation channel to initiate sorting, is accurate, how might such 
substrate ‘sensing’ occur? Although, it is known that there are protein-protein 
interactions between the nascent chain and the translocon during cotranslational 
membrane protein integration (McCormick et al., 2003), a number of interesting issues 
remain unanswered. Does every TMS interact with the same site in the translocon (e.g. a 
particular translocon α helix)? Is it possible that nascent chains move to different sites 
within the translocon depending on their TM sequences? One possible mechanism by 
which the translocon may initiate cotranslational membrane protein sorting is if TMSs of 
INM-directed proteins occupied a (binding) site within the translocon that is different 
from the site ocuupied by the TMS of a resident ER protein. And further, if this binding 
site (exclusive for TMSs of INM-directed proteins) is proximal to the site for association 
of INM-specific sorting factors that function downstream (post-integration) in the 
sorting of proteins to the INM.  
Although, the role of the translocon in the sorting of proteins during cotranslational 
membrane integration remains to be examined, the arguments discussed above certainly 
present a compelling case to test the possibility that protein sorting may begin during 
cotranslational integration into the ER membrane. In other words, is it possible that the 
first step in the trafficking of proteins (E66) to the INM (Fig. 13) may be regulated? 
Also, since preliminary data indicates that the sorting of E66 to the INM is a regulated 
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process involving the active participation of other accessory proteins (sorting factors), 
what is the identity of these accessory proteins? Are there viral proteins that (during 
infection) facilitate the trafficking of E66 from the ER to the ONM and the INM (Fig. 
13)? And more interestingly and importantly, are there any cellular proteins that 
facilitate the trafficking of E66 to the INM? Are these accessory proteins translocon-
associated and what stage of biosynthesis (cotranslational or post-translational) do they 
associate with the substrate? These are some of the issues that will be addressed in this 
study. It is possible that once at the INM, the accumulation of E66 into regions 
(microdomains) of the INM that undergo extensive invagination and proliferation is also 
regulated either by protein-protein or protein-lipid interactions. Also, the budding of the 
INM into microvesicles within the nucleoplasm and protein incorporation into the viral 
envelope may be tightly regulated events as well. However, studies examining these 
steps of the pathway are beyond the scope of this study.  
Nucleocytoplasmic transport 
In contrast, to the trafficking of integral membrane proteins to the nuclear 
membranes (ONM & INM), the movement of soluble cargo between the nucleus and the 
cytoplasm has been characterized in extensive detail. The signals mediating nuclear 
import and export are well characterized, and the proteins involved in the 
nucleocytoplasmic shuttling process have not only been identified but also characterized 
at the structural level.  
Cargoes and signals. In eukaryotic cells, the separation of the nucleus and cytoplasm 
by the nuclear envelope implies that there is rapid and vectorial exchange of  
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Figure 13. Possible sites where the INM trafficking of E
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macromolecules such as proteins and RNAs between the two aqueous compartments. 
Most of these transport processes (pathways) are facilitated by soluble transport factors,  
which are members of the karyopherin β family. Based on the importance of their 
cellular function, human cells contain at least twenty members of this family, while yeast 
contains fourteen members (Mosammaparast et al., 2004).  
The large and diverse repertoire of substrates (cargoes) that need to be moved 
between the nucleus and the cytoplasm raises questions regarding the mechanism of 
karyopherin:cargo recognition. Studies have shown that karyopherins directly bind to 
their cargoes via recognition of a nuclear localization sequence (NLS) for nuclear import 
or a nuclear export sequence (NES) for export (Fried et al., 2003; Weis et al., 2003). 
However, the nuclear transport process does not always involve require direct cargo 
binding by the karyopherins. For some cargoes, karyopherin binding is mediated by 
adaptor proteins, most commonly via the related protein karyopherin α.  
Careful analysis of the well-characterized NLSs from SV40 Large-T antigen and 
nucleoplasmin revealed the essential features of a classical NLS, which consists of one 
or two clusters of basic amino acids separated by a linker (Gorlich et al., 1999). NLSs, 
such as the one found in SV40 Large T-antigen (PKKKRKV), which contains a single 
cluster of basic amino acids, are referred to as monopartite NLSs. In contrast, bipartite 
NLSs such as the NLS of nucleoplasmin (KRPAATKKAGQAKKKK) that contain two 
clusters of basic amino acids are referred to as bipartite NLSs. However, recent studies 
have shown that nuclear import is not regulated by import signals (NLSs) alone. NLS 
activity can be regulated by a number of mechanisms including signal modification or 
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signal masking (Kaffman et al., 1999). In addition, modification of residues proximal to 
the NLS has also been shown to result in altered binding to the adaptor protein, 
karyopherin α (Harreman et al., 2004). 
The karyopherin-mediated nuclear transport process is regulated by the interaction 
between karyopherins and Ran (Fig. 14). Ran cycles between its GDP- and GTP- bound 
states. Cytoplasmic Ran is in the GDP-bound state that is promoted by the cytoplasmic 
Ran GTPase activating protein (RanGAP). In contrast, nuclear Ran is in the GTP-bound 
state that is maintained by the Ran guanine-nucleotide-exchange factor (RanGEF), 
whose nuclear localization is mediated via interactions with chromatin. The resulting 
Ran gradient provides directionality to the nuclear transport process (Weis et al., 2003). 
 Karyopherins that mediate import bind to their cargoes in the cytoplasm via 
recognition of the nuclear localization signal (NLS) (Fig. 14). The nuclear translocation 
of the import complex is mediated via interactions with NPC proteins (nucleoporins). 
Once in the nucleus, the karyopherin: RanGTP complex results in cargo dissociation and 
recycling of karyopherin to the cytoplasm.  Conversely, karyopherins that mediate 
export bind cargo in the nucleus via recognition of a nuclear export signal (NES). 
Karyopherin binding to export cargos occurs co-operatively with RanGTP, which results 
in formation of a karyopherin: cargo: RanGTP ternary complex (Fig. 14) that is 
translocated to the cytoplasm. Thus, Ran regulates both the assembly and the 
disassembly of karyopherin: cargo complexes. 
Karyopherin-α and the basic NLS. Importin α functions as an adaptor that links 
cNLS-containing cargo molecules with the nuclear transporter, importin β. The ternary 
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complex formed in the cytoplasm diffuses to reach the nuclear pore complex, where 
protein-protein interactions between importin β and the nucleoporins facilitate the 
translocation of the ternary complex through the central channel of the NPC (Fig. 15). In 
the nucleus, the binding of the small nuclear GTPase Ran-GTP to importin β triggers the 
dissociation of the ternary complex, resulting in the recycling of importin α to the 
cytoplasm bound to the exportin CAS-Ran-GTP. The export complex is disassembled in 
the cytoplasm by Ran-GAP (GTPase activating protein)-induced hydrolysis of GTP by 
Ran that releases free importin α in the cytoplasm. Ran-GDP and CAS are recycled back 
to the nucleus for further rounds of transport, where Ran-GDP is converted to Ran-GTP 
by the guanine nucleotide exchange factor RCC1. 
Membrane association of importin α. A recent study demonstrated that a significant 
proportion (~50%) of importin α fractionates with Xenopus egg membranes (Hachet et 
al., 2004). The association of importin α with membranes in interphase was shown to be 
independent of any of the previously characterized binding partners of importin α, 
including importin β, CAS and Ran. Interestingly, an importin α mutant that does not 
bind NLS proteins, the ED mutant (Gruss et al., 2001), also associates with membranes 
and apparently functions in NE assembly, indicating that membrane association of 
importin α is independent of substrate-binding as well.  
The localization of importin α to either the membrane or cytosolic fractions 
correlates with post-translational modification of the protein. The soluble form of  
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Figure 14. Overview of some major nuclear transport pathways in eukaryotic cells. 
A) Nuclear import of RanGDP mediated by NTF2. B) Nuclear import of nuclear localization sequence (NLS) cargo mediated by the 
karyopherin-α : importin-β1 heterodimer (abbreviated as Imp-α and Imp-β). C) Nuclear export pathways that mediate recycling of 
importin-β1 and karyopherin-α; the latter requires CAS as an export receptor. D) Nuclear export of nuclear export sequence (NES) 
cargo mediated by Crm1. RanGAP is anchored to the cytoplasmic side of the NPC and RanGEF is shown bound to chromatin. For 
simplicity, the model depicts only the minimal components necessary to form the pretranslocation transport complexes, and post-
translocation intermediates and accessory factors are not shown. Reprinted with permission from Traffic (Pemberton & Paschal, 
2005). 
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Figure 15. The nucleocytoplasmic shuttling of importin α. (i) Importin α (α) forms a 
ternary complex with importin β (β) and cargo (blue circles). (ii) The ternary complex docks at the nuclear 
pore complex (NPC) and (iii) translocates into the nucleus. (iv) Binding of Ran-GTP triggers the 
dissociation of the ternary complex. (v) Importin α binds to the exportin CAS-Ran-GTP complex and is 
exported to the cytoplasm. (vi) Ran-GAP-stimulated hydrolysis of GTP by Ran triggers the dissociation of 
the exportin complex and releases free importin α into the cytoplasm for another transport cycle. 
“Reprinted from Trends in Cell Biology, 14, Goldfarb et al., Importin alpha: a multipurpose nuclear-
transport receptor, Page: 508, © 2005, with permission from Elsevier”. 
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importin α present in the cytosolic fraction was found to be more highly phosphorylated 
than the membrane-bound form, as determined both by mobility change on SDS-PAGE  
and by phosphopeptide mapping (Hachet et al., 2004). The authors proposed that the 
modification-dependent membrane association of importin α in principle allows 
regulation via the action of phosphatases and kinases. Although the membrane-bound 
form of importin α has been suggested to be involved in formation of a closed nuclear 
envelope, it is clear that this form functions in quite a different way than the better 
understood soluble form. 
Structural basis of importin α function. Data from structural analyses and in vitro 
binding studies have provided insights into how importin α binds to and regulates 
interactions with NLS-containing cargoes (Herold et al., 1998; Conti et al., 1998; Fontes 
et al., 2000). These studies have revealed that the NLS-binding pocket on importin α is 
composed of a series of series of armadillo (ARM) repeats, which are related to HEAT 
repeats, the structural building block for the importin β karyopherins (Figs. 16 and 17).  
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Figure 16. Domain structure of importin α. (A). Mouse importin alpha (PDB: 1IQ1) 
(monomer) with the IBB highlighted in blue; major NLS-binding site (ARMs 2-4) highlighted in red; 
minor NLS-binding site (ARMs 7-9) highlighted in yellow. (B). IBB (highlighted in red) masking the 
major-NLS binding site of mouse importin alpha in the absence of cargo. The shading of the different 
functional parts of the mouse importin alpha structure was done using PyMol (DeLano, 2002). 
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A. 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
Figure 17. Modeling of importin α. (A) Mouse importin alpha (PDB: 1EJL) with the SV40 
antigen (shown in blue) bound to the major NLS-binding site (ARMs 2-4) (and highlighted in red). The 
minor NLS-binding site (ARMs 7-9) is highlighted in yellow and the rest of the ARM repeats are 
indicated in green. (B). Binding of a cargo molecule containing a bipartite NLS is depicted using PyMol 
(DeLano, 2002). Yeast importin alpha (PDB: 1EE4) is shown with the c-myc peptide (blue) bound to both 
the major NLS-binding site (highlighted in cyan), and the minor NLS-binding sites (highlighted in 
orange).  
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Importin α has an N-terminal domain that binds to importin β (the IBB) (shaded blue 
in Fig. 16), the central ARM domain that constitutes the cNLS-binding pocket and a C-
terminal region, including the tenth ARM repeat that seems to be important for binding 
to the export receptor CAS/Cse1 (Fig. 16).  
The structure of truncated Saccharomyces cerevisiae importin α (amino acid 
residues 89-530) complexed with a cNLS peptide, provided a detailed picture of how the 
central ARM domain of importin α creates specific binding pockets for cNLS cargo  
 (Conti et al., 1998) (Fig. 17). These structural studies revealed the presence of two 
cNLS-binding sites on importin α (ARM repeats 2-4 and 7-9). Structure of the full-  
length mouse importin α solved in the absence of cargo, showed that the N-terminal IBB 
forms an intramolecular interaction with the cNLS-binding pocket, resulting in masking 
of the cNLS-binding pocket in the absence of cargo (Kobe et al., 1999). These structural  
studies have provided molecular snapshots of the architecture of importin α and its 
interaction with cargo molecules that have greatly advanced our understanding of the 
importin α transport cycle. 
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Specific aims 
Previous studies on ODV envelope proteins suggest that the movement of these 
proteins could be mediated via cytoplasmic membranes and the nuclear envelope (Hong, 
1997). Although this model predicts that ODV envelope proteins are incorporated into 
the ER and transported to the outer and inner nuclear membranes, there have been no 
studies that directly address the first step in the INM-trafficking process of ODV 
envelope proteins i.e. targeting to and integration at the ER membrane. Specifically, do 
viral envelope proteins such as E66 integrate into the ER membrane and diffuse through 
the continuous membranes of the ER and the nuclear envelope in a manner analogous to 
INM proteins? If so, is the putative ER-integration process mediated by interactions of 
the viral envelope protein with components of the Sec61 translocon? Following ER-
integration, what is the mechanism by which these INM-directed proteins are sorted 
away from resident ER proteins or proteins of the secretory pathway? Is the sorting 
process protein-mediated, and if so are these sorting factors translocon associated? The 
research outlined in this proposal will use the viral envelope protein E66 to address these 
questions regarding the sorting of INM-directed proteins at the ER membrane. The 
experimental approach will entail a combination of crosslinking techniques: chemical 
crosslinking as well as site-specific incorporation of photoreactive probes using 
aminoacyl tRNA analogs.  
 
1) Is the membrane targeting of E66 cotranslational and SRP-dependent or 
posttranslational and SRP-independent? Full-length E66 has been observed to 
insert into membranes post-translationally, albeit at low efficiency (Hong et al., 
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1997). Hence, it is necessary to ascertain whether E66 is normally targeted to the 
ER membrane in an SRP-dependent manner and integrated cotranslationally. 
2) To examine the role of the ER translocon in sorting of proteins destined for 
the INM. Since the SM of E66 is sufficient to direct non-nuclear proteins into the 
INM when only 13 and 2 residues are exposed on the cytoplasmic and lumenal 
sides, respectively, of the INM or ER bilayer (Hong et al., 1997), SM sorting must 
be mediated by the TMS and/or sequences close to the membrane surface. In this 
study viral and cellular SM-like sequences will be used to address three issues that 
are critical to our understanding of protein sorting to the INM. First, 
photochemical and chemical crosslinking will be used to detect and identify 
proteins that are located adjacent to, and presumably interact with, nascent INM 
proteins at different stages of integration. Second, to determine whether viral and 
host INM proteins use the same sorting machinery and are sorted in the same way, 
the photoadducts obtained with two host and two viral INM proteins will be 
compared. Third, to ascertain at what point, if any, during integration the SM 
sequence directs INM membrane proteins into a different pathway than that taken 
by proteins destined for other cellular membranes, the photocrosslinking of 
nascent chains directed to either the INM or another membrane will be compared. 
3) Identification of accessory proteins involved in the sorting of E66 to the INM. 
Previous work has shown that the lysine residues within the E66SM are at or near 
a functionally important site that influences the trafficking of the SM fusion 
(Braunagel, 2004). Hence, the proteinaceous environment of the lysine residue(s) 
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within the E66SM will be analyzed using lysine specific chemical crosslinkers to 
identify any accessory proteins (sorting factors) that are able to recognize and 
associate with the E66 SM. Chemical crosslinking experiments will be performed 
using both (insect) Sf9 microsomes as well as virus-infected Sf9 microsomes to 
identify any cellular or viral proteins that are involved in the trafficking/sorting of 
E66 to the INM.  
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CHAPTER II 
MATERIALS AND METHODS 
Constructs used for photocrosslinking experiments 
Cotranslational membrane integration of five different TMSs was analyzed in this 
study using photocrosslinking. To analyze the proteinaceous environment of the TMSs 
from four different sides of the TMS α-helix surface, a single amber codon per mRNA 
was substituted in place of each of four sequential in-frame codons in each mRNA 
examined (Fig. 18). Photoreactive probes were incorporated cotranslationally using the 
modified amber-suppressor tRNA (εANB-Lys-tRNAamb) (Flanagan et al., 2003). 
 
 
E66: M S I V L I I V I V V I F L I C F L Y L S N - -
E25: M W G I V L L I V L L I L F Y L Y W T N A L - -
LBR1:M F G G V P G V F L I M G G L P V F L F L L L –
Nur1:M A P A L L L I P A A L A S F I M A F G T G V –
Lep1:M A N M F A L I L V I A T L V T G I L W C V D -
10    11    12    13
 
 
 
 
 
 
Figure 18. Constructs used for photocrosslinking. The N-terminal sequences of E66 and E25 
are shown with the TMS underlined, as are the N-terminal sequences of the constructs containing the first 
TMS of LBR (LBR1), nurim (Nur1), and Lep (Lep1). In each case, an amber codon was substituted for the 
codon shown at position 10, 11, 12, or 13 (boxed in figure) to position the photoreactive probe at a single 
nascent chain location in each sample.  
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ODV-E66. Two constructs, clone 91 and 92 (pGEM 4z based vector), were available 
in the lab (generated by Matthew Powers; MDS) that contained an amber codon at 
positions 10 and 12, respectively, within the coding region of E66 (sequence confirmed). 
Clone 91: ATG TCT ATC GTA TTG ATT ATT GTC ATA TAG GTA ATA TTT ----- 
                   M      S       I       V       L       I        I      V       I       *       V        I       F ------ 
 
Clone 92: ATG TCT ATC GTA TTG ATT ATT GTC ATA GTT GTA TAG TTT ----- 
                   M      S       I       V       L       I       I       V       I       V      V       *       F ------ 
To generate integration intermediates of E66 that were 70 residues long and 
contained an amber codon at position 10, PCR was performed using clone 91 as the 
template and following set of primers: 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: E66 70mer: 5’ TTGCCGAAAGGCCACTATGC 3’ 
To generate integration intermediates of E66 that were 70 residues long and 
contained an amber codon at position 12, PCR was performed using clone 92 as the 
template and following set of primers: 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: E66 70mer: 5’ TTGCCGAAAGGCCACTATGC 3’ 
Following the PCR reaction, the PCR product was purified using the PCR 
purification kit (Qiagen Catalog # 28106), analyzed by agarose-gel electrophoresis, and 
used as template in an in vitro transcription reaction to generate mRNA encoding E66 
70mer with an amber codon at position 10 or 12.  
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An amber codon was introduced at positions 11 and 13 in E66 using a two-step PCR-
based mutagenesis approach. In the first step, the amber codon was introduced at 
position 11 or 13 using clone 60 (generated by Shawn Williamson; MDS) as the 
template (Fig. 19). The PCR reaction involved the following primers: 
Forward primers: TAG11-E66 and TAG13-E66 
TAG11-E66: 5’ATGTCTATCGTATTGATTATTGTCATAGTTTAGATATTTTT    
                          AATATGTTTTTTGTACC 3’ 
TAG13-E66: 5’ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATAGTT 
                                                       AATATGTTTTTTGTACCTATC 3’ 
Reverse primer: E66 70mer: 5’ TTGCCGAAAGGCCACTATGC 3’ 
Following the PCR reaction, the PCR product was purified using the QIAquick PCR 
purification kit (Qiagen, Catalog # 28106). The purified PCR product was analyzed by 
agarose-gel electrophoresis, and was then used as a template for the second PCR 
reaction. The second PCR reaction involved the following primers: 
Forward primer: SP6 Kozak E66: 5’GATTTAGGTGACACTATAGAGGAAACAG         
                                                      CCACCATGTCTATCGTATTGATTATTG 3’ 
Reverse primer: E66 70mer: 5’ TTGCCGAAAGGCCACTATGC 3’ 
Following the second PCR reaction, the PCR product was purified using the PCR 
purification kit (described above), analyzed by agarose-gel electrophoresis, and used as a 
template in the transcription reaction(s) to generate mRNAs encoding E66 70mer with 
an amber codon at position 11 or 13.  
Cloning information. Clone 48 containing the E66 gene was digested using Bam HI, 
and the ~2.0 kb fragment of E66 was gel purified. The vector pGEM4z was also digested 
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using Bam HI and gel purified. The E66 fragment was then ligated into the cut pGEM4z 
and to generate clone 60.  
 
 5’                   Bam HI                                                                   Bam HI                   3’ 
  SP6 promoter                               E66 insert ~2.0 kb                             T7 promoter 
 
 
Figure 19.  Schematic of clone 60. Clone 60 was generated by ligating the Bam HI digested 
products of clone 48 (containing the E66 gene) and pGEM4z.  
 
ODV-E25. The viral envelope protein gene ODV-E25 (E25) was PCR-amplified 
from the Autographa californica nucleopolyhedrovirus (strain E2) HindIII C fragment 
and cloned into pBluescript II KS (generated by Rebecca Parr; MDS). The E25 gene was 
then subcloned into the in vitro translation competent vector pGEM4z to generate the 
pGEM4z-E25 clone.   
To generate integration intermediates of E25 that were 70 residues long and 
contained an amber codon at position 10, 11, 12, and 13 a two-step PCR based 
mutagenesis approach (as described above for E66) was employed using the pGEM4z-
E25 vector as the template. The first PCR reaction involved the following set of primers: 
a) to generate E25 with an amber codon at position 10:  
Forward primer: ODV-E25TAG10: 5’ ATGTGGGGAATCGTGTTACTTATCGTTTAGCT 
                                                                     CATACTGTTTTATCTTTATTGG 3’ 
Reverse primer: ODV-E25 70mer: 5’ CAATTTATTATCGCCGTGTGC 3’ 
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b) to generate E25 with an amber codon at position 11: 
Forward primer: ODV-E25TAG11: 5’ ATGTGGGGAATCGTGTTACTTATCGTTTTGTAG 
                                                                                  ATACTGTTTTATCTTTATTGGACG 3’ 
Reverse primer: ODV-E25 70mer: 5’ CAATTTATTATCGCCGTGTGC 3’ 
c) to generate E25 with an amber codon at position 12: 
Forward primer: ODV-E25TAG12: 5’ ATGTGGGGAATCGTGTTACTTATCGTTTTGCTC 
                                                                                   TAGCTGTTTTATCTTTATTGGACG 3’ 
Reverse primer: ODV-E25 70mer TAG12: 5’ CAATTTATTATCGCCGTGTG 3’ 
d) to generate E25 with an amber codon at position 13: 
Forward primer: ODV-E25TAG13: 5’ATGTGGGGAATCGTGTTACTTATCGTTTTGCTC 
                                                                                 ATATAGTTTTATCTTTATTGGACGAATGC 3’ 
Reverse primer: ODV-E25 70mer: 5’ CAATTTATTATCGCCGTGTGC 3’ 
Following the PCR reaction, the PCR product was purified using the QIAquick PCR 
purification kit (Qiagen, Catalog # 28106). The purified PCR product was analyzed by 
agarose-gel electrophoresis, and was then used as a template for the second PCR 
reaction. The second PCR reaction involved the following primers: 
Forward primer:  SP6/Kozak ODVE25: 5’GATTTAGGTGACACTATAGAGGAAACAGCC      
ACCATGTGGGGAATCGTGTTACTTATC 3’ 
Reverse primer: ODV-E25 70mer: 5’ CAATTTATTATCGCCGTGTGC 3’ 
Following the second PCR reaction, the PCR product was purified using the PCR 
purification kit (described above), analyzed by agarose-gel electrophoresis, and used as a 
template in the transcription reaction(s) to generate mRNAs encoding E25 70mer with 
an amber codon at position 10, 11, 12 or 13.  
 
 59
Lamin B Receptor (LBR). The lamin B receptor-green fluorescent protein fusion 
clone (LBR-GFP) was kindly provided by J. Ellenberg, and this was used as a template 
to PCR a truncated version of LBR. The LBR1 sequence (generated by Tina Heyman; 
MDS) is: MFGGVPGVFLIMFGLPVFLFLLLMCKQKDPPVATM…..GFP, where the 
second residue (F) corresponds to residue 208 in native LBR, the amino acids added in 
cloning are underlined, and “M…..GFP” at the C-terminus represents the GFP sequence.  
To generate integration intermediates of LBR that were 72 residues long and 
contained an amber codon at position 10, 11, 12, and 13 a two-step PCR based 
mutagenesis approach (as described above for E66 & E25) was employed using the 
LBR-GFP clone as the template. The first PCR reaction involved the following set of 
primers: 
a) to generate LBR with an amber codon at position 10:  
Forward primer: LBR TAG10: 5’ATGTTTGGAGGAGTACCTGGTGTGTTTTAGATCATG 
                                                                          TTTGGCCTGCCTGTG 3’ 
Reverse primer: LBR 72mer: 5’ GTAGGTGGCATCGCCCTCG 3’ 
b) to generate LBR with an amber codon at position 11: 
Forward primer: LBR TAG11: 5’ ATGTTTGGAGGAGTACCTGGTGTGTTTCTCTAGAT 
                                                                           GTTTGGCCTGCCTGTGTTC 3’ 
Reverse primer: LBR 72mer: 5’ GTAGGTGGCATCGCCCTCG 3’ 
c) to generate LBR with an amber codon at position 12: 
Forward primer: LBR TAG12: 5’ ATGTTTGGAGGAGTACCTGGTGTGTTTCTCATCTAG 
                                                             TTTGGCCTGCCTGTGTTCCTC 3’ 
   Reverse primer: LBR 72mer: 5’ GTAGGTGGCATCGCCCTCG 3’ 
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d) to generate LBR with an amber codon at position 13: 
Forward primer: LBR TAG13: 5’ ATGTTTGGAGGAGTACCTGGTGTGTTTCTCATCATG 
                                                                            TAGGGCCTGCCTGTGTTCCTC 3’ 
Reverse primer: LBR 72mer: 5’ GTAGGTGGCATCGCCCTCG 3’ 
Following the PCR reaction, the PCR product was purified using the QIAquick PCR 
purification kit (Qiagen, Catalog # 28106). The purified PCR product was analyzed by 
agarose-gel electrophoresis, and was then used as a template for the second PCR 
reaction. The second PCR reaction involved the following primers: 
Forward primer:  SP6/Kozak LBR: 5’ GATTTAGGTGACACTATAGAGCTTACAGCC 
                                                                                  AGCATGTTCGGAGGAGTACCTGGTGTG 3’ 
Reverse Primer: LBR 72mer: 5’ GTAGGTGGCATCGCCCTCG 3’ 
Following the second PCR reaction, the PCR product was purified using the PCR 
purification kit (described above), analyzed by agarose-gel electrophoresis, and used as a 
template in the transcription reaction(s) to generate mRNAs encoding LBR 72mer with 
an amber codon at position 10, 11, 12 or 13.  
Nurim. The nurim construct used for photocrosslinking studies was generated by 
Matthew Powers (MDS) using the following approach: two complementary sets of 
oligonucleotides were synthesized. Oligonucleotides 1 and 2 contained a 5’XbaI site 
followed by the nurim sequence.  The second set of oligonucleotides contained 
overlapping regions with the first, the sequence of Nurim through amino acid #55 and a 
3’PstI site.  Each set was annealed in equimolar ratios, then the two sets allowed to 
anneal to each other and cloned into pGEM 4Z (Fig. 20). 
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Figure 20. Design of nurim construct. The oligos used for generating the nurim construct 
are shown along with the restriction sites used for cloning into pGEM4Z.  
 
The same technique was used to add amino acids 55 through 92.  The final Nurim 
clone contains a conservative amino acid change at position 17 (L?M). The nurim 
sequence was obtained from Genbank #AF143676 (Rolls et al., 1999).  
To generate integration intermediates of Nurim that were 72 residues long and 
contained an amber codon at position 10, 11, 12, and 13 a two-step PCR based 
mutagenesis approach (as described above for E66 & E25) was employed using the 
pGEM4z-Nurim clone as the template. The first PCR reaction involved the following set 
of primers: 
a) to generate Nurim with an amber codon at position 10:  
Forward primer: Nurim TAG 10: 5’ ATGGCCCCTGCACTGCTCCTGATCCCTTAGGTCC 
                                                                               TCGCCTCTTTCATCATG 3’ 
Reverse primer: Nurim 72mer: 5’ GTGATGGTGATGGTGATGGTGATGGTGATGTAGGG 
                                                                           AGACAAGCTTGCATG 3’ 
b) to generate Nurim with an amber codon at position 11: 
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Forward primer: Nurim TAG 11: 5’ ATGGCCCCTGCACTGCTCCTGATCCCTGCTTAGC 
                                                                               TCGCCTCTTTCATCATGG 3’ 
Reverse primer: Nurim 72mer: 5’ GTGATGGTGATGGTGATGGTGATGGTGATGTAGGG 
                                                                           AGACAAGCTTGCATG 3’ 
c) to generate Nurim with an amber codon at position 12: 
Forward primer: Nurim TAG 12: 5’ ATGGCCCCTGCACTGCTCCTGATCCCTGCTGCCT 
                                                                               AGGTCTCTTTCATCATGGCCTTTG 3’ 
Reverse primer: Nurim 72mer: 5’ GTGATGGTGATGGTGATGGTGATGGTGATGTAGGG 
   AGACAAGCTTGCATG 3’ 
d) to generate Nurim with an amber codon at position 13: 
Forward primer: Nurim TAG 13: 5’ ATGGCCCCTGCACTGCTCCTGATCCCTGCTGCCC 
       TCTAGTCTTTCATCATGGCCTTTGGC 3’ 
Reverse primer: Nurim 72mer: 5’ GTGATGGTGATGGTGATGGTGATGGTGATGTAGGG 
                                                                           AGACAAGCTTGCATG 3’ 
Following the PCR reaction, the PCR product was purified using the QIAquick PCR 
purification kit (Qiagen, Catalog # 28106). The purified PCR product was analyzed by 
agarose-gel electrophoresis, and was then used as a template for the second PCR 
reaction. The second PCR reaction involved the following primers: 
Forward primer:  SP6/Kozak Nurim: 5’ GATTTAGGTGACACTATAGAGGAAACACCC 
                                                                                     ACCATGGCCCCTGCACTGCTC 3’ 
Reverse primer: Nurim 72mer: 5’ GTGATGGTGATGGTGATGGTGATGGTGATGTAGGG 
                                                                           AGACAAGCTTGCATG 3’ 
Following the second PCR reaction, the PCR product was purified using the PCR 
purification kit (described above), analyzed by agarose-gel electrophoresis, and used as a 
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template in the transcription reaction(s) to generate mRNAs encoding nurim 72mer with 
an amber codon at position 10, 11, 12 or 13.  
Leader peptidase 1 (Lep1). A plasmid containing E. coli leader peptidase (signal 
peptidase I) gene (lepB) in vector pGEM 1 was a generous gift of Ingmarie Nilsson 
(Stockholm University, Sweden). 
To generate integration intermediates of Lep1 that were 70 residues long and 
contained an amber codon at position 10, 11, 12, and 13 a two-step PCR based 
mutagenesis approach was employed using the Lep1 clone as the template. The first 
PCR reaction involved the following set of primers: 
a) to generate Lep1 with an amber codon at position 10:  
Forward primer: LepB TAG 10: 5’ ATGGCGAATATGTTTGCCCTGATTCTGTAGATTGC 
     CACACTGGTGACGG 3’ 
Reverse primer: LepB 70mer: 5’ TACCGGAAAAACAGAAGCACC 3’ 
b) to generate Lep1 with an amber codon at position 11: 
Forward primer: LepB TAG 11: 5’ ATGGCGAATATGTTTGCCCTGATTCTGGTGTAGGC 
                                                                             CACACTGGTGACGGGC 3’ 
Reverse primer: LepB 70mer: 5’ TACCGGAAAAACAGAAGCACC 3’ 
c) to generate Lep1 with an amber codon at position 12: 
Forward primer: LepB TAG 12: 5’ ATGGCGAATATGTTTGCCCTGATTCTGGTGATTTA 
     GACACTGGTGACGGGCATTTT 3’ 
Reverse primer: LepB 70mer: 5’ TACCGGAAAAACAGAAGCACC 3’ 
d) to generate Lep1 with an amber codon at position 13: 
Forward primer: LepB TAG 13: 5’ ATGGCGAATATGTTTGCCCTGATTCTGGTGATTGC 
 
 64
            CTAGCTGGTGACGGGCATTTTATG 3’ 
Reverse primer: LepB 70mer: 5’ TACCGGAAAAACAGAAGCACC 3’ 
Following the PCR reaction, the PCR product was purified using the QIAquick PCR 
purification kit (Qiagen, Catalog # 28106). The purified PCR product was analyzed by 
agarose-gel electrophoresis, and was then used as a template for the second PCR 
reaction. The second PCR reaction involved the following primers: 
Forward primer:  SP6/Kozak LepB H1: 5’ GATTTAGGTGACACTATAGAGGAAACAGC 
   CACCATGGAGTTTGCCCTGATTCTGG 3’ 
Reverse primer: LepB 70mer: 5’ TACCGGAAAAACAGAAGCACC 3’ 
Following the second PCR reaction, the PCR product was purified using the PCR 
purification kit (described above), analyzed by agarose-gel electrophoresis, and used as a 
template in the transcription reaction(s) to generate mRNAs encoding Lep1 72mer with 
an amber codon at position 10, 11, 12 or 13.  
SM-C construct used for chemical crosslinking experiments 
 
The SM-C construct was designed by Dr. Sharon C. Braunagel and was constructed 
by Matthew Powers (MDS). Features of the SM-C construct (Figs. 21 & 22) that was 
used for chemical crosslinking experiments are the following: (i) The E66-SM sequence 
(N-terminal 33 amino acids of E66) is fused to a lysine/cysteine free domain of Bcl-2. 
(ii) The encoded protein contains an in frame T7 epitope (MASMTGGQQMG) and the 
histidine tag (at the C-terminus). The two affinity tags can be used either singly or in 
tandem for the detection or purification of any crosslinked complex(es). (iii) Protein 
expression is driven by the SP6 promoter, and the vector backbone is the in vitro  
transcription/translation competent: pGEM4Z.  
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Figure 21. SM-C construct. The basic components of the SM-C construct such as the 
E66SM, T7 epitope, Bcl-2 domain and the His epitope are depicted. The different restriction sites 
available for further manipulation of the construct are also indicated. 
 
 
 
 
MSIVLIIVIVVIFLICFLYLSNSNNKNDANKNNAFIGANAMASMTGGQQMGMLQ
MVAISRVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFR
DGVNWGRIVAFFEFGGVIAAAAHHHHHHH 
 
Figure 22. Features of the SM-C construct. Translation of the SM-C construct (driven by the 
SP6 promoter) yields a 136 residue-polypeptide whose sequence is shown. The E66SM sequence, the T7 
epitope, the lysine/cysteine free domain of Bcl-2, and the histidine epitope have been highlighted in blue, 
yellow, green and red respectively. 
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The integration intermediates used in the crosslinking experiments contained nascent 
chains of the following lengths: 60mer, 74mer, 105mer, 120mer, 130mer and the full-
length (normally terminated) 136mer. These different nascent chain lengths were 
generated in vitro using a PCR-based approach. Using the SM-C construct as the 
template, PCR reactions were conducted using different reverse primers (described 
below) (and the same forward primer) to generate DNA products of varying lengths. The 
corresponding PCR products were used in transcription reactions to generate mRNAs 
encoding the different nascent chain lengths. 
(i) E66SM 60mer  
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: E66SM 60mer: 5’GTGATGGTGATGGTGATGCTAGAAATCGCAAC 
                                                             CATCTG 3’ 
 (ii) E66SM 74mer 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: E66SM 74mer: 5’GTGATGGTGATGGTGATGGGAGAAGTCG                      
                                                             TCGCCGGG 3’ 
(iii) E66SM 105mer 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: E66SM 105mer: 5’ GTGATGATGATGATGATGCTCCTCCACCA 
                                                                 CCGTG 3’ 
(iv) E66SM 120mer 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
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Reverse primer: E66SM 120mer: 5’ GTGATGGTGATGGTGATGAAAGAAGGCCA 
                                                                               CAATCCTC 3’ 
(v) E66SM 130mer 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: E66SM 130mer: 5’ GTGATGGTGATGGTGATGAGCTGCAGCTA 
                                                                               TGACCCC 3’ 
(vi) E66SM 136mer (136-R) 
Forward primer: pGMFW: 5’ CGATTAAGTTGGGTAACGCC 3’ 
Reverse primer: Summers reverse: 5’ GTATGTTGTGTGGAATTGTGAGC 3’ 
Primers used for generating different derivatives of clone 2 
1) To generate the full-length clone 2 initiating at the first methionine residue (Met1) and 
T7-tagged at the C-terminus, the following primers were used: 
Forward primer: SP6/Kozak initial 2-2 start (MSG--): 5’ GATTTAGGTGACACTATAGAG 
 
                                                                    GAAACACCCACCATGTCCGAGGAGGGCGAG 3’ 
                                                                                         
 
Reverse primer: T7/ STOP 2-2: 5' CTAGAATGATATTGCGACCATTTGCAGCATTGATG 
                                                                           AAGACTCCCTCTGTG 3' 
2) To generate the internal derivative of clone 2 (Met130-454) that is T7-tagged at the C-
terminus, the following primers were used: 
Forward primer: SP6/Kozak internal 2-2 start (MLEAL…): 5’GATTTAGGTGACACTATA 
                                                                           GAGGAAACACCCACCATGCTGGAGGCGCTGCCC 3’ 
Reverse primer: T7/ STOP 2-2: 5' CTAGAATGATATTGCGACCATTTGCAGCATTGATG 
                                                                           AAGACTCCCTCTGTG 3' 
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3) To generate the Met310-454 derivative of clone 2 that is T7-tagged at the C-terminus, 
the following primers were used: 
Forward primer: SP6/Kozak 2-2: 5' GATTTAGGTGACACTATAGAGGAAACACCCACC 
                                                                             ATGTGCGCCGCCTGTCC 3' 
Reverse primer: T7/ STOP 2-2: 5' CTAGAATGATATTGCGACCATTTGCAGCATTGATG 
   AAGACTCCCTCTGTG 3' 
4) To generate the Met356-454 derivative of clone 2 that is T7-tagged at the C-terminus, 
the following primers were used: 
Forward primer: 2-2 Start: 5’ GATTTAGGTGACACTATAGAGGAAACACCCACC 
                                                                    ATGCCGCGCCTGCCCAC 3’ 
Reverse primer: T7/ STOP 2-2: 5' CTAGAATGATATTGCGACCATTTGCAGCATTGATG 
                                                             AAGACTCCCTCTGTG 3' 
5) To generate the Met1-309 derivative of clone 2 that is T7-tagged at the C-terminus, the 
following primers were used: 
Forward primer: SP6/Kozak initial 2-2 start (MSG…..): 5’ GATTTAGGTGACACTATAGA 
 
                                                                                GGAAACACCCACCATGTCCGAGGAGGGCGAG 3’ 
Reverse primer: T7 Internal stop/2-2: 5’ CTAGAATGATATTGCGACCATTTGCAGCATG 
ACCCACAGCAGCCGCAG3’ 
6) To generate the Met130-309 derivative of clone 2 that is T7-tagged at the C-terminus, 
the following primers were used: 
Forward primer: SP6/Kozak internal 2-2 start (MLEAL…): 5’ GATTTAGGTGACACTATA 
                                                                           GAGGAAACACCCACCATGCTGGAGGCGCTGCCC 3’ 
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Reverse primer: T7 Internal stop/2-2: 5’ CTAGAATGATATTGCGACCATTTGCAGCATG 
                   ACCCACAGCAGCCGCAG3’ 
Preparation of Lys-tRNAamb
Lys-tRNAamb was prepared by Yiwei Miao and Yuanlong Shao using the protocol 
described below. Using a plasmid encoding the wild-type Escherichia coli (E.coli) lysine 
tRNA gene, site-directed mutagenesis was performed to change the anticodon loop to 
CUA and thus create an amber suppressor tRNA (hereafter termed tRNAamb) that was a 
generous gift from Dr. Greg Beckler (Promega, Madison, WI). PCR was performed to 
amplify the region of the plasmid that contained the T7 promoter sequence and the 
amber-suppressor tRNA gene. A typical PCR reaction contained in 100µl: 1X Ex TaqTM 
polymerase buffer (supplied with Ex TaqTM polymerase from Panvera, Madison, WI), 
1.5mM MgCl2, 200µM dNTPs, 100pmol upstream primer (1035-YM), 100pmol of 
downstream primer (1043-YM), and 2.5 units of Ex TaqTM polymerase. The reaction 
was started with 2 min at 94°C, followed by 30 cycles of denaturation (94°C for 15 s), 
annealing (60°C for 15 s) elongation (72°C for 15 s), followed by a final extension step 
of 10 min at 72°C. Next a 10µl aliquot of the PCR reaction was run on a 1.6% 
agarose/TBE [90mM Tris-borate, 2mM EDTA pH 8.0] gel to confirm the size of the 
desired product. Following purification of the PCR product using the Qiagen PCR 
purification product, the purified product was then in vitro transcribed in a standard 
100µl reaction that contained 80mM HEPES (pH 7.5), 16mM Mg Cl2, 2mM spermidine, 
10mM DTT, 4mM ATP, 4mM CTP, 0.4mM GTP, 4mM UTP, 12µl of the purified PCR 
product, 0.1 units of pyrophosphatase, 2 units of RNasinTM (Promega, Madison, WI) and 
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2.5µl of T7 RNA polymerase (1.35-1.45 A280 units/ml). The reaction was incubated at 
37°C for at least 4 hours. 
An aliquot of the transcription reaction was analyzed on a 1.6% agarose /TBE gel 
and following confirmation of the expected product, the remainder of the sample 
underwent purification by anion exchange chromatography using a Mono Q HR 10/10 
column on an FPLC (Pharmacia). The tRNA was eluted in 10mM NaOAc (pH 4.5), 
5mM MgCl2 using a 115ml linear gradient of NaCl from 480mM to 1M. 
Aminoacylation was performed to determine which fractions were enriched in tRNAamb 
as described previously (Crowley et al., 1983; Johnson et al., 1982; Krieg et al., 1989) 
with the modification that 6mM MgCl2 and no KCl was used. The majority of the tRNA 
eluted near 550mM NaCl and the fractions with the highest functional tRNAamb content 
were aminoacylated with [14C]-Lysine and stored at -80°C until needed (Flanagan et al., 
2003). 
Chemical modification of Lys-tRNAamb
Aminoacylation and purification of E.coli tRNAamb was performed by Yuanlong 
Shao and Yiwei Miao as outlined above and described previously (Flanagan et al., 
2003). The specific activity of an aminoacylated tRNA sample is expressed in pmoles 
Lys/A260 units of tRNA, with pure Lys-tRNAamb having a specific activity near 1600 
pmol Lys/A260 unit tRNA. Chromatographically purified Lys-tRNAamb, usually at a 
specific activity in excess of 1000 pmol Lys/A260 unit was used for the chemical 
modification process along with the N-5-azido-2-nitrobenzoic acid (ANB-NOS; Pierce 
Chemicals). In a typical reaction, ANB-NOS reagent (stored at -20°C) was allowed to 
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come to room temperature in the dark, and 7.5 g of ANB-NOS was added to 1.75 ml of 
dimethylsulfoxide (DMSO; Gold Label, Aldrich Chemicals) for each reaction. Fresh 
solutions of 4M KOH, 4M HOAc, 2M KOAc (pH 5.0), and 500mM potassium 
phosphate (pH 7.0) were also prepared. A 3 dram vial and a 2mm x 7mm stir bar were 
washed with ddH20 and acetone to ensure that they were clean and nuclease-free. The 3 
dram vial was then set in an ice water bath and held in place using a retort stand and 
clamp. The ice water bath was set on top of a stir plate to ensure constant stirring during 
the course of the entire labeling reaction. All of the following steps were performed in 
the dark room illuminated only with red safety lights, the kind used in photographic dark 
rooms. [14C]Lys-tRNAamb (5000pmoles) was added to the vial along with ddH20 and 
0.5M potassium phosphate (pH 7.0) to yield a final concentration of 50mM of the latter 
in a total volume of 750µl. Then 1.75 ml of the ANB-NOS/DMSO solution was added 
and the stirring speed was quickly reset due to the increased volume of the solution. 
Next 15µl of 4M KOH was added, and the reaction was allowed to proceed for only 14 
sec (absolutely no longer than 14 sec) at which point 15µl of 4M HOAc was added along 
with 2.5 ml of 2M KOAc (pH 5.0). The KOH was added to deprotonate the ε-amine 
group of the lysine residue and initiate the nucleophilic attack of the ANB-NOS reagent. 
The HOAc was added to stop the reaction by lowering the pH back to neutral. The 
contents of the 3 dram vial were then transferred to an SW-28 polyallomer centrifuge 
tube and 26 ml of cold 100% EtOH was added to precipitate the tRNA. After a second 
reaction volume was added to the same SW-28 polyallomer centrifuge tube (Beckman 
 
 72
Instruments), the tubes were wrapped in aluminum foil to prevent exposure to light and 
placed at -20°C overnight.  
The next day the samples were loaded in the dark in an SW-28 rotor (Beckman 
Instruments) and centrifuged at 28,000 rpm for 2.5 hrs at 4°C. The supernatant, which 
contains free ANB, was discarded, and the pellet was dried under a stream of nitrogen 
gas. The dried pellet was resuspended in 300µl of tRNA buffer [1mM KOAc (pH 5.0), 
2mM MgCl2]. The modified Lys-tRNAamb, Nε-(ANB)-[14C]Lys-tRNAamb (termed 
εANB-Lys-tRNAamb from here on), was then dialyzed against 3 volumes of tRNA buffer 
for 2 hrs at 4°C in the dark by wrapping everything in aluminum foil. The tRNA 
solutions were then split into 25µl aliquots in microfuge tubes, wrapped in aluminum 
foil, frozen in liquid N2, and stored at -80°C. An aliquot of the sample was then used in 
the characterization of the εANB-Lys-tRNAamb. 
Characterization of modified Lys-tRNAamb
εANB-Lys-tRNAamb was normally characterized by Yiwei Miao and Yuanlong Shao 
prior to its use in photocrosslinking experiments. Typically 2µl of the dialyzed εANB-
Lys-tRNAamb was aliquoted into four duplicate tubes, then diluted to 400µl with buffer 
A [1mM KOAc (pH 5.0), 5mM MgCl2]. Two tubes were used to measure the absorbance 
at 260 nm to obtain the tRNA concentration, while the remaining two tubes were used to 
determine the amount of [14C]Lys-tRNAamb by liquid scintillation counting. Typically, 
the εANB-Lys-tRNAamb preparations had specific activities that ranged from 500-1100 
pmol Lys/A260 unit. The decrease in the specific activity after modification was due to 
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deacylation of the Lys-tRNAamb during the reaction at high pH and the subsequent 
workups.  
The extent of lysine modification was assayed by paper electrophoresis as described 
earlier (Johnson et al., 1976). Briefly, εANB-Lys-tRNAamb (~15,000dpm) was 
hydrolyzed in freshly prepared 50mM triethylamine at 37°C for 90 minutes and dried 
under nitrogen gas. The sample was resuspended in water and spotted onto 
electrophoresis paper (Whatmann 3mm) at the origin (20 cm from the anode, 80 cm 
from the cathode). Free lysine, Nα-acetyl-Lys and Nε-acetyl-Lys standards were also 
spotted onto the same electrophoresis paper in different lanes, and all samples were 
separated in buffer B [10% (v/v) glacial acetic acid, 1% (v/v) pyridine] at 25V/cm for 3 
hours. After drying overnight, in a fume hood, the sample lane was cut into one hundred 
1 cm strips and then counted in a liquid scintillation counter, while the strips containing 
the standards were stained with ninhydrin to determine the position of the unlabeled α-
labeled, and ε-labeled lysine. Typically, greater than 82% of the Lys was labeled with 
ANB at the ε-amino group of Lys, while <3% was labeled at the α-amino group, and 
<12% remained unmodified.  
Preparation of wheat germ extract 
Nuclease treated wheat germ extract was prepared by Yiwei Miao and Yuanlong 
Shao as described by Erickson and Blobel (1983), except that the material was resolved 
by chromatography using a Sephadex G-25 column and stored in 40mM HEPES (pH 
7.4), 100mM KOAc (pH 7.5), 5mM Mg(OAc)2, 2mM glutathione and 100µM EGTA. 
The gel filtration step was necessary to remove the amount of endogenous amino acids 
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in the wheat germ extract. This was critical with respect to lysine and methionine, 
because endogenous Lys and Met would compete with εANB-Lys-tRNALys and 
[35S]Met for incorporation into polypeptides. The wheat germ extract was in buffer that 
contained 2mM glutathione rather than dithiothreitol (DTT) because the latter was a 
much stronger reducing agent and chemically reacts with the aryl azide, thereby 
quenching or preventing the photocrosslinking.  
Sf9 microsomes 
To prepare virus-infected Sf9 microsomes, Sf9 cells were infected with the E2 strain 
of AcMNPV (moi=10) and collected 33 hours post infection (Infrastructure for all cell 
culture, virus work was provided by Summers laboratory staff). 30 g of cells were 
diluted with 4 ml/per gram cell mass of buffer A [50 mM triethanolamine (pH 7.5), 50 
mM KOAc, 6 mM Mg(OAc)2, 1 mM EDTA, 1 mM DTT and 0.5 mM 
phenylmethylsulfonyl fluoride] and homogenized with 10-12 strokes using a motor-
driven drill homogenizer, avoiding foam formation and heating. The homogenate was 
centrifuged for 10 min at 1000g. The supernatant was recentrifuged for 10 min at 
10,000g. Crude rough microsomes were collected by centrifugation of the 10,000g  
supernatant for 2.5 h at 140,000g (Beckman Ti50.2 rotor at 40,000 rpm) through a 
cushion of 1.3 M sucrose in buffer A. The pellets were resuspended by manual 
homogenization in a Dounce homogenizer in buffer B [250 mM sucrose, 50 mM 
triethanolamine (pH 7.5) and 1 mM DTT] to a concentration of 50 A280 units/ml. The 
microsomes were active, as judged by their ability to target and translocate preprolactin  
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Figure 23. Translocation competence of Sf9 microsomes. Signal sequence processing of 
preprolactin using different aliquots of virus-infected and uninfected Sf9 microsomes. Processed product 
is indicated by the arrowhead. 
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in rabbit reticulocyte lysate at levels comparable to canine pancreatic microsomes (Fig. 
23, lanes 7-10). 
Uninfected Sf9 microsomes were prepared using the same procedure as described 
above with the exception that homogenization involved 6-8 dounces using a motor-
driven drill homogenizer, avoiding foam formation and heating. The microsomes were 
active, as judged by their ability to target and translocate preprolactin in rabbit 
reticulocyte lysate at levels comparable to canine pancreatic microsomes (Fig. 23, lanes 
1-6). 
Microsomes were also isolated (33 h p.i.) from Sf9 cells infected with the 
recombinant virus expressing E66SM∆T7. Recombinant virus development, cell culture 
and microsome isolation was performed by Summers laboratory staff (Sharon Braunagel 
and Genevieve Ledwell).  
Purification of signal recognition particle and canine pancreatic microsomes 
The purification of SRP from canine pancreatic tissue was performed by Yuanlong 
Shao and Yiwei Miao as previously described (Walter and Blobel, 1983a). The isolation 
of column-washed rough microsomal membranes was also performed as described 
elsewhere (Walter and Blobel, 1983b), except that the microsomes were eluted with, and 
stored in 50mM HEPES (pH 7.5) and 1mM glutathione after treatment with 
Staphylococcus Nuclease (Boehringer-Mannheim). 
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PCR-generated translation intermediates 
Using 5’-primers designed to include the start methionine, and the SP6 polymerase 
binding site and 3’-primers designed to generate DNA products of appropriate lengths, 
PCR was performed on the relevant genes.  
In vitro run-off transcription 
Typically a 100µl in vitro run-off transcription consisted of the following: 2µg of 
PCR-amplified DNA fragments (see above), 80mM HEPES (pH 7.5), 16mM MgCl2, 
2mM spermidine, 10mM DTT, 0.3mM GTP, 3mM each of ATP, UTP, and CTP, 500µM 
diguanosine triphosphate [G(5’)ppp(5’) (Amersham) which serves as a synthetic mRNA 
cap, 150 units of RNasin (Promega Biotech) and 100 units of purified SP6 RNA 
polymerase. The reaction was incubated at 37°C for 90 min and then 3.2µl of 100mM 
GTP was added and the reaction was continued for another 30 min. Following this, a 
standard ethanol precipitation was performed and the mRNA was resuspended in 120µl 
of ddH20. The yield and homogeneity of the transcription products were confirmed on a 
1.6% agarose/TAE gel.  
In vitro translations using wheat germ extract 
mRNAs generated from the in vitro run-off transcriptions were translated in a cell-
free protein synthesis system using wheat germ extract. A typical reaction volume was 
standardized to 50µl although increments of this volume (e.g. 100µl etc.) were often 
used. The reactions were performed in 1.5ml eppendorf tubes at 26°C for 40 min. The 
translations contained 100mM KOAc (pH 7.5), 20mM HEPES (pH 7.5), 3.2mM 
Mg(OAc)2, 200µM spermidine, 8µM S-adenosylmethionine (Sigma), 0.0024% (v/v) 
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NikkolTM (octaethyleneglycol-mono-N-dodecyl ether, Nikkol Chemicals), 2mM 
glutathione (pH 7.5), and 20% (v/v) wheat germ extract. An energy-generating system 
(containing ATP, GTP, creatine phosphate, creatine phosphokinase, and nineteen amino 
acids excluding methionine), RNAsinTM (ribonuclease inhibitor, Promega), and protease 
inhibitors (antipain, leupeptin, pepstatin, chymostatin, trasylol; Sigma) were also 
included in the translations. [35S]-methionine (MP Biomedical) was added to the in vitro 
translation reaction at a final concentration of 0.5µCi/µl.  
The in vitro translations were normally checked by either hot trichloroacetic acid 
(TCA) precipitation to assess the efficiency of the translation reaction or by sodium 
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) to assess the integrity of 
the protein products and also for molecular weight determination.  
In vitro translations using rabbit reticulocyte lysate 
mRNAs generated from the in vitro run-off transcriptions were translated in a cell-
free protein synthesis system using nuclease-treated rabbit reticulocyte lysate (Promega). 
The reactions were performed in 1.5ml eppendorf tubes at 30°C for 40 min. The 
translations contained amino acid mixture minus methionine (Promega), RNAsinTM 
(ribonuclease inhibitor, Promega), and microsomes. [35S]-methionine (MP Biomedical) 
was added to the in vitro translation reaction at a final concentration of 0.5µCi/µl. 
The in vitro translations were normally checked by either hot trichloroacetic acid 
(TCA) precipitation to assess the efficiency of the translation reaction or by sodium 
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) to assess the integrity of 
the protein products and also for molecular weight determination.  
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Trichloroacetic acid precipitation 
The in vitro translations were often checked by hot trichloroacetic acid (TCA) 
precipitation followed by filtration through nitrocellulose filters. Typically, 2µl of a 
translation mix was removed and added to a 13 x 100 mm glass test tube that contained 1 
ml of 10% (w/v) TCA, and 3% (w/v) casamino acids (CAA). The samples were 
subsequently incubated at 85°C for 10 min using a water bath (the heating in acid 
destroyed any RNA molecules, but precipitated polypeptides). The test tubes were 
placed in ice for 2 min to cool the sample prior to filtration. The samples were vortexed 
and then filtered under vacuum through a 25mm Metrical membrane filter (45µm pore 
size; Gelman Sciences) that had been prewashed with 3 ml of cold 5% (w/v) TCA. The 
precipitate on each filter was then washed three times with 3 ml of cold 5% (w/v) TCA. 
The filters were dried under a heat lamp for 10 min and then counted in a liquid 
scintillation counter (Beckman Coulter). Translations that lacked any added mRNA 
served as the reference and their counts were operationally defined as background. 
An alternative method that was often used to check in vitro translation was to 
precipitate the translation reaction with cold TCA and then analyze the samples by SDS-
PAGE. Typically, after the translation reaction was completed, an equal volume of cold 
25% (w/v) TCA was added to each sample. The samples were incubated on ice for 10 
min and then sedimented at 4°C for 5 min in a microcentrifuge tube at maximum speed. 
The supernatants were removed by aspiration, and the pellets were washed with 1ml of 
acidic acetone (19 volumes acetone: 1 volume 0.1M HCl). The samples were again 
sedimented at 4°C for 2 min and the pellets were dried under vacuum in a Speed Vac 
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concentrator (Savant) for 15 min. The pellets were ultimately resuspended in sample 
buffer and electrophoresed on SDS-PAGE gels. 
Generation of integration intermediates 
Integration intermediates were generated by including in the in vitro translation 
reactions (50µl), SRP and column-washed rough microsomes (CRMs) at final 
concentrations of 40nM and 8 equivalents (1 eq = 50 A280 units/µl; Walter and Blobel, 
1983b) respectively. Fully assembled integration intermediates with nascent chains of a 
defined length were prepared in vitro by translating mRNAs that were truncated in the 
coding region. Ribosomes halt when they reach the ends of such mRNAs, but they do 
not dissociate from the mRNA because the absence of a stop codon prevents normal 
termination from occurring. Thus, the nascent chain remains bound to the ribosome as a 
peptidyl-tRNA, and the length of the nascent chain is dictated by the length of the 
truncated mRNA added to the translation. To examine the environment of a TMS at 
different stages of integration, we prepared integration intermediates with [35S]Met-
labeled nascent chains of different lengths, each with a single photoreactive probe 
located at or near the center of its TMS. 
Photoreactive probes were incorporated into nascent chains by translating the mRNA 
in the presence of Nε-(5-azido-2-nitrobenzoyl)-Lys-tRNAamb (εANB-Lys-tRNAamb) that 
recognizes an amber stop codon. To ensure that each nascent chain received only a 
single probe, each coding sequence contained only a single in-frame amber stop codon. 
It is important to note that the modified Lys-tRNA incorporates an uncharged amino acid 
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into the protein instead of a charged lysine residue, so this experimental approach does 
not compromise the hydrophobicity of the TMS.  
Integration intermediates to be used that are to be used in photocrosslinking studies 
were generated by in vitro translation reactions similar to those described above, with a 
few modifications. The final concentration of [35S]methionine in the translation was 
increased to 2µCi/µl so that the photoadducts could be detected on SDS-PAGE gels. 
Seventy-two pmoles of εANB-Lys-tRNAamb were included in the incubations in the dark 
to allow incorporation of the photoreactive probes into nascent polypeptide chains. All 
translations were performed at 26°C for 40 min in the dark.  
Photoreactions 
The translation reaction was stopped by placing the samples on ice for 10 min prior 
to ultraviolet radiation exposure. In some experiments, puromycin was added to a final 
concentration of 2mM and incubated at 26°C for 30 min either prior to or after 
photolysis. The samples were photolyzed at 0°C for 15 min using a 500-W mercury arc 
lamp (Oriel) at a distance of 12cm through a filter combination (Oriel 59855 and 66236) 
that provides a 300-400nm bandpass. 
After photolysis, the microsomal membranes were isolated by sedimentation through 
a sucrose cushion [0.5M sucrose/100mM KOAc (pH 7.5)/20mM HEPES (pH 
7.5)/3.2mM Mg(OAc)2] at 100,000g for 4 min in a TLA 100 rotor (Beckman). The 
supernatants were discarded, while the membrane pellets were resuspended in sample 
buffer (with DTT) and analyzed by SDS-PAGE.  
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Chemical crosslinking 
All chemical crosslinking reactions performed in this work were done following the 
translation of the substrate using nuclease-treated rabbit reticulocyte lysate (Promega). In 
vitro translations (30°C, 45 min, 100µl) were performed in the presence of nuclease-
treated Rabbit reticulocyte lysate (Promega), amino acid mixture minus methionine 
(Promega), RNasin (Promega), 30 equivalents of Sf9 rough microsomes (Saksena, 
2004), and 50µCi of [35S] Met (1Ci = 37GBq). After translation, samples were 
sedimented through a 100µl sucrose cushion [0.5M sucrose/20mM Hepes, pH 
7.5/100mM KOAc/3.2mM Mg(OAc)2] in a Beckman TLA ultracentrifuge at 4°C for 
4mins at 100,000 rpm in a TLA 100 rotor. The resulting membrane pellet was 
resuspended in 100µl of crosslinking buffer (25mM Na-phosphate/150mM NaCl, pH 
7.0) and the crosslinking reagent BS3 (Pierce) was added to 2.5mM or 50µM in some 
cases. Samples were incubated at 22°C for 30mins. In the case where SMPB (Pierce) 
was used as the chemical crosslinker, the membrane pellet was resuspended in 100µl of 
crosslinking buffer (20mM Hepes, pH 7.5/20mM KOAc/5mM MgCl2) and the 
crosslinking reagent was added to 50µM. Samples were incubated at 22°C for 30 mins 
and the crosslinking reagent quenched by the addition of 40mM DTT and 40mM Tris-
HCl (pH 7.5). The quenching reaction was allowed to proceed for 20 mins at 22°C.  
Purification of crosslinked products using TALON beads 
Following crosslinking, the samples were treated with a dentauring solution (4M 
urea/1% SDS) for 30 min at 37°C, prior to being incubated with 40µl of Dynabeads 
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TALON (Dynal Biotech) pre-equilibrated (22°C , 1hr) with 0.75 ml of washing & 
binding buffer (50mM Na-phosphate, pH 8.0/300mM NaCl/0.01% Tween-20). After 
allowing 35 mins at 22°C for the binding reaction to occur, the sample-containing tubes 
were placed on a magnet until the beads migrated to the side of the tube and the 
supernatant was discarded. The beads were washed four times with 0.7 ml of the 
washing & binding buffer (50mM Na-phosphate, pH 8.0/300mM NaCl/0.01% Tween-
20), following which the bound material was eluted using 40µl SDS-sample buffer. The 
eluted material was heated at 95°C for 10 mins prior to being analyzed by SDS-PAGE. 
Alkaline extraction 
The standard operational criterion to determine whether a protein is integrated into 
microsomal membranes is to assess its solubility in alkaline (pH 11-12) buffers (Fujiki et 
al., 1982). A protein is considered membrane-integrated if the protein is insoluble in 
alkaline buffers. 
Samples to be analyzed by alkaline extraction were subjected to alkaline conditions 
after photolysis. Typically, Na2CO3 (pH 11.5) was added to each photolyzed sample to a 
final concentration of 100mM, and then incubated on ice for 20 min. The samples were 
sedimented through an alkaline cushion [0.5M sucrose/100mM Na2CO3 (pH 11.5)] at 
100,000g for 4 min in a TLA 100 rotor (Beckman). The supernatant and membrane 
pellet fractions were separated and analyzed by SDS-PAGE. 
High-salt wash 
Samples to be analyzed by high salt wash were treated with 0.5M KOAc (potassium 
acetate) and incubated on ice for 20min. Following the incubation, samples were 
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sedimented through a high salt cushion (20mM HEPES, 500mM KOAc, 3.2mM 
Mg(OAc)2, 0.5M sucrose) at 100,000g for 4 min in a TLA 100 rotor (Beckman). The 
supernatant and membrane pellet fractions were separated and analyzed by SDS-PAGE. 
Immunoprecipitations 
Prior to immunoprecipitation, the microsomal membranes were isolated by 
sedimentation as described above. For immunoprecipitations using affinity-purified 
antibodies raised against the C-terminal 14 residues of Sec61α (Research Genetics, 
Huntsville, AL), the membrane pellet was solubilized in 50µl of resuspension buffer [2% 
(w/v) SDS, 100mM Tris-HCl (pH 7.5)] by heating at 55°C for 30 min. The samples were 
thoroughly mixed, transferred to new 1.5 ml microfuge tubes, and then diluted to 500µl 
with buffer A [140mM NaCl, 10mM Tris-HCl (pH 7.5), 2% (v/v) Triton X-100]. 
Individual samples were precleared by adding 40µl of protein A-Sepharose (Sigma) and 
rocking at room temperature for 1 hr before the sepharose beads were removed by 
sedimentation. Sec61α specific antibodies were added to each sample and rocked at 4°C 
overnight. On the following day, 40µl of 2x-diluted protein A-Sepharose in buffer A was 
added to each sample and the incubation was allowed to continue for another 3 hours at 
4°C. The immunoprecipitate was recovered by sedimentation, washed twice with buffer 
A, and then washed a final time with the same buffer containing no detergent. 
Immunoprecipitated material was separated by SDS-PAGE as before (Do et al., 1996) 
and visualized using a Bio-Rad FX phosphorimager.  
For immunoprecipitations using affinity-purified antibodies raised against the C-
terminal 13 residues of TRAM (Research Genetics, Huntsville, AL), the membrane 
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pellet was solubilized in 50µl of resuspension buffer [1% (w/v) SDS, 100mM Tris-HCl 
(pH 7.5)] by heating at 55°C for 30 min. Each sample was diluted to 500µl with buffer B 
[150mM NaCl, 50mM Tris-HCl (pH 7.6), 2% (v/v) Triton X-100, 0.2% (w/v) SDS] and 
rocked overnight at 4°C after the addition of TRAM-specific antibodies. On the 
following day, 40µl of 2x-diluted protein A-Sepharose in buffer A was added to each 
sample and the incubation was allowed to continue for another 3 hours at 4°C. The 
immunoprecipitate was recovered by sedimentation, washed twice with buffer B, and 
then washed a final time with the same buffer containing no detergent. The 
immunoprecipitated material was separated by SDS-PAGE, and visualized using a Bio-
Rad FX phosphorimager.  
For immunoprecipitations using antibodies specific for SRP54 (provided by 
Ingmarie Nilsson), FP25K (generated by Robert Harrison), E26 (generated by Hideo 
Beniya), p39 (provided by Loy Volkman), polyhedrin and E25 (generated by Sharon 
Braunagel), T7 tag (Novagen), and karyopherin alpha (BD Biosciences), the same 
conditions were used as described above for the TRAM antibody. The antibody raised 
against bacterially expressed E26 (antisera #12500) was a generous gift of Jared Burks.  
SDS-PAGE electrophoresis 
Samples of in vitro translations or photocrosslinking experiments were separated by 
sodium dodecylsulfate polyacrylamide electrophoresis (SDS-PAGE). The resolving gel 
was ~14cm in height, 19cm wide, and 0.8mm thick. Samples were loaded into sample 
wells in a 2 cm stacking gel located on top of the resolving gel. Unless indicated 
otherwise, the majority of the resolving gels used in this dissertation were linear 10-15% 
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(w/v) polyacrylamide gradient gels [diluted from a 30% (w/v) acrylamide, 0.8% 
bisacrylamide stock solution]. The resolving gel also contained 400mM Tris (pH 8.8), 
0.08% (w/v) SDS, 0.02% (v/v) N, N, N’, N’-tetramethyl ethylenediamine, and 0.017% 
ammonium persulfate (all materials were purchased from Sigma Chemicals). The 
stacking gel was 4% (w/v) polyacrylamide that contained all the other components of the 
resolving gel except that this gel was buffered in 60mM Tris (pH 6.8). 
Samples were prepared for electrophoresis either by boiling for 10 min or by 
incubating at 37°C for 10 min in sample buffer [120mM Tris base, 3.6% (w/v) SDS, 
7.5mM EDTA, 125mM DTT, 15% (v/v) glycerol, and a trace amount of bromophenol 
blue]. The samples were run at 15 milliamperes through the stacking gel and then 
separated at 30 milliamperes through the resolving gel using a running buffer that 
contained 400mM glycine/50mM Tris base/0.1% (w/v) SDS (pH 8.8). 
After SDS-PAGE, the gels were stained for 15 min at room temperature with gentle 
shaking in 50% (v/v) methanol/10% (v/v) glacial acetic acid/ and 0.125% (w/v) 
Coomassie Brilliant Blue (Sigma). The gels were destained for at least 30 min at room 
temperature with shaking in 35% (v/v) methanol/10% (v/v) glacial acetic acid. The gels 
were then washed thoroughly with distilled water prior to drying at 80°C to remove the 
acetic acid, because the Bio-Rad phosphorimaging screens will be damaged by residual 
acids. The dried gels were then exposed on the phosphorimaging screens and visualized 
using a Bio-Rad GS-250 phosphorimager.  
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SDS-PAGE, western transfer and immunoblotting 
Following SDS-PAGE (described above), gels were either stained with Commassie 
blue (0.1% Commassie R-250, 10% methanol) and destained/fixed (45% acetic acid, 
10% methanol), or transferred to Immobilon-P membrane (Millipore, Billerica, MA, 
catalog # IPVH 000 10) using the tank transfer method. Blots were treated with blocking 
solution (3% non fat dried milk, 50mM Tris-HCl, 150mM NaCl, 0.05% Tween-20, pH 
7.4) for 30 minutes at RT, then incubated with primary antibody (diluted in blocking 
solution) for either 2 hours at RT, or overnight at 4°C. Blots were washed three times 
(10 minutes per wash, RT) with TBS-T (50mM Tris-HCl, 150mM NaCl, 0.05% Tween-
20, pH 7.4), followed by incubation with secondary antibody conjugated to horseradish 
peroxidase (HRP) (1:10000, blocking solution, 1 hour, RT). The blots were washed three 
times with TBS-T, and developed using the Western LightningTM chemiluminescence 
reagent kit (Perkin Elmer, Boston, MA, NEL100) and Kodak X-Omat Blue XB-1 film 
(Eastman, Kodak Company, New Haven, CT).  
cDNA expression-library screen 
 Sf9 cDNA expression library was a generous gift of Christian Gross and was 
screened using the E26 antibody under the guidance of Sharon Braunagel. 
Primary screen. 100µl of undiluted Sf9 cDNA expression library was added to 
0.6mls of plating cells (BB4) followed by incubation at 37°C for 30 min. The adsorbed 
phage was mixed with 15 ml of prewarmed (42°C ) top agarose (0.7% agarose/0.2% 
maltose/10mM MgSO4) and plated on NZCYM plates. The plates were left for 6 hrs at 
37°C and once pin-sized zones of clearing (plaques) became visible, they were overlaid 
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with nitrocellulose membranes {137MM (pore size:0.45µm) Pure Nitrocellulose transfer 
and immobilization membrane, Schleicher & Schnell, Dassel, Germany} presoaked in 
10mM IPTG. Once the membranes were placed, appropriate registration marks were 
made on both the membrane and the plate surface to allow accurate superimposition of 
any positive plaque on the membrane with the corresponding plaque on the plate.  
Following an overnight incubation, the nitrocellulose membranes were lifted from 
the plates, treated with a blocking solution [150mM NaCl, 10mM Tris (pH 8.0), 3% 
(w/v) non fat dried milk, 0.1% Tween 20] (22°C, 45min), and incubated with 30µl of 
antisera # 12499 (4°C, 12 hrs). After incubation with the antibody, the membranes were 
washed three times (15min/wash) with TTBS [150mM NaCl, 10mM Tris (pH 8.0), 0.1% 
Tween 20] and then incubated with 2µl of [125I]-Protein A {MP Biomedical} (22°C, 6 
hrs). Membranes were washed three times with TTBS as described above, air dried and 
exposed for 3 days to a X-ray plate (XOMAT-AR, Kodak) for visualization. Making use 
of the registration marks, the positive plaques on the NZCYM plates were identified and 
cored into a sterile tube containing 0.5ml of phage buffer (0.1M NaCl, 8mM 
MgS04.7H20, 50mM Tris pH 7.5, 0.01% gelatin) and 20% chloroform. Secondary and 
tertiary screens were conducted in the same way as described above except that 200µl of 
plating cells was mixed with 100µl of the cored phage stock.  
In vivo excision and rescue. 200µl of XL-1 Blue cells (OD600=1.0) were mixed with 
200µl of an appropriate dilution (10-1/10-2/10-3) of the cored phage stock (derived from 
the tertiary screen), 10µl of R408 helper phage [1x1011 pfu/ml – 1x106 pfu/ml] 
(Stratagene), and incubated at 37 °C for 15 min. 5.0 ml of 2XYT media was added to the 
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sample and incubated overnight in a 37°C shaking incubator. Following overnight 
incubation, the samples were heated at 70°C for 20 min and the phagemids packed as 
filamentous phage particles were recovered in the supernatant following centrifugation 
(4°C , 4min, 4500 rpm). 200µl of the supernatant was added to 200µl of XL-1 Blue cells 
(OD600=1.0), incubated at 37°C for 15 min, and 25µl of the mix was plated on LB/amp50 
plates. The pBluescript plasmid with the cloned cDNA insert was isolated from the 
resultant colonies by using the Qiagen DNA Miniprep kit. 
DNA sequencing 
Polymerase chain reaction (PCR) was performed using a MJ Research DNA Engine 
Peltier Thermal Cycler, PTC-200 (MJ Research, Inc., Reno, NV). Double stranded DNA 
sequencing was performed using the ABI PRISM Big Dye Terminator Cycle Sequencing 
Core kit with Amplitaq DNA Polymerase. Sequencing reactions were performed by 
Gene Technologies Laboratory (Texas A&M University) using an ABI 373 XL or 373 
XL DNA sequencer (Applied Biosystems Inc., Foster City, CA). Enzymes were 
purchased from Promega (Madison, WI) unless otherwise noted. 
Primer extension analysis 
Transcript initiation was mapped using primer extension techniques (Sambrook et 
al., 1989) under the guidance of Sharon Braunagel. The oligonucleotide 5’ 
GGGATCAATTCAACTTGCTCCTGATGC 3’ was 5’ end labeled with T4 
polynucleotide kinase and probed against 105µg of total cellular RNA. Extension 
products were generated using Superscript II-Reverse transcriptase in the presence of 
2.3µg actinomycin D, 28 units RNasin, and 0.5mM dNTPs for 1 hr at 42°C. Extension 
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products were precipitated and digested with 0.1N NaOH for 30 min at room 
temperature, resuspended in 80% formamide loading buffer, and boiled for 3 min before 
loading onto a denaturing gel (7.0 M Urea, 6% polyacrylamide, 100mM Tris-borate, 
20mM EDTA, pH 8.3). Transcript initiation sites were identified by comparison with a 
concurrent DNA sequence using the same oligonucleotide as used for generating the 
extension products. A maxiprep of clone 2 was used as a template for the sequencing 
reaction using the SequenaseTM 2.0 DNA sequencing kit (USB). The three different 
primer extension products were resolved individually by modulating the time of the 
electrophoretic runs.  
The oligos used for the primer extension analyses are: 
2-2 IP: 5’ GGATCAATTCAACTTGCTCCTGATGC 3’ 
 
2-2 IP-2: 5’ GCGGGGGCTGCACCACCAACAGTTG 3’ 
The oligo 2-2 IP was used to determine the transcription initiation site for the first and 
second primer extension products. While, the third transcription initiation site was 
determined using the oligo: 2-2 IP-2. The DNA sequencing gels used to resolve the 
primer extension products were run for varying lengths of time to individually resolve 
the three products.  
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CHAPTER III 
COTRANSLATIONAL INTEGRATION AND INITIAL SORTING 
AT THE ER TRANSLOCON OF PROTEINS DESTINED FOR THE 
INM∗
 
Experimental design 
 
Any proteins directly involved in the sorting of newly synthesized polypeptides 
(hereafter termed substrates) into the INM or other membranes will recognize some 
structural feature(s) of the substrate that directs each protein to a particular location. 
Because the SM sequence is sufficient to direct a polypeptide to the INM (Hong et al., 
1997; Braunagel et al., 2004), this sequence must contain the structural features that 
constitute an INM-sorting signal. If sorting is protein-mediated, then recognition of this 
sequence would require a direct interaction between the SM sequence and a protein 
involved in sorting. Thus, one approach to identifying the proteins that mediate sorting 
to the INM is to determine which proteins are adjacent to, and presumably interact with, 
an INM substrate as it progresses through different stages of the sorting process. A direct 
method for detecting interacting proteins is crosslinking, since a substrate can only react  
covalently with proteins that are in close proximity. Furthermore, the use of 
photosensitive crosslinking reagents allows one to create fully assembled intermediates  
at different stages of substrate synthesis and sorting prior to initiating the crosslinking 
                                                 
∗ Part of the data reported in this chapter is reprinted with permission from “Cotranslational integration 
and initial sorting at the endoplasmic reticulum translocon of proteins destined for the inner nuclear 
membrane” by Saksena et al., 2004. PNAS, 101, 12537-12542. Reprinted in accordance with Copyright © 
1993-2004 by The National Academy of Sciences of the United States of America, all rights reserved  
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reaction. Since increasing the length of the truncated mRNA (and hence the nascent 
chain) yields intermediates that are progressively further along the processing pathway, 
alterations in the proteinaceous environment surrounding the substrate can therefore be 
monitored at different stages of integration by varying the length of the nascent chain.  
By comparing different lengths of INM and non-INM substrates, the stage at which the 
processing of an INM substrate diverges from that of a protein destined to function in 
another membrane can be established experimentally. 
Crosslinking experiments in a complex biochemical system that includes the 
substrate, ribosomes, ER microsomes, and many associated factors can yield a myriad of 
crosslinked proteins.  However, by selectively positioning photoreactive probes only in 
the substrate, one can limit the crosslinking targets solely to those proteins adjacent to 
the substrate.  Since the nascent or full-length substrate typically comprises less than 
0.1% of the polypeptide in an in vitro translation incubation, selective labeling of the 
substrate can only be achieved by incorporating the photoreactive probes into the 
substrate polypeptides as they are being made by the ribosome. To accomplish this, the 
translation incubation must contain a modified aminoacyl-tRNA (aa-tRNA) that 
recognizes a particular mRNA codon, but incorporates an amino acid with a 
photoreactive probe covalently attached to the side chain. The probe will then be 
incorporated into the substrate nascent protein chain wherever the mRNA contains a 
codon recognized by the aa-tRNA analogue. Johnson & colleagues were the first to 
demonstrate the successful incorporation of non-natural amino acids into polypeptides in 
vitro using aa-tRNA analogues (Johnson et al., 1976), and this approach has since been 
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used successfully by many groups to examine various aspects of protein trafficking 
using either photoreactive and/or fluorescent probes (Johnson et al., 2001; Johnson et al., 
1999; Woolhead et al., 2004). 
Fully-assembled integration intermediates with nascent chains of a homogeneous, 
defined length can be prepared in vitro by translating, in the presence of ER microsomes 
and signal recognition particle (SRP), mRNAs that are truncated within the coding 
region.  Ribosomes halt when they reach the end of the mRNA, but the nascent chains 
do not dissociate from the tRNA and ribosome because the absence of a stop codon 
prevents normal termination from occurring. The length of the nascent chain in the 
ribosome•nascent chain complex (RNC) is therefore determined by the length of the 
truncated mRNA added to the translation.  Translations contain [35S]Met to radiolabel 
the synthesized substrate and Nε-(5-azido-2-nitrobenzoyl)-Lys-tRNAamb (εANB-Lys-
tRNAamb) to incorporate a photoreactive probe into the substrate {Krieg et al., 1986 ; 
Flanagan et al., 2003}. Since the εANB-Lys-tRNAamb amber suppressor tRNA 
recognizes and translates an amber stop codon, the position of the probe in the substrate 
is dictated by the location of the single amber stop codon in the mRNA. Since our goal 
was to identify proteins that may interact with the SM sequence, we positioned an amber 
stop codon within the nonpolar region of the SM-containing proteins for many 
experiments in this study. (Note that the lysine is no longer charged after modification 
by the probe.) Moreover, to examine all sides of the putative α-helix formed by the 
hydrophobic TMS in the SM, a single amber codon was substituted in place of each of 
four sequential in-frame codons in each mRNA examined.  
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Targeting of the SM to the ER membrane occurs cotranslationally and is SRP-
dependent 
Full-length E66 has been observed to insert into membranes post-translationally, 
albeit at low efficiency (Hong et al., 1997). Hence, it was first necessary to ascertain 
whether E66 is normally targeted to the ER membrane in an SRP-dependent manner and 
integrated cotranslationally. Thus, E66 was modified by extending its N-terminus to 
position a consensus glycosylation acceptor sequence sufficiently far (18 residues) from 
the nonpolar TMS to be glycosylated when the -N-S-T- is translocated into the ER 
lumen (Nilsson et al., 1993). The resulting construct, here termed E66G (Fig. 24A), has 
also been used to determine the normal orientation of E66 in the INM (Braunagel et al., 
2004). 
The targeting to the ER membrane of most ribosome•nascent chain complexes 
synthesizing eukaryotic membrane proteins is SRP-dependent (Keenan et al., 2001). 
When E66G was translated in the presence of canine column-washed rough ER 
microsomes (CRMs) containing SRP, much of the nascent E66G was glycosylated (Fig. 
24B, lane 1). However, when the CRMs were added after nascent E66G had been 
released from the ribosomes, no E66G was glycosylated (Fig. 24B, lane 2), thereby 
showing that the signal sequence-containing nascent E66G could not be targeted and 
translocated post-translationally. The SRP dependence of this targeting was further 
examined using microsomes that had been stripped of their SRP and residual ribosomes 
by washing in EDTA and high salt (EKRMs). E66G proteins synthesized either in the 
presence (Fig. 24B, lane 3) or in the absence (Fig. 24B, lane 4) of EKRMs were not 
 95
glycosylated, but were glycosylated if SRP was included with EKRMs in the incubation 
from the beginning (Fig. 24B, lane 5). Thus, the targeting, translocation, integration, and 
glycosylation of E66G is SRP-dependent and occurs co-translationally. 
The above results suggest that the SM sequence acts as a signal sequence to target 
RNCs synthesizing E66G to the translocon. If true, one would predict that the SM 
sequence would bind to SRP, and that this association could be detected by nascent 
chain photocrosslinking to the 54 kDa subunit of SRP (SRP54) (Krieg et al., 1986). An 
amber stop codon was substituted into the nonpolar core of E66 at position 12 to create a 
construct designated E66-A12 (Fig. 24A; other amber codon-containing constructs are 
identified similarly), and a truncated mRNA transcribed from this DNA was translated in 
the presence of SRP and either εANB-Lys-tRNAamb or unmodified Lys-tRNAamb, but in 
the absence of microsomes to block the targeting pathway at the RNC•SRP intermediate. 
Upon illumination, a ~61 kDa photoadduct containing the 70-residue nascent chain and a 
larger protein was formed (Fig. 24C, lane 4), and this target protein was shown to be 
SRP54 by immunoprecipitation with SRP54-specific antibodies (Fig. 24C, lane 5). As 
expected, no photoadduct was observed in the absence of light (Fig. 24C, lane 2) or 
probe (Fig. 24C, lane 1). Furthermore, a nascent chain lacking the SM sequence (termed 
E66-∆33; generated by Tao Hong), but containing a photoreactive probe at position 12, 
did not photocrosslink to SRP54 (Fig. 24C, lane 3), thereby showing the requirement of 
the SM sequence for nascent chain binding to SRP. 
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Figure 24. Targeting of E66 to the ER membrane is cotranslational and SRP-
dependent. (A) The N-terminal sequence of E66 and some derivatives used in this study. The TMS is underlined and the 
glycosylation sequence is boxed. The asterisk denotes the position of the amber codon within the E66-A12 construct. (B) The N-
terminal 200 residues of E66G were translated in the presence (cotranslationally or C; lanes 1,3,5) or absence (microsomes were then 
added post-translationally or P; lanes 2,4) with the indicated microsomes. The sample in lane 5 also received 40 nM canine SRP. The 
closed circle denotes the glycosylated protein. (C) Translation intermediates containing 70-residue nascent chains of the indicated 
E66 derivatives were prepared in the presence of unmodified Lys- tRNAamb or εANB-Lys- tRNAamb as indicated. Only the sample in 
lane 2 was not exposed to UV light. The sample in lane 5 was immunoprecipitated with antibodies to SRP54 prior to analysis by 
SDS-PAGE, and the closed circle denotes the SRP54-nascent chain photoadduct. 
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Viral SM sequence proximity to translocon proteins 
A number of studies by different groups have demonstrated that a signal or signal-
anchor (SA) sequence is adjacent to translocon proteins after SRP-dependent targeting 
(Johnson & van Waes, 1999; Alder & Johnson, 2004). To determine whether the SM 
sequence also passes through the translocon, parallel samples of 70-residue E66 nascent 
chains were translated in the presence of SRP, microsomes, εANB-Lys-tRNAamb, and 
truncated mRNAs with an amber stop codon at position 10, 11, 12, or 13 (Fig. 25A). 
After photolysis, the extents of photocrosslinking of each E66 derivative to both Sec61α 
and TRAM were determined by immunoprecipitation using affinity-purified antibodies 
specific for Sec61α and TRAM (SDS-PAGE analyses of the total samples did not reveal 
any other major photoadducts; and no photoadducts were observed in the absence of 
light or ANB; data not shown). As shown in Fig. 25B, E66 reacts covalently with 
Sec61α primarily via probes positioned at residues 10 and 12.  Probes at positions 11, 
13, and, to a lesser extent, 10 photocrosslink to TRAM. As others have observed and 
discussed elsewhere (McCormick et al., 2003), the disparity in the magnitude of 
photocrosslinking from adjacent positions in the TMS of the SM reveals that it is not 
oriented randomly within the translocon, nor is the SM TMS free to rotate in or next to 
the translocon. Instead, the SM TMS appears to be bound in a fixed orientation by one or 
more translocon proteins. If the SM TMSs were randomly oriented and not bound to the 
translocon, then one would expect to see a symmetric photocrosslinking pattern in which 
each probe position reacts more or less equally with a given target protein (note that the 
probes are at the end of a 12 Å-long flexible lysine side chain, so a 1.5 Å difference in  
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Figure 25. Photocrosslinking of viral INM-directed TMSs to translocon proteins.  
(A) The N-terminal sequences of E66 and E25 are shown with the TMS underlined, as are the N-terminal sequences of the constructs 
containing the first TMS of LBR (LBR1), nurim (Nur1), and Lep (Lep1). In each case, an amber codon was substituted for the codon 
shown at position 10, 11, 12, or 13 (boxed in figure) to position the photoreactive probes at a single nascent chain location in each 
sample. The probes extend from different sides of the TMS α-helix surface. (B) Integration intermediates containing 70-residue E66-
A10, E66-A11, E66-A12, or E66-A13 nascent chains were photolyzed, immunoprecipitated with affinity-purified antibodies to 
Sec61α (lanes 1-4) or TRAM (lanes 5-8), and analyzed by SDS-PAGE. Photoadducts to Sec61α and TRAM are indicated by the 
closed circle and arrowhead, respectively. The relative extent of photoadduct formation was quantified by comparing each 
photoadduct band intensity with that of the most intense photoadduct band in the gel (taken to be 100%). 
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bilayer depth of probes located at adjacent residues in the TMS helix could not explain 
 
o position 10, 11, 12, or 13 (Fig. 
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1 
 TMS proximity to translocon proteins 
The unexp uestions.  Is 
the
and 
the differences in photoadduct formation for adjacent probe locations seen in Fig. 25B). 
Thus, following SRP-dependent targeting, the TMS of the E66 SM sequence appears to 
occupy and be bound to a specific site within the translocon. To assess the generality of 
these results, we examined the proximity to the translocon of nascent ODV-E25 (E25), a
viral membrane protein that is also sorted to the INM. 
 As above, an amber stop codon was substituted int
) to yield constructs designated E25-A10, etc. When truncated mRNAs coding for 
70 residues of each of these nascent chains were translated in parallel and then 
photolyzed, the photocrosslinking patterns were very similar to those of nascent
Sec61α was in close proximity to residues 10 and 12 in the E25 TMS, while residues 1
and 13 were adjacent to TRAM (Fig. 26). Thus, the locations of the E66 and E25 TMS 
sequences within the translocon are indistinguishable early in integration. Furthermore, 
both viral TMSs were clearly adjacent to TRAM: an average of 11% of the nascent 
chains photocrosslinked to translocon proteins, and approximately half of the 
photoadducts contained TRAM. 
Mammalian INM
ected photocrosslinking of viral TMSs to TRAM raised two q
 close association with TRAM a property of viral proteins, or is this close association 
a property of INM-directed proteins, but not other membrane proteins? To ascertain 
which of these two possibilities, if either, is correct, the same approach was used to 
examine two mammalian proteins that localize in the INM: lamin B receptor (LBR) 
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nurim. Both LBR and nurim are multi-spanning membrane proteins, but the first TMS 
and the flanking charged amino acids of both LBR (Soullam et al., 1995) and nurim 
(Rolls et al., 1999) are important for directing the protein to the INM. Thus, construc
that retained these features were generated and termed LBR1 and Nur1, respectively. 
After co-translational insertion into the membrane, the LBR1 sequence adopts an 
orientation opposite to that of the first TMS in native LBR (Worman et al., 2000; S
et al., 1993); however, this difference in TMS orientation has no detectable effect on 
protein sorting to the INM because both LBR and LBR1 are each directed to the INM
(submitted). Derivatives of LBR1 and Nur1 were then prepared by substituting an amb
stop codon for a codon at positions 10, 11, 12, or 13 (Fig. 25A). 
When 70-residue nascent chains of the LBR1 constructs were
ts 
mith 
 
er 
 translated, targeted, 
and
d the pattern 
nt, 10 
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tocrosslinking targets were the 
sam
RAM  
 photolyzed, SDS-PAGE analyses of the TRAM- and Sec61α-specific 
immunoprecipitates revealed that the photocrosslinking was asymmetric an
was very similar to that seen with the viral INM TMSs. Sec61α was adjacent to 
positions 10 and 12 in the LBR TMS, while positions 11, 13, and, to a lesser exte
were in close proximity to TRAM (Fig. 27). As was seen with the viral INM-directed 
proteins, 11-12% of the total LBR1 and Nur1 nascent chains synthesized were 
photocrosslinked to TRAM plus Sec61α. The first LBR TMS and the viral TMS
therefore appear to occupy similar sites in the translocon. 
When the Nur1 TMS sequence was examined, the pho
e, but the photocrosslinking efficiencies at different probe locations differed 
significantly from those of other INM TMSs. The extent of photocrosslinking to T
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igure 27. Photocrosslinking of mammalian INM-directed TMSs to translocon 
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proteins.  Integration intermediates containing 70-residue LBR1-A10, -A11, -A12, or -A13 nascent
chains were photolyzed, immunoprecipitated with affinity-purified antibodies to Sec61α (lanes 1-4) or 
TRAM (lanes 5-8), and analyzed by SDS-PAGE. Photoadducts to Sec61α and TRAM are indicated by t
closed circle and arrowhead, respectively. The relative extent of photoadduct formation was quantified by 
comparing each photoadduct band intensity with that of the most intense photoadduct band in the gel 
(taken to be 100%). 
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Figure 28. Photocrosslinking of Nur1 TMS to translocon proteins. Integration 
intermediates containing 70-residue E66-A10, E66-A11, E66-A12, or E66-A13 nascent chains were 
photolyzed, immunoprecipitated with affinity-purified antibodies to Sec61α (lanes 1-4) or TRAM (lanes 
5-8), and analyzed by SDS-PAGE. Photoadducts to Sec61α and TRAM are indicated by the closed circle 
and arrowhead, respectively. The relative extent of photoadduct formation was quantified by comparing 
each photoadduct band intensity with that of the most intense photoadduct band in the gel (taken to be 
100%). 
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from positions 11 and 13 of Nur1 were similar to those observed with LBR1 (Fig. 27 & 
28), while photocrosslinking to Sec61α was most efficient from position 12 and much 
less efficient from position 11 (Fig. 28). Only a trace of photocrosslinking to Sec61α 
was obtained from position 10, in contrast to the trace photocrosslinking obtained from 
position 11 in the other three INM TMSs (Figs. 25, 26, 27). The asymmetry of the 
photocrosslinking to Sec61α and TRAM shows that the first nurim TMS is bound in a  
fixed orientation within the translocon. Furthermore, the nurim TMS clearly occupies a 
site in the translocon adjacent to TRAM. But the differences in photocrosslinking yields 
from different probe positions indicate that the nurim TMS does not interact with the 
translocon in exactly the same way as the viral TMSs.  
Non-INM TMS proximity to translocon proteins 
To determine whether the crosslinking patterns shown in Figs. 25-28 were unique to 
INM-directed membrane proteins, two non-INM TMSs were examined using the same 
techniques. The first TMS of leader peptidase (Lep1) has been shown previously to 
photocrosslink, at least transiently (Mothes et al., 1997; Heinrich et al., 2000; Heinrich et 
al., 2003) and in an asymmetric fashion (McCormick et al., 2003), with Sec61α. We 
therefore determined whether Lep1 also photocrosslinked to TRAM. The Lep1 construct 
was substituted with a single amber stop codon at each of four adjacent codons in the 
first TMS (Fig. 25A), and a 70-residue nascent chain of each of these constructs was 
translated, targeted, photolyzed, and examined as above. In contrast to the results 
obtained with INM-directed TMSs, Sec61α photocrosslinked to the Lep1 TMS from 
positions 11, 13, and, to a lesser extent, 10 (Fig. 29). But no photocrosslinking to TRAM 
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was detected from any of the four probe positions (for comparison, the extent of TRAM 
photocrosslinking obtained in a parallel sample containing a 70-residue E66-A11 
nascent chain is shown in lane 9 of Fig. 29).  Thus, the Lep1 TMS appears to occupy a 
fixed position within the translocon, but this site differs markedly from that occupied by 
the INM-directed TMSs. 
 
 
 
 
Figure 29. Photocrosslinking of Lep1 to translocon proteins. Integration intermediates 
containing 70-residue nascent chains of Lep1-A10, Lep1-A11, Lep1-A12, or Lep1-A13 were photolyzed 
and analyzed as in Fig. 22. Lep1-Sec61α photoadducts are indicated by the closed circle. As a positive 
control, a parallel sample containing 70-residue E66-A11 integration intermediate was 
immunoprecipitated with TRAM antibody (lane 9).  
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 Similarly, four probe locations in the TMS of transferrin receptor (TfR) 
photocrosslink asymmetrically to Sec61α, but they do not photocrosslink at all to 
TRAM (McCormick et al., 2003).  Thus, the TfR TMS occupies a specific site in the 
translocon during co-translational integration, but this site differs substantially from that 
occupied by the INM-directed TMSs. 
Nascent chain length-dependence of photocrosslinking 
Previous studies have shown that TMSs of non-INM proteins are retained in the 
translocon even when the length of the nascent chain is far in excess of that required to 
release the TMS into the lipid bilayer (McCormick et al., 2003; Do et al., 1996).  
Moreover, the lengthening of the nascent chain did not substantially alter the asymmetric 
photocrosslinking patterns obtained with different TMSs (McCormick et al., 2003). To 
assess the retention of INM TMSs in the translocon, we monitored the photocrosslinking 
of E66SM-A10 as a function of nascent chain length in parallel incubations (E66SM was 
created by fusing the N-terminal 33 amino acids of E66 to a lysine-free sequence 
described previously in Braunagel et al., 2004). After photolysis, the samples were split 
for immunoprecipitation with antibodies specific for either Sec61α or TRAM. The 
extent of E66SM-A10 (Fig. 30) photocrosslinking to Sec61α decreases rapidly as the 
nascent chain lengthens. At 70 residues, the TMS has just emerged from the ribosome, 
and lengthening the chain by 5-17 residues results in a substantial decrease in nascent 
chain photocrosslinking to Sec61α. By the time  the nascent chain reaches 100 residues, 
the E66 TMS has moved away from Sec61α. 
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Figure 30. Nascent chain length-dependence of E66 photocrosslinking to translocon 
proteins. Photoadducts were detected by immunoprecipitation with antisera specific for either Sec61α 
(A) or TRAM (B). Nascent chain lengths (amino acids) in the photolyzed E66SM-A10 (A) or -A11 (B) 
integration intermediates are indicated below the gel. Normally-terminated full-length 136-residue E66SM 
is shown in lanes A6 and B5. Photoadducts are identified as in Figs. 25-28. 
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In contrast, the E66 TMS was adjacent to TRAM until later in the process. The 
extent of E66SM-A11 (Fig. 30) photocrosslinking to TRAM was the same for nascent 
chain lengths of 75-87, but photoadducts were still visible when the nascent chain 
reached 120 residues (Fig. 30). Thus, during its passage through the translocon, the E66 
SM appears to remain adjacent to TRAM for a longer period of time than to Sec61α. 
SM sequence crosslinking to non-translocon proteins 
Another approach that can be used to identify proteins that associate with the SM 
sequence is chemical crosslinking. Since the E66SM construct contains only two lysine 
codons near the C-terminal end of the SM sequence (Fig. 25A), the crosslinking of the 
E66SM substrate to another protein via bis(sulfosuccinimidyl)suberate (BS3), a lysine-
specific homobifunctional reagent, would require a Lys residue on the target protein to 
be in close proximity to a Lys residue in the substrate. Since the sample contains many 
proteins with surface-exposed lysine amino groups, the detection of a specific covalent 
complex would be explained most reasonably by the association of the substrate SM 
sequence with a particular target protein. 
Using this approach, we showed that the SM sequence in full-length E66SM was 
chemically crosslinked to viral proteins FP25K and/or E26 (Braunagel et al., 2004). This 
crosslinking was observed in nuclei from insect Sf9 cells that had been infected with a 
recombinant baculovirus expressing E66SM. The crosslinking of E66SM with FP25K 
and/or E26 could be the result of a stable interaction occurring within the virion or 
represent a trafficking intermediate. To discern which of the two possibilities was true, 
E66SM was translated in the presence of ER microsomes isolated from virus-infected 
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Sf9 cells and then treated with the chemical crosslinker BS3. As was observed with the 
crosslinking experiments conducted in nuclei derived from virus-infected Sf9 cells, 
antibodies specific for the T7 epitope, immunoprecipitated a crosslinked complex of ~32 
kDa (Fig. 31, lane 4). Antibodies specific for the viral proteins FP25K and E26 were 
able to immunoprecipitate the crosslinked complex (Fig. 31, lanes 5 & 6). To confirm 
that the crosslinked complex did not represent a stable interaction occurring within the 
virion, antibodies that would precipitate the virus in various stages of maturation were 
used: p39, ODV-E25 and polyhedrin (precipitate nucleocapsids, mature virus and 
partially occluded virus respectively). None of the antibodies precipitated the crosslinked 
complex (Fig. 31, lanes 1-3), indicating that the crosslinked complex does not represent 
protein-protein interactions occurring within the assembled virion but rather represents a 
trafficking intermediate within the ER membrane. 
Having demonstrated that the full-length (ribosome released & membrane integrated) 
E66SM crosslinks with FP25K and/or E26, we wanted to determine at what point in 
E66SM integration the SM sequence interacts with FP25K and/or E26. Using 
microsomes from infected Sf9 cells, we observed essentially no crosslinking of E66SM 
nascent chains to FP25K (Fig. 32A) or E26 (Fig. 32B). Crosslinked species containing 
the substrate and one of the two putative sorting factors were only seen with full-length 
E66SM substrate polypeptides (Fig. 32). Thus, it appears that FP25K and/or E26 
associate with the SM sequence after it has been released from the translocon into the 
lipid bilayer. 
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Figure 31. The E66SM crosslinks with FP25K and/or E26. Full-length (normally 
terminated & ribosome released) E66SM protein was translated in the presence of virus-infected Sf9 
microsomes, chemically crosslinked, and immunoprecipitated with antisera specific for either ODV-E25 
(lane 1); p39 (lane 2); polyhedrin (lane 3); T7 tag (lane 4); FP25K (lane 5) and E26 (lane 6). The 
crosslinked product precipitated by the antibody is indicated by the arrowheads.  
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Figure 32. Nascent chain length-dependence of SM chemical crosslinking to FP25K 
and E26. (A) Nascent or full-length E66SM proteins were translated in the presence of virus-infected 
Sf9 microsomes, chemically crosslinked, and immunoprecipitated with antisera specific for either FP25K 
(A) or E26 (B) as before (Braunagel et al., 2004). Nascent chain lengths in integration intermediates are as 
indicated. Covalent crosslinks between full-length E66SM and FP25K or E26 are identified by the 
arrowhead adjacent to lane 5 in each gel. 
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Membrane association of FP25K & E26 
Most FP25K is present in the cell as a soluble, cytoplasmic protein (Rosas-Acosta et 
al., 2001). Clusters of FP25K associating with the ER at the nuclear periphery have been 
observed using immunogold labeling, but this observation is rare (Harrison et al., 1995). 
Thus, the identification of a membrane-associated form of FP25K that crosslinks to 
E66SM raised questions regarding the nature of its membrane association. When virus-
infected insect (Sf9) microsomes were washed with high salt (0.5M KOAc), FP25K was 
found to fractionate in the supernatant fraction (as detected by immunoblotting) (Fig. 
33). In contrast, a significant proportion of E26 was able to associate with the membrane 
pellet after treatment with high salt (Fig. 33). The fractionation pattern that we observed 
with E26 was similar to the one obtained with the ER integral membrane protein Sec61α 
(Fig. 34). Thus, while the membrane association of FP25K appears to be mediated via 
electrostatic interactions (either with the head groups of phospholipids, other integral 
membrane proteins etc.), the membrane association of E26 appears to be more stable. 
Although, E26 lacks any predictable TMS, the presence of an amphipathic helix, C-
terminal amidation site(s) have allowed us to explain its membrane association. More 
recently, E26 has also been shown to undergo palmitoylation during viral infection 
(unpublished data), which could be another explanation for its membrane association.  
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Figure 33. Membrane association of FP25K & E26. Virus-infected Sf9 microsomes were 
washed with high salt (0.5M KOAc) and sedimented using a high salt cushion. The resulting membrane 
pellet (P) and supernatant (S) fractions were analyzed by immunoblotting using antibodies specific for 
FP25K & E26. 
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Figure 34. Membrane association of Sec61α. Microsomes derived from canine pancreas were 
washed with high salt (0.5M KOAc) and sedimented using a high salt cushion. The resulting membrane 
pellet (P) and supernatant (S) fractions were analyzed by immunoblotting using antibodies specific for the 
translocon protein Sec61α. 
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However, one of the most important observations to consider is that the ER membrane-
associated forms of both FP25K and E26 represent only a small portion of the total 
FP25K or E26.  
Not every substrate crosslinks to FP25K and E26 
Lep1 contains lysines in approximately the same positions as E66SM, and hence it is 
pertinent to ask whether Lep crosslinks to FP25K or E26. No chemical crosslinks to 
FP25K (Fig. 35A, lane 1) or E26 (Fig. 35A, lane 3) were observed with nascent, 
puromycin-released Lep intermediates after integration into ER microsomes from 
infected cells. In contrast, efficient crosslinks to FP25K (Fig. 35A, lane 2) and E26 (Fig. 
35A, lane 4) were seen with full length E66SM after integration into infected ER 
microsomes and incubation with bis(sulfosuccinimidyl)suberate. The difference in the 
crosslinking efficiencies of Lep1 and SM were not based on differences in levels of 
translation (Fig. 35B). We therefore conclude that FP25K and E26 do not crosslink (and 
presumably do not bind to) every protein, but that they are selective in their association 
with substrates. 
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Figure 35. FP25K and E26 are selective in their association. (A) Integration intermediates 
containing 110-residue nascent chains of Lep1 were translated in the presence of virus-infected Sf9 ER 
microsomes, treated with 2 mM puromycin, chemically crosslinked, immunoprecipitated with antibodies 
to FP25K (lane 1) or E26 (lane 3), and analyzed by SDS-PAGE. In parallel samples, full-length E66SM 
was translated, crosslinked, and immunoprecipitated with antibodies to FP25K (lane 2) or E26 (lane 4). 
Covalent crosslinks between full length E66SM and FP25K or E26 are identified by the arrowhead 
adjacent to lane 4. (B) Aliquots of translation reactions containing either full-length E66SM protein  (lane 
1) or puromycin-released 110mer-Lep1 protein (lane 2) were removed prior to crosslinker addition and 
then analyzed by SDS-PAGE. The closed circle adjacent to lanes 1 & 2 identifies the translation products. 
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Discussion 
Several important conclusions can be drawn from the data reported here. First, the 
asymmetric photocrosslinking to TRAM and to Sec61α of each TMS examined here 
reveals that each is bound to a protein(s) within the mammalian translocon (cf. 
McCormick et al., 2003). Second, the proteinaceous environment within the translocon 
is very similar for both cellular and viral INM TMSs. Third, the proteinaceous 
environment within the translocon differs markedly for INM TMSs and for TMSs 
directed elsewhere. Fourth, an integrated viral SM sequence is crosslinked to two viral 
proteins after being released from the translocon in ER microsomes purified from 
infected insect cells. Fifth, this study confirms the widely-held presumption that some 
INM-directed proteins are targeted to the ER membrane by SRP and integrated 
cotranslationally at the translocon. Other INM proteins may be inserted post-
translationally as C-tail-anchored proteins (Wattenberg et al., 2001). Taken together, 
these results strongly suggest that some membrane protein sorting to the INM is initiated 
within the translocon early in the integration process, is protein-mediated, and involves 
substrate recognition by and interaction with a sequence of proteins that function as 
sorting factors to facilitate the movement of proteins to the INM. 
As discussed elsewhere (McCormick et al., 2003), the binding of a substrate TMS to 
a translocon protein is revealed by the non-random and asymmetric photocrosslinking of 
the TMS to TRAM and/or Sec61α from different photoreactive probe locations that 
encircle the middle of the cylindrical TMS α-helix. This high-resolution approach for 
characterizing a TMS’s environment within the translocon has so far been applied to 11 
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TMSs in this (Figs. 25-28) and in a previous study (McCormick et al., 2003). Since each 
of these 11 TMSs was not free to rotate and randomize its orientation relative to TRAM 
and Sec61α in the translocon, each TMS binds to a translocon protein(s). This 
interaction presumably plays a direct (but as-yet undefined) mechanistic and/or 
regulatory role in the integration process. 
When the translocon environments of the viral E66 and E25 TMSs were examined, 
the photocrosslinking of these two TMSs to TRAM and Sec61α were found to be 
indistinguishable (Figs. 25B & 26). In addition, a similar photocrosslinking pattern was 
obtained when the proximity of the first TMS of mammalian LBR to translocon proteins 
was investigated (Fig. 27). The close similarity of the photocrosslinking results for these 
three INM proteins seems more than coincidental. Furthermore, the first TMS of 
mammalian nurim also photocrosslinked to TRAM and Sec61α from the same probe 
positions as the other three TMSs, though the extent of Sec61α photocrosslinking from 
positions 10 and 11 of Nur1 was reversed from that of the other three substrate TMSs 
(Fig. 28). Most striking, however, was the observation that 4 of 4 INM TMSs were 
efficiently photocrosslinked to TRAM. Furthermore, these TMSs were in very similar, 
but not identical, proteinaceous environments or sites within the translocon based on the 
photocrosslinking-detected proximities of different TMS surfaces to Sec61α and TRAM. 
In contrast, of the 10 total non-INM-directed TMSs whose photocrosslinking to Sec 
61α and TRAM has been examined by different groups, only the two native TMSs of the 
VSV G protein (McCormick et al., 2003; Do et al., 1996) and the Ii invariant chain 
(Martoglio et al., 1995) were crosslinked to TRAM via photoreactive probes in the 
 119
middle of the TMS. Two non-native Lep derivatives with 1 or 2 charged residues 
inserted into the TMS were also photocrosslinked to TRAM (Heinrich et al., 2000). But 
the non-INM VSV G TMS was not located in the same site in the translocon as the INM 
TMSs. In fact, of the 7 non-INM TMSs that have been examined at high resolution using 
photoreactive probes on different TMS surfaces, none gave a photocrosslinking pattern 
similar to the 4 INM TMSs (McCormick et al., 2003) (Figs. 25-28). Although the Ii and 
two charged Lep TMSs have yet to be examined using the same approach, the clear 
distinction between the high-resolution photocrosslinking patterns of the 4 INM and 7 
non-INM TMSs strongly suggests that the two classes of TMS occupy different sites 
within the translocon. 
It is, of course, possible that INM and non-INM TMS binding sites within the 
translocon overlap to some extent. Consistent with the close juxtaposition of potentially 
different interaction sites within the translocon, both nascent secretory and nascent 
membrane proteins have previously been photocrosslinked to TRAM, usually from sites 
that flank the TMS or the nonpolar signal sequence core (e.g., Johnson & van Waes, 
1999; Falcone et al., 1999). On the other hand, because of variations in probe length, 
reactivity, location, and target atom, one must be cautious in extrapolating from a 
crosslink to a specific structural arrangement between two macromolecules. For 
example, the second TMS in opsin was chemically crosslinked to TRAM (Meacock et 
al., 2002), but no crosslinking to TRAM was detected when photoreactive probes were 
positioned in the middle of the second opsin TMS in a chimeric protein (McCormick et 
al., 2003). Thus, high-resolution experiments using multiple different probes will be 
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necessary to assess the extent to which the INM and non-INM TMS binding sites in the 
translocon overlap spatially and dynamically. 
Based on photocrosslinking data obtained with charged Lep1 mutants, Heinrich et al. 
(2000) proposed that TRAM interacts with TMSs that were charged or hydrophilic. Yet 
of the four INM-directed TMSs found adjacent to TRAM during integration, none 
contains a charged amino acid (Fig. 25A). Furthermore, based on the White-Wimley 
values (∆Gwoct – ∆Gwif) for quantifying amino acid movement from the aqueous to the 
nonpolar phase, the free energies of transfer of the 4 INM TMSs range from –3.0 
kcal/mole for the first nurim TMS to –10.5 kcal/mole for the E66 TMS (a more negative 
number indicates a more hydrophobic sequence)(Braunagel et al., 2004; White et al., 
1999). Thus, even the E66 TMS, which is the most hydrophobic of the 11 TMSs that we 
have thoroughly examined to date, is positioned adjacent to and photocrosslinks to 
TRAM during co-translational integration. It therefore appears that TRAM functions in a 
different or an additional role than that proposed by Heinrich et al. (2000). 
We have here compared the photocrosslinking targets of probes that are in different 
constructs, but are positioned the same number of residues from the N-terminus. Another 
approach would be to compare the photocrosslinking targets for probes positioned the 
same number of amino acids from another reference point, such as the N-terminal 
residue in the putative TMS. But since only small variations in photocrosslinking 
patterns were observed with E66, E25, LBR1, and Nur1 TMSs (Figs. 25-28), it appears 
that the differences in TMS length and location (i.e., the number of residues between the 
N-terminus and the putative start of the TMS) shown in Fig. 25A do not significantly 
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alter the positioning of the TMS within the translocon. Instead, TMS-translocon 
interactions are apparently dictated by some other feature of the TMS (see below). This 
conclusion is supported most strongly, of course, by the fact that the Lep1 TMS does not 
photocrosslink to TRAM (Fig. 29). 
What, then, is the key structural determinant of the SM that is recognized by the 
translocon? The sample size is still too small to provide a clear answer to this question, 
but there are some interesting clues in the results presented here. First, as was noted 
above, we have here examined constructs containing the first TMSs of LBR and nurim 
because these TMSs are important in terms of sorting to the INM (Soullam et al., 1995; 
Rolls et al., 1999) and we wished to facilitate comparisons with the INM-directed viral 
proteins that contain only a single TMS. Yet the orientation of the LBR1 TMS in the 
bilayer is opposite to the bilayer orientation of the same TMS in native LBR. Strikingly, 
and unexpectedly, both LBR1 and native LBR are sorted and directed to the INM 
(submitted). Since the LBR TMS is directed to the INM no matter what its orientation, it 
appears that the structural features recognized by the sorting machinery as a signal for 
INM-directed TMSs are not dependent upon the orientation of the TMS in the 
translocon. Second, both E66 and E25 are directed to the INM, even though E25 lacks 
the cytosolic positive charge that is characteristic of a SM sequence. Since the E66 and 
E25 TMSs photocrosslink to TRAM and Sec61α identically (Figs. 25B & 26), it appears 
that the positive charge that flanks the TMS is not involved in positioning an INM TMS 
at a particular site within the translocon. Moreover, both E66 and Lep1 have positive 
charges flanking the TMS, yet their TMSs occupy different locations in the translocon 
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(Fig. 25B, 29). It therefore appears that the properties of the TMS itself dictate where it 
moves in the translocon, while the positive charge may be important for interactions that 
occur after leaving the translocon, such as recognition and/or association with FP25K 
and/or E26 (Figs. 32, 35). These results, taken together, strongly suggest that the 
characteristic structural elements that identify a protein as an INM protein and initiate 
sorting to the INM are located within the TMS itself. Further experiments with multiple 
INM-directed TMSs and derivatives will be required to determine what TMS features 
correlate with INM sorting. 
The distinctive photocrosslinking pattern observed with INM TMSs indicates that 
INM and non-INM TMSs occupy distinctly different sites within the translocon, which 
in turn suggests that INM-directed TMSs are first identified and sorted by components of 
the translocon. Since INM TMSs are adjacent to both Sec61α and TRAM (Figs. 25-28), 
either or both could be actively involved in recognizing and sorting INM TMSs; future 
experiments will clarify their involvement. Also, since an INM TMS remains adjacent to 
TRAM longer than to Sec61α (Fig. 30), it is possible that TRAM may be involved in the 
hand-off of INM TMSs to the next participant in the putative INM sorting pathway. 
Upon leaving the translocon, the viral INM-directed proteins interact with other viral 
proteins that are required for sorting to the INM. Since viruses typically appropriate host 
mechanisms to achieve their objectives, the identification membrane-associated viral 
proteins that are predicted as required for the sorting of viral proteins to the INM 
strongly suggests that a similar host protein(s) may also be involved in INM sorting.  
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CHAPTER IV 
IDENTIFICATION OF ACCESSORY PROTEINS INVOLVED IN 
THE SORTING OF E66 TO THE INM 
Experimental design 
The first 33 amino acids of E66 (referred to as the SM) contain the information for 
sorting proteins to the INM (Hong et al., 1997; Braunagel et al., 2004). Because the SM 
sequence is sufficient to direct a polypeptide to the INM, this sequence must contain the 
structural features that constitute an INM-sorting signal. If sorting is protein mediated, 
then recognition of this sequence would require a direct interaction between the SM 
sequence and a protein involved in sorting. A direct method for detecting interacting 
proteins is crosslinking because a substrate can react covalently only with proteins that 
are in close proximity. 
Crosslinking experiments in a complex biochemical system that includes the 
substrate of interest, ribosome, ER microsomes, and many associated factors can yield a 
myriad of crosslinked proteins. However, by selectively positioning photoreactive or 
chemical probes only in the substrate (of interest), one can limit the crosslinking targets 
solely to those proteins adjacent to the substrate. In order to accomplish this, we have 
performed crosslinking experiments using the E66SM construct (Braunagel et al., 2004), 
which contains the first 33 amino acids of E66 (SM) fused to a K/C free domain of BCl-
2. The K/C free sequence of the BCl-2 domain allows for selective incorporation of 
probes (amine- or sulfhydryl reactive) into the SM region of the fusion protein and thus 
enables us to directly monitor the proteinaceous environment of the SM sequence. In 
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addition, the encoded fusion protein carries a C-terminal (His)7 tag as well as the T7 
epitope that can be used either singly or in tandem for detection and/or purification of 
crosslinked complexes. 
The SM sequence is adjacent to two cellular proteins: SMAP-10 & SMAP-25 
Since, the SM-C construct contains only two lysine codons near the C-terminal end 
of the SM sequence (Fig. 36A), the proteinaceous environment of the SM sequence can 
be directly monitored using a lysine-specific crosslinking reagent, and any crosslinked 
product(s) can be detected and/or purified via the (His)7 tag (using TALON beads). Also, 
since the sample contains many proteins with surface-exposed lysine amino groups, the 
detection of a specific covalent complex would be explained most reasonably by the 
association of the substrate SM sequence with a particular target protein. Using this 
approach, we showed that the SM sequence was chemically crosslinked to viral proteins 
FP25K and/or E26, either in nuclei from insect Sf9 cells that had been infected with a 
recombinant baculovirus expressing SM-C or when SM-C was cotranslationally 
integrated into ER microsomes from infected cells in vitro (Braunagel et al., 2004; 
chapter III in this study).  
The potential existence of viral proteins that associate (crosslink) with the SM 
sequence led us to examine more closely the environment of the SM sequence in ER 
microsomes purified from uninfected Sf9 cells. When the proximity of SM-C to other 
proteins was examined by chemical crosslinking, a prominent crosslinked species with a 
relative mobility (Mr) of about 10 kDa was observed (Fig. 36B, lane 2). This cellular 
protein was tentatively named SM-associated protein or SMAP-10. In addition to 
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SMAP-10, the SM-C also crosslinked to another cellular protein with a relative mobility 
(Mr) of about 25kDa (Fig. 36B, lane 2) that was tentatively named SMAP-25. No 
crosslinks to SMAP-10 or SMAP-25 were seen when the samples were not treated with 
chemical crosslinker (Fig. 36B, compare lanes 1 & 2). 
To assess the generality of this observation, SM-C was translated in an in vitro 
incubation containing ER microsomes purified from canine pancreas. As shown in Fig. 
36B (lane 4), SM-C crosslinks to a ~10 kDa protein with an efficiency similar to that 
seen in the insect microsomes (Fig. 36B, lane 2). It therefore appears that even divergent 
(insect and mammalian) species contain an endogenous protein that associates with the 
SM sequence after it has been released from the translocon.  
Since the TMS within the SM sequence contains a cysteine residue, we wished to 
determine whether crosslinks to SMAP-10 could also be observed using sulfhydryl 
group- reactive crosslinkers. To this end, crosslinking reactions were performed using 
homo-and hetero-bifunctional sulfhydryl group-reactive crosslinkers (BMH and MBS 
respectively). As shown in Fig. 37A, crosslinks to SMAP-10 were seen in both the cases 
(lanes 2 and 3), and the highest efficiency of crosslinking was observed using BMH 
(compare lanes 1-3). This indicates that SMAP-10 contains cysteine residue(s) that are 
adjacent to the TMS of the SM sequence.   
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Figure 36. Chemical crosslinking of E66SM to SMAP-10 & SMAP-25. (A) The N-
terminal sequence of the SM-C and Lep1 constructs is shown with the TMS underlined. (B) The (His)6-
tagged SM-C construct was translated in the presence of Sf9 microsomes (lanes 1 & 2) or canine 
pancreatic microsomes (lanes 3 & 4), and either treated with 50µM BS3 (lanes 2 & 4) or with crosslinking 
buffer alone (mock) (lanes 1 & 3). Following crosslinking, the samples were incubated with TALON 
beads to purify the (His)6-tagged translation product and any crosslinked product(s). The samples that 
received the crosslinking buffer alone (mock) or the chemical crosslinker are identified by the symbols 
“0” and “X” respectively. Covalent crosslinks between SM-C and SMAP-10 or SMAP-25 are identified 
by the closed circle and asterix respectively.  
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Figure 37. SMAP-10 crosslinking  using different chemical crosslinkers and 
substrates. (A) SM-C construct was translated in the presence of Sf9 microsomes and crosslinking 
reactions were performed using three different chemical crosslinker: BS3, BMH and MBS. The 
crosslinked product(s) were purified using TALON beads. Crosslinks to SMAP-10 are identified by the 
closed circle. (B). (His)6-tagged SM-C and Lep1 constructs were translated in the presence of Sf9 
microsomes and either treated with 50µM BS3 (lanes 2 & 4) or with crosslinking buffer alone (mock) 
(lanes 1 & 3). The crosslinked product(s) were purfiied using TALON beads as in (A). 
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We previously demonstrated that the viral proteins FP25K and E26 do not associate 
with the first TMS of leader peptidase (Lep1) even though Lep1 contains lysines in 
approximately the same position as the SM sequence (chapter III in this study). To test 
whether cellular SMAP-10 exhibits similar substrate specificity, the Lep1 construct (Fig. 
36A) was translated in vitro and treated with the lysine-specific crosslinker. No 
crosslinks to SMAP-10 were observed with Lep1 (Fig. 37B, lane 2) in contrast to the 
efficient crosslinking observed with SM-C (lane 4).  
Having demonstrated that cellular SMAP-10 exhibits substrate specificity similar to 
the viral proteins FP25K and E26, we wanted to test whether SMAP-10 associates 
(crosslinks) with the SM sequence only after release from the translocon {as observed 
with the viral proteins (chapter III in this study)}, or if it can associate prior to translocon 
release. To this end, we examined the proximity of SM-C nascent chains (nascent 
implying a ribosome-bound integration intermediate) to other proteins by chemical 
crosslinking at different stages of integration. Although crosslinks to SMAP-10 were 
seen with the different SM-C nascent chains (Fig. 38, lanes 1-5), the efficiency of SM-C 
crosslinking to SMAP-10 increased dramatically upon release from the translocon 
(denoted as 136-R; Fig. 38, lane 6). These experiments reveal that the SM sequence is in 
close proximity to SMAP-10 before and after leaving the translocon. 
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Figure 38. SM sequence is in close proximity to SMAP-10 before and after the 
leaving the translocon. (His)6-tagged nascent or full-length (ribosome-released) SM-C proteins were 
translated in the presence of Sf9 microsomes, chemically crosslinked (using 50µM BS3), and subjected to 
TALON purification. Nascent chain lengths (amino acids) in the chemically-crosslinked SM-C integration 
intermediates are indicated below the gel. Normally terminated (ribosome-released) full-length SM-C 
(indicated as 136-R) is shown in lane 6. Covalent crosslinks between the SM-C integration intermediates 
and SMAP10 or SMAP25 are identified as above.  
 
  
 130
BV/ODV –E26 shares epitopes with SMAP-10 
Since viruses are highly skilled at manipulating cellular pathways, and the Mr of 
SMAP-25 is similar to the molecular mass of the two viral proteins (FP25K & E26) that 
have been shown to crosslink with SM-C, antibodies specific for viral FP25K & E26 
were tested for cross-reactivity with a cellular protein of similar Mr using Sf9 extracts. 
Antisera specific for FP25K demonstrated no cross-reactivity, however antibodies raised 
against bacterially expressed E26 cross-reacted predominantly with a cellular protein of 
~25kDa, and to a lesser extent with a cellular protein of ~10kDa. Since, this cross-
reactivity was seen in both Sf9 extracts and Sf9 microsomes (Fig. 39) we decided to test 
whether the E26 antiserum could recognize either SMAP-10 or SMAP-25.  
 
 
 
Figure 39. E26 antiserum crossreacts with a ~25kDa cellular protein.  Thirty 
equivalents each of virus-infected microsomes (I) and uninfected Sf9 microsomes (U) were resolved by S-
PAGE and immunoblotted using the E26 antiserum (generous gift of Jared Burks).  
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To this end, the SM-C construct was translated in vitro in the presence of Sf9 
microsomes, and following crosslinking, the samples were either incubated with 
TALON beads or the E26 antiserum. As shown in Fig. 40, the E26 antiserum was able to 
precipitate a radiolabeled product (lane 2) having the same Mr as the crosslinked 
complex purified via the (His)6 tag on the SM-C (Fig. 40 lane 1 & Fig.36B lane 2), 
indicating that the molecular mass of the protein recognized by the E26 antiserum is 
similar to SMAP-10. The immunoprecipitation reaction was specific, since the 
preimmune serum failed to precipitate the crosslinked complex (Fig. 40, lane 3).  
Having shown that SMAP-10 can associate with the SM sequence both before and 
after it leaves the translocon (Fig. 38), we decided to test whether the cellular protein 
recognized by E26 antiserum also demonstrated the same ability. As shown in Fig. 41A, 
the protein recognized by E26 antiserum was able to associate with the SM sequence 
both before (Fig. 41A, lanes 1-5) and after it was released from the translocon (denoted 
as 136-R; Fig. 41A, lane 6). Thus, as previously observed with SMAP-10 (Fig. 38), the 
cellular protein recognized by E26 antiserum appears to be translocon-associated (Fig. 
41A) and not unique to insect microsomes, but also present in microsomes derived from 
mammalian (canine pancreatic) cells (Fig. 41B). 
Put together, these results suggest that the E26 antiserum recognizes epitopes within 
Sf9 SMAP-10. As such, the antiserum should serve as a useful tool in the identification 
of SMAP-10, and hence was used to screen an Sf9 cDNA expression library. 
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Figure 40. E26 shares epitopes with cellular SMAP-10. The SM-C construct was translated 
in the presence of Sf9 microsomes. Following translation, the membrane pellet was recovered by 
sedimentation, treated with the chemical crosslinker, and the crosslinked products were either purified 
using TALON beads (lane 1), or immunoprecipitated using the E26 antisera (lane 2), or 
immunoprecipitated using pre-immune antiserum (lane 3). 
  
  
       
 
Figure 41. Immunoprecipitations using E26 antiserum. Crosslinked adducts containing SM-C derived from Sf9 (A) or canine pancreatic 
(B) microsomes were detected by immunoprecipitation using the E26 antiserum. Nascent chain lengths in the samples were the following: 60 in lane 1; 
74 in lane 2; 105 in lane 3 ; 120 in lane 4; 130 in lane 5. Samples containing normally terminated SM-C polypeptide chains (denoted as 136-R) are 
shown in lane 6. Crosslinked adducts are indicated by the closed circles. 
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Antibody screening of an Sf9 cDNA expression library using E26 antibody 
identifies clone 2 
A lambda-ZAP cDNA expression library comprised of cDNA fragments derived 
from Sf9-mRNA (provided by Christian Gross) was used to infect E.coli (BB4) cells at 
an appropriate dilution. The resultant plaques containing phage particles expressing a 
beta-galactosidase fusion of the cDNA insert were transferred onto nitrocellulose 
membranes and probed with the E26 antisera (provided by Jared Burks). Following 
incubation with the antibody, the blots were treated with [125I]-Protein A to allow for 
visualization of the positive plaques using autoradiography. The results of a typical 
primary screen and secondary screen are depicted in Fig. 42. Typically, an isolated 
positive plaque obtained from the primary screen generated several positive plaques on 
the secondary screen. A total of 40 primary positive plaques were subjected to secondary 
and tertiary rounds of antibody screening prior to phagemid rescue, excision and 
sequencing of the cDNA insert(s).  
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Figure 42. Sf9 cDNA expression library screen. The results of a typical primary and 
secondary screen are depicted in (A) and (B) respectively. The positive plaques are identified by the 
arrowheads in (A).  
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Sequence analyses revealed that a significant majority (33/40) of the plaques 
contained only the C-terminal 20-30 amino acids (including the in frame stop codon) of 
the insert, which proved to be insufficient (too short) to provide any meaningful 
information regarding the identity of SMAP-10. However six plaques were found to 
contain the same cDNA insert  (454 amino acids) referred to as clone 2 (Fig. 43). The 
high representation of clone 2 sequence in the positives identified by the E26 antiserum 
and the identification of a large region of the ORF (454 amino acids) led us to focus on 
it, to determine the identity of SMAP-10. Another positive identified in the screen, clone 
15 (504 amino acids) was also analyzed but it did not associate with the viral SM-C.  
While, the E26 antiserum crossreacted with SMAP-10 (Fig. 40), the protein encoded 
by clone 2 consists of atleast 454 amino acids. Although, the molecular mass of the 
clone 2- encoded protein was far in excess of 10kDa we tested whether any portion (N- 
or C- terminal domain/internal fragment) of clone 2 could associate (crosslink) with SM-
C. ER microsomes containing membrane-integrated and (His)6-tagged SM-C were added 
to translation reactions programmed with transcripts encoding T7-tagged versions of a 
series of clone 2 derivatives (Fig. 44A & 44B). Since two derivatives (Met310-454 & 
Met356-454; Fig. 44B: construct # 5 & 6) lacked any lysine residue, the crosslinking 
reactions were performed using the sulfhydryl-reactive crosslinker, SMPB rather than 
the lysine-specific crosslinker BS3. The presence of unique tags on the in vitro generated 
clone 2 derivative(s) (T7 tag) and the membrane-integrated SM-C {(His)6 tag}allows the 
specific detection of a crosslinked complex. 
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Figure 43. Clone 2 identified in the screen using E26 antiserum. The annotated sequence 
of clone 2 identified in the library screen is shown. The PE oligo used for primer extension analysis is 
underlined. The transcription initiator sequences identified by primer extension are indicated by the red 
asterix, and the corresponding initiator methionine residues are highlighted in yellow.  
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Figure 44. Clone 2 derivatives and set up of chemical crosslinking reactions. (A). The 
set-up of the chemical crosslinking reaction is depicted. The different clone 2 derivatives are translated in 
the presence of SM-C microsomes. Any complex containing the clone 2 derivative chemically-crosslinked 
to SM-C (in the membrane) can be either purified using TALON beads, since the SM-C in the membrane 
is (His)6 tagged  or immunoprecipitated using antibodies specific for the T7 epitope, since the in vitro 
translated product is radiolabeled (indicated by the asterix) and T7 tagged. (B). The different derivatives of 
clone 2 generated in vitro are shown. The asterix indicates the in frame stop codon either naturally 
occuring in the clone 2 ORF (codon 454) or introduced by PCR (codon 309) to generate internal truncates 
of clone 2. The expected molecular weight (MW) of the different clone 2 derivatives and chemically 
crosslinked products (if any) with SM-C are indicated. 
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No crosslinked complexes containing SM-C (whose expected molecular masses are 
indicated in Fig. 44B) were purified (using TALON beads) when crosslinking 
experiments were performed using different derivatives of clone 2 initiating at Met356 
(Fig. 45, lane 2), Met130 (data not shown) or the initiator methionine (Met1) (data not 
shown). In contrast, the clone 2 derivative initiating at Met310 was able to crosslink with 
SM-C in the microsomes: this association was dependent on the presence of crosslinker 
(Fig. 45, lanes 3 & 4), and the crosslinked product (of the expected molecular weight: 
Fig. 44B) could be purified using TALON beads. The crosslinked product could also be 
immunoprecipitated using antibodies specific for the T7 epitope (lane 5). The results of 
the crosslinking experiment demonstrated that a derivative of clone 2 (Met310-454) 
contains the structural features necessary for association with SM-C.  
Similar crosslinking experiments were conducted using a series of in vitro generated 
derivatives of clone 15 (data not shown). However, no crosslinking to SM-C was 
observed with any of the clone 15 derivatives. 
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                                              Met356-454            Met310-454
 
Figure 45. Crosslinking of clone 2 derivatives. In vitro generated transcripts initiating either at 
Met310 or Met356 and T7 tagged at the C-terminus were generated using SP6 RNA polymerase. The 
transcripts were translated in vitro in the presence of SM-C microsomes, treated either with crosslinking 
buffer alone (lanes 1 & 3) or with 50µM SMPB (lanes 2, 4 & 5), and either purified using TALON beads 
(lanes 1-4) or immunoprecipitated using antibodies specific for the T7 epitope (lane 5). The crosslinked 
product purified by the TALON beads and immunoprecipitated by antibodies specific for the T7 epitope is 
indicated by the closed circle adjacent to lane 4 and the arrowhead adjacent to lane 5 respectively. 
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We had previously determined that the ~10kDa cellular protein recognized by E26 
antiserum remains membrane-associated when alkaline conditions (sodium carbonate at 
pH 11.5) are used to strip the microsomal membranes of peripherally associated proteins 
(data not shown). When a similar test was performed using the different derivatives of 
clone 2, the Met310-454 derivative remained membrane associated (Fig. 46, lane 4). In 
contrast, membrane association of the Met356-454 derivative (lanes 1 and 2) and the other 
clone 2 derivatives (lanes 5-12) was sensitive to alkaline treatment. Thus, the Sf9 cDNA 
(clone 2) identified using the E26 antisera encodes within its sequence a protein, Met310-
454 that has the following features: (1) has a molecular mass {16 kDa} similar to that 
predicted for SMAP-10; (2) contains epitope(s) that are shared with viral E26; (3) 
crosslinks with the SM-C; and (4) remains membrane-associated under alkaline 
conditions.  
Met310-454 is a translocon-assciated protein 
Crosslinking data shows that SMAP-10 is adjacent to the SM sequence before it is 
released from the translocon (Fig. 38), indicating that it is a translocon-associated 
protein. Since, antibodies specific for Met310-454 are currently not available, we used an 
alternate approach to directly test its ability to associate with translocon components. 
Met310-454 was translated in vitro, and incubated posttranslationally with canine 
pancreatic microsomes and two different concentrations of SMPB. When the 
crosslinking reactions were analyzed by SDS-PAGE, a prominent crosslinked product of 
~56kDa was observed (Fig. 47A lanes 1 & 4), indicating crosslinks to one of the  
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Figure 46. Membrane association of clone 2 derivatives. The membrane association of the 
different clone 2 derivatives was examined by peforming in vitro translations followed by treatment with 
Na2CO3 (pH 11.5) and sedimentation through an alkaline cushion. S, proteins in the supernatant fraction 
after carbonate extraction; P, nonextracted proteins in the carbonate pellet.  
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Figure 47. Met310-454 is a translocon-associated protein, which is selective in 
substrate selection. (A). Met310-454 was translated in vitro, incubated posttranslationally with canine 
pancreatic microsomes and treated with either 50µM SMPB (lanes 2, & 5) or with 100µM SMPB (lanes 3 
& 6). Following the crosslinking reaction, the samples were immunoprecipitated by using either antibodies 
specific for Sec61α (lanes 2 & 3), or antibodies specific for TRAM (lanes 5 & 6). Aliquots of the 
crosslinking reactions analysed in lanes 2 & 5, were removed prior to immunoprecipitation and analysed 
in lanes 1 & 4. The crosslinked product and immunoprecipitated material are identified by the arrowheads. 
(B). Met310-454 was translated in the presence of Sf9 microsomes containing cotranslationally integrated 
SM-C and Lep1. Following crosslinking with the BS3, the samples were incubated with TALON beads, 
and analyzed by SDS-PAGE. The crosslinker concentrations used are indicated and the sample labeled ‘O’ 
represents the sample which received only the crosslinking buffer (mock).  
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translocon protein(s) Sec61α or TRAM (both of which are ~40kDa).   Crosslinks to 
Sec61α were seen at both the crosslinker concentrations tested as judged by the ability 
of antibodies specific for Sec61α to immunoprecipitate the crosslinked complex (lanes 2 
& 3). In contrast, extremely inefficient or no crosslinking was seen with the translocon 
protein TRAM (Fig. 47A, lanes 5 & 6). The ability of Met310-454 to be chemically-
crosslinked to the translocon component Sec61α, suggests that analogous to SMAP-10, 
it is a translocon-associated protein and thus is able to gain access to the SM sequence 
while it is still being synthesized by the ribosome (Fig. 38).  
Having demonstrated that Met310-454 is associated with the translocon, we wished to 
determine whether it exhibited the same substrate specificity as SMAP-10. To this end, 
we examined the ability of in vitro translated Met310-454 to associate (crosslink) with 
(His)6-tagged SM-C and Lep1 cotranslationally integrated into Sf9 microsomes. As 
shown in Fig. 47B, the crosslinked complex containing Met310-454 chemically crosslinked 
to SM-C was purified using TALON beads (lane 2). In contrast, no crosslinked complex 
containing Met310-454 crosslinked to Lep1 was purified, indicating that analogous to 
SMAP-10, Met310-454 is selective in substrate association.   
Met310-454 is derived via internal initiation of transcription 
There are multiple ways to produce a smaller protein from a larger cDNA. It is 
possible that although the E26 antisera recognized clone 2; a smaller copy number, 
alternatively spliced cDNA is the source of the cellular SMAP-10 like protein (Met310-
454). It is equally possible that this smaller protein is a product of proteolytic or post 
translational processing, or transcriptional initiation at an internal methionine residue 
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(selection of alternative initiation sites). Examination of the clone 2 (cDNA) sequence 
revealed the presence of two internal arthropod promoter motifs (CAGT and GATA) 
associated with transcription initiation elements, including a TATA box and an 
appropriately spaced Met start codon (Met310). Thus, it was straightforward to test if 
transcripts corresponding to internal transcription initiation sites of clone 2 were 
produced.  
To test for internal transcripts (if any) derived from internal initiation, we isolated 
total cellular RNA from  Sf9 cells and performed primer extension analyses using a 
primer [PE oligo] that anneals downstream of Met310 (Fig. 43). The results of primer 
extension analyses show that three internal transcripts are produced from this larger 
cDNA (Fig. 48A). One transcript initiation site corresponds with a known insect 
promoter (GATA box) with an appropriately spaced (24nts) upstream TA rich sequence. 
The first methionine residue associated with this promoter sequence is Met310, and this 
transcript would encode the Met310-454 isoform of clone 2 (Fig. 43). The second transcript 
which initiates at a cryptic sequence (CGACT) (Fig. 46B), would encode the Met356-454 
isoform of clone 2 (Fig. 43). Thus, consistent with our hypothesis Met310-454 represents 
an isoform of clone 2 derived via internal initiation of transcription.  
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Figure 48. Primer extension analysis. Transcription initiation sites were mapped using 100µg of 
Sf9 RNA. The sequence of the oligo used for primer extension (PE oligo), and the sequence of clone 2 
where it anneals are indicated in Fig. 43. (A) and (B) represent the resolution of the two internal initiation 
products.  
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Met310-454 is an isoform of Sf9 importin α 
The combined data suggest that the smaller isoform of the clone 2-encoded protein 
(Met310-454) shares a number of features with SMAP-10: (1) the molecular mass of the 
encoded protein (16.2kDa) is close to the predicted molecular mass of SMAP-10; (2) 
both proteins share epitopes with the viral protein E26 (Fig. 40); (3) both proteins 
associate with the SM sequence before and after it is released from the translocon (Figs. 
38 & 41); (4) both proteins appear to be associated with the translocon (Figs. 38, 41 & 
47A); (5) both proteins exhibit substrate specificity (Figs. 37B & 47B) and (6) both 
proteins are insoluble in sodium carbonate at pH 11.5 (Fig. 46). Yet, while the growing 
evidence suggests that Met310-454 and SMAP-10 are the same protein, these observations 
provide no information regarding the identity of Met310-454 or SMAP-10. To gain insights 
into the identity of clone 2 and its smaller isoform (Met310-454), computer-based sequence 
homology searches were performed.  
The BLAST search paradigm (Altschul et al., 1990) revealed that clone 2 displayed 
significant sequence homology with the nuclear transport adaptor protein: importin α 
(Fig. 49). If this predicted homology were true, one might expect antibodies specific for 
importin α to recognize the SM•SMAP-10 (SM•Met310-454) crosslinked complex 
(provided the epitope used to generate the antibodies shared sequence/fold homology 
with the Met310-454 sequence). To test this possibility, antibodies raised in mice against 
the C-terminal 244 residues (underlined in Fig. 49) of Drosophila Karyopherin α3 or 
human Rch1 were tested for their ability to precipitate the SM•SMAP-10 crosslinked  
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Figure 49. SMAP-10 is an Sf9 importin alpha isoform. The sequences of different importin alpha 
isoforms from Arabidopsis (O04294), Saccharomyces cerevisiae (Q02821), Drosophila melanogaster (O76521), and Homo sapiens 
(O15131) were aligned with the clone 2-encoded protein (indicated as Sf9 importin alpha). Identical amino acids (based on 
conservation within the Sf9 importin alpha sequence) are shaded in yellow; similar amino acids are indicated in blue. The major 
(ARMs 2-4) and minor (ARMs 7-9) NLS-binding sites are highlighted in orange. The exportin (CAS)-binding site (ARM 10) is 
highlighted in green. The initiator methionine residue (Met310) of SMAP-10 is highlighted in red. 
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Figure 50. Immunoprecipitation using antibodies specific for Karyopherin alpha. 
Crosslinked adducts between SM-C and SMAP-10 derived from Sf9 microsomes were detected by 
immunoprecipitation using antibodies raised against drosophila karyopherin α3. The epitope used for 
generating this antibody is underlined (solid black line) in Fig. 44. Nascent chain lengths in the samples 
were the following: 60 in lane 1 ; 74 in lane 2 ; 105 in lane 3 ; 120 in lane 4 ; 130 in lane 5. Samples 
containing normally terminated (ribosome-released) SM-C (136-R) polypeptide chains are shown in lane 
6. Crosslinked adducts are indicated by the closed circles. 
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complex. As observed with the E26 antiserum, the importin α antiserum was able to 
precipitate the complex containing SMAP-10 crosslinked to a variety of SM-C 
integration intermediates (ribosome bound) (Fig. 50 lanes 1-5) as well as the full-length 
protein that has been released from the translocon and integrated into the membrane 
bilayer (denoted as 136-R, lane 6).  
In addition to sequence homology searches we (in collaboration with Christos Savva, 
Texas A&M University) used the program CPHmodels 2.0 {X3M a computer program 
to extract 3D models} (Lund et al., 2002) to perform homology-based modeling of clone 
2 (Sf9 importin α). In this program, a large sequence database is iteratively searched to 
construct a sequence profile until a template can be found in a database of proteins with 
known structure. Query and template sequences are subsequently aligned using a score 
based on profile-profile comparisons. The results of the modeling program revealed that 
a significant portion (residues 62-302; side chains depicted in yellow in Fig. 51) of the 
Sf9 importin α (shaded red in Fig. 51) has a three dimensional fold similar (super 
imposable) to mouse importin α (PDB code: 1IAL) (shaded purple in Fig. 51). The 
region of mouse importin α that shares a similar fold with Sf9 importin α includes the 
region between ARM 2 and ARM 6 (including the major NLS-binding site). However, 
there was not enough sequence homology between the insect and mouse importin α 
isoforms in the region between ARM 7 and ARM10 for the program to model the Sf9 
importin α in three-dimensional space (the region of mouse importin α that could not be 
used as a template for modeling Sf9 importin α is shaded blue in Fig. 51).  
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Thus, the results of the modeling program indicate that clone 2 represents an isoform 
of Sf9 importin α whose C-terminal (ARM 7-ARM10) fold is different from importin α 
isoforms of other (mouse) species. Interestingly, SMAP-10 (Met310-454) initiates very 
close to the start of ARM 7, and hence represents a novel, membrane-bound Sf9 
importin. 
 
 
 
Figure 51. Homology based modeling. The program CPHmodels 2.0 was used to perform homology-based 
modeling of clone 2 (Sf9 importin α). The predicted three-dimensional fold (homology-based) of Sf9 importin α is shaded in red. 
Region of Mouse importin α (1IAL) that has good homology with Sf9 importin α is highlighted in purple, and the region with low 
homology is shaded in blue. The side chains of the first (Q62) and the last (T302) residue within the Sf9 importin α sequence to be 
modeled based on homology are indicated in yellow.  
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Discussion 
In this work, we have analyzed the proteinaceous environment of the E66 SM 
sequence in ER microsomes purified from insect Sf9 cells. Five major conclusions can 
be drawn from our results. First, we have identified a membrane-bound Sf9 importin α 
isoform (SMAP-10) that associates with the SM sequence before and after it leaves the 
translocon. Second, transcription is initiated at at least three internal sites within the Sf9 
importin α gene resulting in three different isoforms. One of the isoforms obtained via 
internal initiation is SMAP-10. Third, SMAP-10 shares epitopes with viral E26, which 
was previously shown to associate with the E66 SM (Braunagel et al., 2004; this study). 
Fourth, we demonstrate that SMAP-10 is a translocon-associated protein, which is 
selective in substrate association, indicating that it may potentially be involved in 
membrane protein sorting to the INM.  Fifth, crosslinks to SMAP-10 are seen in ER 
microsomes purified from insect and mammalian cells, suggesting that this protein is 
found in divergent species.  Finally, the results of this study and our previous work 
(Braunagel et al., 2004) suggest that the sorting of INM proteins at the ER membrane is 
a protein-mediated, multistep process in which the INM sorting signal sequentially 
associates with various sorting factors. 
There is growing evidence that protein transport to the INM is not mediated by 
simple diffusion in the interconnected ER and nuclear membranes as proposed by the 
diffusion-retention model (Worman et al., 2000). The INM transport process instead 
appears to be energy-dependent (Ohba et al., 2004), and mediated by other proteins, 
which are potentially involved in the active restructuring of the NPC to facilitate protein 
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movement across the lateral channels (Ohba et al., 2004). Also, if INM transport were 
governed by simple diffusion alone, one would predict INM localization of a substrate to 
be independent of any other protein(s) or putative interacting partner(s). However, a 
recent report by Murthi et al. shows that YIL090W/Ice2p, an integral membrane protein 
located in the ER, is necessary for efficient tethering of Trm1p-II-GFP (tRNA specific 
m22G methyltransferase) to the INM. In addition, the INM transport process exhibits 
remarkable specificity contrary to the randomness predicted by simple diffusion in the 
interconnected membranes (Smith & Blobel, 1993; Soullam & Worman, 1993; Soullam 
& Worman, 1995; Ellenberg et al., 1997; Furukawa et al., 1995; Lin et al., 2000; Rolls et 
al., 1999; Imreh et al., 2003). This specificity reflects the existence of sorting events 
mediated by putative INM-sorting factors, which confer directionality to protein 
transport towards the INM and prevent random protein distribution.  
This study identifies a membrane-bound, isoform of Sf9 importin α that includes the 
NLS-binding site (ARMS 7-9), and the CAS binding site (ARM 10), and appears to play 
a role in the sorting of proteins to the INM. Although it has been proposed that importin 
α acts as an adaptor molecule between importin β and cNLS-bearing proteins, we show 
that SMAP-10 associates with the INM sorting signal within E66 without the need for 
importin β. This is not totally surprising, since soluble importin α has recently been 
shown to transport CaMKIV to the nucleus through the central channel of the NPC 
without the need for importin β (Kotera et al., 2005). Although one needs to be careful 
while drawing parallels between importin α-mediated transport through the central 
channel of the NPC and importin α-mediated transport in the membranes of the nuclear 
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envelope, the fact that soluble importin α can facilitate nuclear import in an importin β-
independent process, allows us to speculate that the same case may be applicable in 
membrane protein transport. The crosslinking data presented in this paper does not 
provide any information regarding function of the SM•SMAP-10 interaction, however, 
based on what is known about the function(s) of soluble importin α, it is tempting to 
speculate that SMAP10 functions as a nuclear transporter (carrier) that facilitates protein 
sorting to the INM. As described by Kotera et al (Kotera et al., 2005), at least three 
requirements must be satisfied for a molecule to be classified as a nuclear transporter: 
the ability to form a complex with a cargo protein, the ability to penetrate the NPC on its 
own, the ability to release the cargo and return to the cytoplasm for another round of 
trafficking.  
By examining the proximity of SM-C nascent chains to other proteins using 
chemical crosslinking at different stages of integration, we examined the first 
requirement for SMAP-10 to be classified as a nuclear transporter (carrier). Although, 
crosslinks to SMAP-10 were seen with the SM-C integration intermediates (Fig. 38, 
lanes 1-5), the highest efficiency of SM-C crosslinking to SMAP-10 was observed with 
the full length protein that had been released from the translocon (lane 6). The increased 
crosslinking may result from easier access of the reagent to the lysines in the absence of 
the translocon, a more favorable alignment of the lysines or cysteines in the SM•SMAP-
10 complex after the proteins leave the translocon, and/or an increase in SM•SMAP-10 
association in the absence of the translocon proteins that bind to SM (chapter III in this 
study).  Whatever the case, these experiments confirm the formation of a complex 
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between the SM sequence (putative cargo/substrate) and SMAP-10 (carrier) (Figs. 36, 
38). Although, the structures of the Saccharomyces Cerevisiae and Mus musculus 
importin α’s bound to cNLS peptides have revealed two NLS-binding sites consisting of 
ARM repeats 2-4 (major NLS-binding site) and 7-9 (minor NLS-binding site) (Fontes et 
al., 2000; Conti et al., 1998; Conti et al., 2000; Fontes et al., 2003), SMAP-10 includes 
only the minor NLS-binding site (ARM repeats 7-9). While, it is difficult to extrapolate 
the crosslinking data to function of the interaction, our results suggest that the IBB and 
the major NLS-binding site are dispensable for interaction with the SM sequence and 
seem to be consistent with the observations of other groups that the carboxyl terminus of 
importin α (in isolation) can mediate nuclear import of Human Immunodeficiency Virus 
Type 1 Vpr (Kamata et al., 2005).  
The second requirement is the ability of importin α to penetrate the NPC without 
importin β. It has been reported that the carboxyl terminus of importin α, which partially 
or completely includes the region between residues 360-495, binds several nucleoporins 
such as Nup1p (Belanger et al., 1994), Nup2p (Belanger et al., 1994; Solsbacher et al., 
2000), Npap60/Nup50 (Lindsay et al., 2002), and Nup153 (Moroianu et al., 1997), 
which are FG repeat nucleoporins. While, the homology between SMAP-10 and other 
importin α isoforms is much lower in the region between residues 360-495 compared to 
the N-terminus (Fig. 51), we speculate that SMAP-10 could potentially facilitate the 
passage of the cargo(E66SM)-importin α complex via the lateral channels of the NPC 
via interactions with nucleoporins.  
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Currently, the  recycling mechanism of the membrane-bound importin α remains 
unclear, however since SMAP-10 includes the CAS (exportin) binding site it is possible 
that CAS/RanGTP may potentially be involved in cargo dissociation and recycling.  
From these results, it seems reasonable to conclude that SMAP-10 satisfies the 
requirements for being classified as a nuclear transporter. However, a number of issues 
remain unresolved. For instance, how does importin α associate with membranes? 
Secondly, since our results suggest that the membrane-bound importin α may be 
involved in the cotranslational sorting of E66SM to the INM, what, then, is the key 
structural or sequence determinant of the SM that is recognized by importin α?  
The localization of importin α to either the membrane or cytosolic fractions has been 
found to be linked to post-translational modification of the protein. The soluble form of 
importin α present in the cytosolic fraction is more highly phosphorylated than the 
membrane-bound form (Hachet et al., 2004). An alternate mechanism would involve the 
presence of either a TMS, an amphipathic helix, or a hydrophobic domain that allows 
stable and/or reversible membrane association of importin α. Indeed, when the Sf9 
importin α sequence identified in this study was analysed using a number of TMS 
prediction programmes, two separate stretches of amino acid residues were found to be 
sufficiently hydrophobic to constitute a TMS. One such stretch (residues 304-325 of the 
putative Sf9 importin α) exists right at the N-terminus of  SMAP-10 which may be one 
possible explanation for its ability to associate with ER microsomes. An alternate 
explanation could be via the predicted amphipathic helix within SMAP-10 ( shaded gray 
in Fig.43).  
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The nuclear import signals for soluble proteins generally are basic and often part of 
DNA- or RNA- binding sites (Kalderon et al., 1984; Makkerh et al., 1996). Indeed, the 
INM sorting motif (SM) consists of 18 hydrophobic amino acids that form a TMS with 
positively charged amino acids that are located four to eight residues from the TMS on 
the nucleoplasmic or cytoplasmic face of the membrane (Braunagel et al., 2004). In 
addition, deletion of the lysine residues or any changes in the spacing of the lysine 
residues from the TMS within the SM results in dramatic changes in the efficiency of 
protein accumulation at the INM, suggesting that the lysine residues in the SM are at or 
near a functionally important site that influences protein trafficking to the INM. Based 
on these observations, we speculate that analogous to cargo recognition by soluble 
importin α, substrate binding of SMAP-10 (membrane-bound form of importin α) is 
mediated by basic residues.  
Does the association of SM sequence with SMAP-10 imply sorting? The sample size 
is still too small to provide a clear answer to this question, but there are some interesting 
clues in the results presented here. First, as we have shown elsewhere, the SM sequence 
is sufficient to direct reporter proteins (such as GFP, beta-galactosidase etc.) to the INM 
en-route to the viral envelope (Hong et al., 1997), indicating that the SM sequence 
contains the structural features that constitute an INM sorting signal and recognition of 
this sequence would require a direct interaction between the SM sequence and a protein 
involved in sorting. In addition, well-characterized cellular INM proteins have a SM-like 
sequence (Braunagel et al., 2004) implying that the sorting process of the viral SM 
closely resembles the sorting of other INM proteins. Thus, the association of SMAP-10 
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with the INM sorting signal most likely reflects a sorting event shared by other INM 
proteins. Second, although Lep1 contains lysines in the approximately the same 
positions as E66SM, the fact that Lep1 shows no crosslinking to SMAP-10 indicates 
substrate specificity and thus sorting (Fig. 37B & 47B).  
Just as transcription, splicing, translation, and protein degradation are carried out by 
core machinery subjected to the action of regulatory factors, the sorting of proteins at the 
ER membrane is likely to be regulated similarly. Given that the ‘space’ around the 
nascent chain during translocation/integration at the ER membrane is limited, it is likely 
that the translocon is dynamic providing the nascent chain access to appropriate enzymes 
and/or sorting factors. How might such events be regulated? In order to specialize the 
translocon for particular substrates, it is possible that topogenic sequences within the 
nascent chain are recognized by the translocation machinery to initiate dynamic changes 
in the translocon. Several experimental results support the existence of such long-range 
signal transduction pathways, where topogenic sequences within the ribosomal tunnel 
are able to initiate changes in the translocon structure and dynamics (Liao et al., 1997; 
Hamman et al., 1998; Woolhead et al., 2004). We have already demonstrated that the 
translocon seems to discriminate between INM and other membrane proteins while they 
are nascent chains (chapter III in this study), and thus the identification of a membrane-
bound form of importin α that is translocon associated (Fig. 47A), and proximal to the 
INM sorting signal within E66 (Fig. 36B & 38), suggests that the recruitment of 
importin α at the translocon may represent translocon dynamics in response to the 
nascent chain (substrate).  
 
 159
CHAPTER V 
SUMMARY 
A number of studies have shown that translocon proteins play an active role in the 
lipid partitioning of TMSs (Do et al., 1996; Heinrich et al., 2000; McCormick et al., 
2003). Since the TMS of E66 contains the signal for INM localization (Hong et al., 
1997), the first part of the study focused on examining the role of the translocon in the 
sorting of proteins destined for the INM (chapter III). A photocrosslinking approach 
based on the cotranslational incorporation of a photoreactive probe into the nascent 
substrate of interest (Johnson et al., 1976) was used to examine the role of the translocon 
in membrane protein sorting. Several important conclusions can be drawn from the 
results presented. First, the asymmetric photocrosslinking to TRAM and to Sec61α of 
each TMS examined in this study reveals that each is bound to a protein(s) within the 
mammalian translocon (cf. McCormick et al., 2003). Second, the proteinaceous 
environment within the translocon is very similar for both cellular and viral INM TMSs. 
Third, the proteinaceous environment within the translocon differs markedly for INM 
TMSs and for TMSs directed elsewhere. Fourth, an integrated viral SM sequence is 
crosslinked to two viral proteins after being released from the translocon in ER 
microsomes purified from infected insect cells. Fifth, this study confirms the widely-held 
presumption that some INM-directed proteins are targeted to the ER membrane by SRP 
and integrated cotranslationally at the translocon. Other INM proteins may be inserted 
post-translationally as C-tail-anchored proteins (Wattenberg et al., 2001). Taken 
together, these results strongly suggest that some membrane protein sorting to the INM 
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is initiated within the translocon early in the integration process, is protein-mediated, and 
involves substrate recognition by and interaction with a sequence of proteins that 
function as sorting factors to facilitate the movement of proteins to the INM. 
The striking similarity in the photocrosslinking pattern observed for viral (E66 & 
E25) and cellular INM TMSs (LBR1 & Nur1), suggests that INM-directed TMSs occupy 
the same binding site within the translocon. The difference in the photocrosslinking 
pattern observed for non-INM TMSs (Lep1 & TfR) suggests that the proteinaceous 
environment of non-INM TMSs within the translocon is clearly different from that of 
INM-directed TMSs. Thus, our results suggest a model in which once a TMS arrives in 
the translocon pore, the translocon is able to ‘sense’ (by an as yet undefined mechanism) 
whether it has been engaged with a ribosome synthesizing an INM substrate or a non-
INM substrate (Fig. 52). Following this ‘sensing’ event, the translocon appears to 
participate in membrane protein sorting by moving TMSs of an INM protein to a binding 
site (formed by transmembrane helices of translocon proteins) different from the site 
occupied by TMSs of proteins destined for other cellular membranes. The model thus 
suggests that all TMSs do not occupy the same binding site within the translocon during 
membrane integration, and proposes an active role for the translocon in cotranslational 
protein sorting.  
What may regulate the movement of INM-directed TMSs to a binding site within the 
translocon that is not occupied by other TMSs? It is possible that the INM-binding site 
within the translocon is associated with sorting factors that function downstream (and 
possibly posttranslationally) in the sorting of proteins to the INM.  This idea is  
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Figure 52. Cotranslational sorting of INM-directed TMSs at the ER translocon. 
Although there is a controversy in the field regarding the oligomeric state of the active translocon, for 
simplicity it is depicted as a tetramer in this schematic. The translocon pore is shown surrounded by 
translocon proteins with interspersed phospholipids(PLs). The translocon proteins are surrounded by the 
phospholipids in the membrane of the ER (depicted in gray). Once engaged with a ribosome, the 
translocon is able to ‘sense’ whether the TMS in the pore represents an INM protein or a protein of 
another cellular membrane. Following this initial ‘sensing’ event, the translocon responds by moving 
INM-directed TMSs (depicted in red) to a binding site which is different from the binding site occupied by 
other membrane proteins (non-INM proteins; depicted in blue).    
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clearly supported by the identification of viral proteins FP25K and E26 that associate 
with the E66SM posttranslationally, but do not associate with the non-INM protein, 
Lep1 (Fig. 53).  
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Figure 53. Posttranslational sorting of INM-directed TMSs. Although there is a 
controversy in the field regarding the oligomeric state of the active translocon, for simplicity it is depicted 
as a tetramer in this schematic. The translocon pore is shown surrounded by translocon proteins with 
interspersed phospholipids(PLs). The translocon proteins are surrounded by the phospholipids in the 
membrane of the ER (depicted in gray). The viral proteins FP25K (indicated by the green asterix) and E26 
(indicated by the yellow triangle) are shown to be proximal to the INM-binding site. This proximity allows 
for substrate-specific, posttranslational sorting of proteins to the INM.  
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The identification of viral proteins that associate with the E66SM prompted the 
second part of this study to focus on the proteinaceous environment of the E66 SM 
sequence in ER microsomes purified from insect Sf9 cells to identify accessory proteins 
involved in the sorting of E66 to the INM. Five major conclusions can be drawn from 
the results presented. First, a membrane-bound Sf9 importin α isoform (SMAP-10) that 
associates with the SM sequence before and after it leaves the translocon has been 
identified. Second, transcription is initiated at atleast three internal sites within the Sf9 
importin α gene resulting in three different isoforms. One of the isoform obtained via 
internal initiation is SMAP-10. Third, SMAP-10 shares epitopes with viral E26, which 
was perviously shown to associate with the E66 SM (Braunagel et al., 2004). Fourth, 
SMAP-10 is a translocon-associated protein, which is selective in substrate association, 
indicating that it may potentially be involved in membrane protein sorting to the INM.  
Fifth, crosslinks to SMAP-10 are seen in ER microsomes purified from insect and 
mammalian cells, suggesting that this protein is found in divergent species.  Finally, the 
results of this study and previous work (Braunagel et al., 2004) suggest that the sorting 
of INM proteins at the ER membrane is a protein-mediated, multistep process in which 
the INM sorting signal sequentially associates with various sorting factors. 
The identification of a translocon-associated sorting factor (SMAP-10) that 
associates with the E66SM co- and post-translationally allows us to further refine the 
model presented in Fig. 52. The crosslinking data (Fig. 47A) suggests that SMAP-10 
associates with the translocon protein Sec61α, yet it provides no clues regarding its 
binding site. However, based on the substrate specificity exhibited by SMAP-10 (Fig. 
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47B) it seems reasonable to conclude that SMAP-10 associates with the translocon at a 
site proximal to the binding site for INM-directed TMSs. This arrangement would 
explain the ability of SMAP-10 to associate with the E66SM before it is released from 
the translocon.  
How is the translocon association of SMAP-10 regulated? Is it recruited at the 
translocon in response to translocon-mediated ‘sensing’ of an INM substrate (Fig. 54) or 
is it associated with an empty translocon at a site that attracts/pulls and thus determines 
the binding site for INM-directed TMSs (Fig. 55)? Indeed, while both of these 
possibilities are likely, it is difficult to discern in our crosslinking experiments, which 
one is a more accurate depiction of the in vivo situation.  
The ability of SMAP-10 to associate with the E66SM posttranslationally raises a 
number of interesting issues. What induces the dissociation of the complex at the INM? 
After dissociation, how does free SMAP-10 recycle to its binding site at the ER 
translocon? How is the membrane association of SMAP-10 regulated? A TMS and an 
amphipathic helix are predicted within the SMAP-10 sequence (Fig. 43). However, since 
we conclude that SMAP-10 is an isoform of Sf9 importin α, it remains to be tested 
whether the membrane association of SMAP-10 can be regulated via posttranslational 
modification of the protein (eg. phosphorylation).  
Although this study demonstrates that SMAP-10 associates with the INM-directed 
viral protein (E66), it remains to be determined whether SMAP-10 participates in the 
sorting of cellular proteins (LBR, nurim etc.) to the INM. Further, since cellular proteins 
of the INM including LBR and nurim are multispanning proteins, it will be  
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Figure 54. SMAP-10 recruitment at the translocon. The translocon pore is shown 
surrounded by translocon proteins (tetramer) with interspersed phospholipids(PLs). The translocon 
proteins are surrounded by the phospholipids in the membrane of the ER (depicted in gray). Translocon-
mediated ‘sensing’ of an INM-directed TMS initiates recruitment of SMAP-10 (indicated by the yellow 
triangle) at the translocon. SMAP-10 associates with the translocon at a site proximal to the binding site 
for INM-directed TMSs (depicted in red). This arrangement allows for substrate-specific, cotranslational 
association of INM-directed TMSs with SMAP-10.  
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Phospholipids (PL)
 
 
Figure 55. Translocon-bound SMAP-10 determines the binding site for INM-
directed TMSs . The translocon pore is shown surrounded by translocon proteins (tetramer) with 
interspersed phospholipids(PLs). The translocon proteins are surrounded by the phospholipids in the 
membrane of the ER (depicted in gray). A ribosome-free translocon contains bound SMAP-10 (depicted 
by the yellow triangle). INM-directed TMSs (depicted in red) that arrives in the translocon pore are 
shunted/pulled towards the SMAP-10-binding site within the translocon. In contrast, non-INM TMSs 
(depicted in blue) move to a site that is not adjacent to the SMAP-10-binding site.  
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interesting to determine whether SMAP-10 associates with all the TMSs of these 
proteins or with the TMSs that are critical for INM localization?  
Clearly, the identification of SMAP-10 has set the stage for some exciting research 
in the field of protein sorting to the INM. It will be interesting to see the results of 
studies focused on the identity of SMAP-25 and studies focused on the identification of 
other proteins that facilitate protein trafficking to the INM.  
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